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RONALD M. BURCH. Studies on the Interactions Between Arachidonic Acid 
Metabolism and Calcium in Regulating Vasopressin-Induced Water 
Permeability in the Toad Urinary Bladder. (Under the direction of 
PERRY V. HALUSHKA). • 
The toad urinary bladder and epithelial cells isolated from it 
were found to synthesize prostaglandin E (PGE) and thromboxane A2 
(TXA2). The syntheses of both of these compounds were found to be 
stimulated by arginine-vasopressin and by its non-pressor antidiuretic 
analog I-deamino-8-D-arginine-vasopressin. cAMP, a putative second 
messenger for vasopressin in the toad bladder, when added to the 
incubation media, did not affect TXA2 synthesis. However, in the 
isolated cells both TXA2 and PGE syntheses were found to be stimu-
lated by calcium. 
In studies using the isolated toad bladder, inhibition of TXA2 
• 
synthesis with imidazole (1 roM) and 7-(1-imidazolyl)-heptanoic acid 
(50-100 ~M) was found to inhibit vasopressin-stimulated water flow 
to a maximum of 30%. Similarly, an antagonist of TXA2 action, trans-
13-azaprostanoic acid (50-300 ~M) inhibited vasopressin-stimulated 
water flow in a dose-dependent fashion to a maximum of 35%, while 
the biologically inactive cis isomer was without effect. 
Several compounds which exhibit TXA2-like effects 1n other sys-
tems, (15Z)-hydroxy-9a,11a-(epoxymethano)prosta-5Z,13E dienoic acid 
(U44069), its 9a,11a-(methanoepoxy) isomer (U46619), and TXB
2
, mim-
icked the hydroosmotic effect of vasopressin. This action was 
inhibited in a dose-dependent fashion by trans-13-azaprostanoic acid 
while cis-13-azaprostanoic acid was without effect. 
Vasopressin was found to elicit an enhancement in 45Ca efflux 
from prelabelled toad bladder epithelial cells. Compartmental anal-
ysis of 45Ca efflux from prelabelled cells revealed three components. 
Studies using EGTA, lanthanum, and mitochondrial inhibitors suggested 
that the first component of efflux (Sl) represented 45Ca bound to 
heterogenous sites on the extracellular surface of the plasma membrane, 
the second component (S2) represented 4SCa bound to some intracellular 
site(s), and the third component (S3) was composed of two sites, a 
slowly exhanging site near the plasma membrane, and mitochondria. 
Vasopressin reduced the sizes of calcium pools 81 and S3. Exo-
genous cAMP also reduced the size of 53' but increased the size of 
82" The TXA2 mimetic, U46619, acted similarly to cAMP; it decreased 
the size of pool 8
3 
and increased the size of pool S2' The TXA2 
synthesis inhibitor 7-(1-imidazolyl)-heptanoic acid blocked the effect 
of vasopressin to reduce the size of S3" The TXA2 antagonist trans-13-
azaprostanoic acid, in concentrations not lethal to the isolated 
cells, inhibited vasopressin-stimulated water flow only slightly 
(17%) and did not significantly alter vasopressin's effects on 4SCa 
kinetics. However, trans-13-azaprostanoic acid significantly blocked 
the effect of U46619 to decrease the size of S3' 
Exogenous PGE 1, 1 ~M, a concentration which completely inhibits 
vasopressin-stimulated water flow, enhanced both the efflux and influx 
of 45Ca. However, net cellular 45Ca was increased. The increased 
4SCa was located entirely in pool S3" 
These results are consistent with a hypothesis wherein vasopressin 
causes a net release of calcium from an intracellular storage site, 
perhaps mitochondria. PGE and TXA2 syntheses are stimulated, perhaps 
by the altered calcium fluxes. TXA2 , like vasopressin, reduces the 
size of a putative mitochondrial calcium compartment, and inhibition 
of TXA2 synthesis, or antagonism of TXA2 action, inhibits vasopressin-
stimulated water flow. PGE enhances 45Ca uptake into the epithelial 
cells and increases the size of pool S3' resulting in inhibition of 
vasopressin-stimulated water flow. 
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The molecular mechanism of vasopressints antidiuretic action is 
unclear. This is due, in part, to the difficulty in obtaining suffi-
cient quantities of pure vasopressin-sensitive tissue from the struc-
turally complex kidney. The toad urinary bladder has been extensively 
used as an alternative model for the study of vasopressin-mediated 
alterations in water permeability for a number of reasons: 1) it is 
responsive to vasopressin, water permeability being enhanced up to 
laO-fold, 2) the tissue is large, several square centimeters, and 
easy to isolate, 3) the whole bladder, or epithelial cells derived 
from it, remain viable for many hours in vitro, 4) it is composed of 
a single layer of epithelial cells which is supported by only a thin 
layer of connective tissue, and, most important, 5) it appears that 
where studied, the biochemical and physiological responses to vaso-
pressin in the toad bladder are similar to those which occur in the 
mammalian collecting tubule. 
Vasopressins and oxytocins of anuran or mammalian orlgln act to 
increase water permeability across the toad bladder (Bentley, 1966). 
Permeability to urea is also enhanced by vasopressin (Haffly, et 
al., 1960). The toad urinary bladder actively transports sodium and 
this transport is also enhanced by vasopressin (Leaf, et al., 1958). 
While the stimulation of water, urea, and sodium transport are similar 
in many respects, they are independent and can be dissociated by 
means of a number of chemical modifications of the membrane and by 
drugs (Andreoli and Schafer, 1976). Vasopressin is active only when 
3 
placed on the serosal surface of the bladder (Bentley, 1958). How-
ever, all available evidence points to the mucosal surface as the 
permeability barrier to water, urea, and sodium (Andreoli and Schafer, 
1976). Thus, an information transfer system must exist to enable 
vasopressin to influence the permeability of the opposite surface of 
the cell. Several candidate mediators have been suggested and this 
dissertation presents data gathered concerning two of these putative 
mediators, thromboxane A2 and calcium. 
Vasopressin and cyclic adenosine 3'-S'-monophosphate (cAMP) 1n the 
toad bladder 
Vasopressin enhances the cellular accumulation of cAMP in toad 
bladder epithelial cells (Handler et al., 1965) and enhances the 
activity of adenylate cyclase in broken epithelial cell preparations 
from toad bladder (Bar et al., 1970). Further, exogenous cAMP and 
theophylline, a cyclic nucleotide phosphodiesterase inhibitor, mimic 
the actions of vasopressin on water, urea, and sodium transport 
(Orloff and Handler, 1962). Together, these data provide evidence 
that cAMP plays a role in the mediation of the response to vasopressin. 
However, investigations into the molecular mechanism of action of 
cAMP in the toad bladder have met only very limited success to date 
(Strewler and Orloff, 1977). Greengard and associates (DeLorenzo et 
al., 1973; Greengard, 1976) have identified a protein which is dephos-
phorylated in response to vasopressin or cAMP. The dephosphorylation 
appears to be correlated to the rate of sodium transport and not to 
alterations in water permeability (Walton et al., 1975). The iden-
tity of this protein remains unknown as does its significance to 
transport. 
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Vasopressin and calcium in the toad bladder 
While calcium has for some time been implicated in the mediation 
of vasopressin's actions, studies of its role are hampered because, 
in addition to possibly serving as a second messenger, calcium plays 
a role in maintaining the structural integrity of the tight junctions 
between the epithelial cells. If calcium is removed from the bathing 
medium, the tight junctions become permeable, allowing enhanced water 
permeability unrelated to vasopressin's effect (Hays et al., 1965). 
Further, calcium is necessary for the transduction of information 
from the vasopressin receptor to the adenylate cyclase. Absence of 
calcium or high calcium concentrations inhibit vasopressin receptor-
mediated stimulation of adenylate cyclase activity (Bockaert et al., 
1972; Hynie and Sharp, 1971). However, calcium has no effect on the 
binding of vasopressin to its receptor (Roy et al., 1973). 
High concentrations of calcium in the serosal bathing medium 
inhibit vasopressin-stimulated water flow without affecting vaso-
pressin-stimulated sodium transport (Petersen and Edelman, 1964; 
Argy e~ al., 1967). Similarly, other divalent and trivalent cations, 
added serosally, inhibit vasopressin-stimulated water flow (Bentley, 
1959; Weitzerbin et al., 1974). The effects of exogenous cAMP are 
not altered by high serosal calcium (Argy et al., 1967). These data 
led to the hypothesis that vasopressin stimulates cAMP formation at 
two sites, one calcium-sensitive and responsible for enhanced water 
permeability, and the other insensitive to calcium and responsible 
for sodium transport (Petersen and Edelman, 1964). 
A second hypothesis concerning the role of calcium in vaso-
pressi.n's actions considers calcium to be not only a coupling factor, 
but incorporates it as a second messenger for vasopressin (Berridge, 
1975). Thorn and Schwartz (1965) showed that the efflux of 45Ca 
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from prelabelled bladders increased after the addition of vasopressin. 
Snart and Dalton (1972) found only a single activation energy for 
the stimulation of cAMP synthesis by vasopressin and suggested that 
the dual adenylate cyclase hypothesis might be better replaced by a 
hypothesis in which vasopressin directly elicits a release of membrane 
calcium which leads to enhanced water permeability. Cuthbert and 
Wong (1974) confirmed the findings of Thorn and Schwartz and further 
reported that the enhancement of efflux occurs only from the mucosal 
surface of the bladder. They considered the release to be from the 
plasma membrane since hemibladders labelled on only the serosal side 
with 45Ca exhibited no enhancement of efflux from the mucosal side 
upon the addition of vasopressin. This observation was also made by 
Walser (1970). Exogenous cAMP did not mimic vasopressin, causing 
instead an inhibition of efflux from the side to which it was added. 
Interestingly, phospholipase C incubation on the serosal surface 
inhibited vasopressin-stimulated water flow and vasopressin-stimulated 
45Ca efflux (Cuthbert et al., 1971; Cuthbert and Wong, 1973), but 
did not inhibit the accumulation of cAMP in response to vasopressin. 
Recent unconfirmed work of Hardy (1978) demonstrates that alter-
ations in calcium flux alone can mimic the water permeability response 
to vasopressin~ In bladders pretreated with the divalent cation 
ionophore A23187 and then exposed to an increased serosal calcium 
concentration, a water flow response was generated which was compar-
able to that elicited by vasopressin. Lowering the serosal calcium 
concentration during the water flow response to vasopressin or A23187 
inhibited the response. Further, the effects of a submaximal concen-
tration of vasopressin on water flow were enhanced when the ionophore 
was added together with vasopressin. These results suggest that 
vasopressin may stimulate calcium uptake. This hypothesis is suppor-
ted by the observations of Humes et ale (1980), who found that vera-
pamil, an organic calcium uptake inhibitor, inhibited vasopressin-
stimulated water flow across the toad bladder in a dose-dependent 
manner. 
In contrast to the studies cited above, a number of indirect 
studies have suggested that vasopressin causes a decrease in the 
concentration of cytoplasmic ionized calcium. When toad bladders 
6 
were pretreated with A23187 a slight enhancement in basal water flow 
was observed (Taylor et al., 1979). However, A23187 inhibited the 
enhancement in water flow elicited by vasopressin (Taylor et a1., 
1979). This effect was observed over a wide range of serosal calcium 
concentrations, and, when A23187 was added to the mucosal bathing 
medium, a nominally calcium-free solution in these experiments, a 
similar inhibition of vasopressin-stimulated water flow was observed 
(Taylor et a1., 1979). These observations suggest that A23187 acted 
to release calcium from intracellular binding sites to increase cyto-
plasmic ionized calcium. However, Humes and Weinberg (1980) observed 
that A23187 inhibited respiration in isolated toad bladder epithelial 
cells and reduced viability as assessed by trypan blue exclusion. 
Thus, A23187 may have inhibited vasopressin-stimulated water perme-
ability by a mechanism separate from any effect on calcium metabolism. 
Taylor et a1. (1979), on the assumption that lowered serosal 
sodium concentration would enhance calcium uptake into the isolated 
7 
toad bladder, an assumption confirmed by Grinstein and Erlij (1978) 
in frog skin, assessed the effects of lowered serosal sodium concen-
tration on vasopressin-stimulated water flow. They found that as 
sodium concentration was progressively lowered, vasopressin-stimulated 
water flow was increasingly inhibited. This effect was dependent 
upon serosal calcium concentration, suggesting that lowered serosal 
sodium concentration may inhibit calcium efflux by some sort of sodium-
calcium exchange process (Taylor et al., 1979). In fact, Chase and 
Al-Awqati (1981) have found a sodium-dependent calcium pump in serosal 
plasma membrane vesicles isolated from the toad bladder. These results 
suggest that a low intracellular calcium concentration is required 
for vasopressin to exert its antidiuretic action. 
Studies have been carried out using Ringer's solutions without 
added potassium to inhibit the sodium pump (Taylor et al., 1979; 
Finn et al., 1966). Lack of potassium was found to inhibit vaso-
pressin-stimulated water flow, presumably by inhibition of the sodium 
pump to increase intracellular sodium concentration, which would in 
turn increase intracellular calcium concentration by means of a sodium-
calcium exchanger pumping the excess sodium out of the cell. As 
with the experiments with lowered extracellular sodium concentration, 
the effect of lowered extracellular potassium on water flow was 
calcium-dependent (Taylor et al., 1979). However, the mechanism of 
inhibition of vasopressin-stimulated water flow by lack of potassium 
may not be so readily explained. Ouabain, which also inhibits the 
sodium pump, does not appear t.o affect vasopressin-stimulated water 
flow (Davis et al., 1978) across the toad bladder, although one study 
did report an inhibition by ouabain (Finn et al., 1966). Of course 
potassium removal would also result in a more negative membrane 
potential, which would also increase the activity of the sodium-
calcium exchanger. 
Several other agents including acetylcholine and several of its 
analogs, seem to act in many tissues to increase cytoplasmic ionized 
calcium. These agents also inhibit vasopressin-stimulated water 
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flow in the toad bladder (Wiesmann et a1., 1978; Arruda and Sabatini, 
1980b). All enhance 4SCa uptake into isolated toad bladder epithelial 
cells (Wiesmann et al., 1978; Arruda and Sabatini, 1980b). Further, 
these agents do not block vasopressin-stimulated water flow when the 
extracellular calcium concentration is lowered, or in the presence 
of low concentrations of lanthanum ion or pentobarbital, agents which 
block the enhanced uptake of 45Ca in response to these agents (Wiesmann 
et al., 1978; Arruda and Sabatini, 1980b). 
Ramwell and Shaw (1970) noted that PGE
1 
or high serosal calcium 
concentration inhibited vasopressin-stimulated water flow, while 
PGE
1 
or low serosal calcium concentration enhanced sodium transport 
in frog skin and toad bladder. They preloaded frog skin with 4SCa 
and added PGE
1 
at the beginning of desaturation. PGE 1 was found to 
enhance 45Ca efflux from the skins, leading to the suggestion that 
PGE 1 may exert its effects on transport by modifying calcium metabo-
lism. Cuthbert and Wong (1974) confirmed that PGE 1 enhances efflux 
of 4SCa from prelabelled bladders, but the experimental protocol 
used by each group precluded determination of whether the enhanced 
efflux was due to net extrusion of calcium from the epithelium or 
enhanced exchange due to increased membrane fluxes. 
In summary, calcium appears to playa second messenger role in 
the antidiuretic action of vasopressin in the toad bladder. While 
data are limited, it seems clear that vasopressin mobilizes calcium 
from some unknown site. Whether increased 45Ca efflux noted in 
several studies represents net calcium extrusion or enhanced exchange 
rate is unknown. The results with A23187 and verapamil suggest that 
calcium uptake may also playa role in the action of vasopressin. 
However, no studies have examined 4SCa uptake into the toad bladder 
in response to vasopressin. 
Metabolism of arachidonic acid in the isolated toad bladder 
9 
Arachidonic acid, the precursor for both prostaglandins and 
thromboxanes of the 2 series, is stored primarily in membrane phos-
pholipids (Hong and Levine, 1976). The rate-limiting step in the 
synthesis of prostaglandins and thromboxanes is the catalysis by 
phospholipases of the release of arachidonic acid from its membrane 
storage sites (Kunze and Vogt, 1971) (Fig. 1). Arachidonate is metabo-
lized by fatty acid cyclooxygenase (prostaglandin synthetase) to 
produce the labile endoperoxides, prostaglandin G
2 
(PGG2) and PGH2 
(Samuelsson et al., 1978). These endoperoxide intermediates serve a 
pivotal role since all prostaglandins and thromboxanes are synthesized 
from them. The toad urinary bladder synthesizes PGE
2 
(Zusman et 
al., 1977) and thromboxane A2 (TXA2) (this dissertation). The synthesis 
of PGE2 is catalyzed by prostaglandin endoperoxide E isomerase, while 
the synthesis of TXA2 is catalyzed by an as yet poorly characterized 
enzyme, thromboxane synthetase. TXA2 is the biologically active 
































Figure 1. Pathways of arachidonic acid metabolism in the toad urinary bladder. 
...... 
o 
37 sec, undergoing spontaneous hydrolysis to the stable, much less 
active TXB
2 
(Hamberg et a1., 1975). 





based on radioimmunoassay data. However, 
in thin-layer chromatogram scans of [ 14C]-arachidonate metabolites 
from intact hemibladders and from bladder homogenates, other peaks 
were observed (Zusman et al., 1977; this dissertation). Thus, the 
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question of whether the toad bladder synthesizes other prostaglandins 
remains open. 
Role of arachidonate metabolites in vasopressin's actions 
Exogenous PGE
1 
and other prostaglandins (Urakabe et al., 1975) 
have two effects in the isolated toad urinary bladder, inhibition of 
vasopressin-stimulated water flow (Orloff et al., 1965) and stimula-
tion of sodium transport (Lipson and Sharp, 1971). PGE
1 
also inhibits 
theophylline-stimulated water flow, but not cAMP-stimulated water 
flow, suggesting an inhibitory effect on an adenylate cyclase pool 
affecting water permeability (Orloff et al., 1965). Zusman et ale 
(1977) found that vasopressin stimulates PGE synthesis in the toad 
bladder by activating a phospholipase A
2
. However, an earlier study 
(Wong et al., 1972) and a recent study (Bisordi et al., 1980) found 
no stimulation of PGE biosynthesis by vasopressin. These differing 
findings will be discussed in detail in Chapter II. 
Inhibition of PGE biosynthesis by cyclooxygenase inhibitors or 
phospholipase inhibitors results in enhanced vasopressin-stimulated 
water flow (Zusman et al., 1977). Further, addition of arachidonic 
acid causes inhibition of vasopressin-stimulated water flow while 
addition of arachidonic acid plus cyclooxygenase inhibitors is without 
12 
effect (Zusman et al., 1977). Neither theophylline nor exogenous 
cAMP enhance PGE biosynthesis (Zusman et al., 1977). Thus, it appears 




inhibits the cellular accumulation of cAMP in 
response to vasopressin (Omachi et al., 1974) although this observa-
tion has not been confirmed in other laboratories (Lipson et al., 
1971; Wong et al., 1972). This observation supports the widespread 
hypothesis that PGE
1 
inhibits vasopressin-sensitive adenylate cyclase 
(Orloff et al., 1965; Lipson and Sharp, 1971). However, several 
laboratories have reported that PGE
1 
has no effect on vasopressin-
sensitive adenylate cyclase activity in broken cell preparations 
(Bar et al., 1970). These data suggest that PGE
1 
inhibits vaso-
pressin-stimulated cAMP accumulation by an indirect mechanism. 
Similar findings have been reported for the effects of PGE 1 on 
hormone-sensitive adenylate cycla~es in adipocytes (Ramwell and Shaw, 
1970). 
Prostaglandins, thromboxanes, and calcium 
Prostaglandins and thromboxanes have been suggested to exert 
their actions through calcium-dependent mechanisms in a variety of 
tissues (Rubin and Laychock, 1978). That calcium and prostaglandin 
metabolism are related is undoubted, since many of the phospholipases 
which catalyze the rate-limiting step in prostaglandin and thromboxane 
synthesis require calcium for activity (Kunze and Vogt, 1971), and 
the increased prostaglandin synthesis observed in response to many 
peptide hormones is dependent on increased phospholipase activity 
(Zusman and Keiser, 1977). Further, the divalent cation ionophore 
A23187 mimics phospholipase activation in a number of tissues and is 
associated with increased prostaglandin and thromboxane synthesis 
(Oelz et al., 1978). 
PGE
1 
has been reported to be a "calcium ionophore ft based on its 
ability to stimulate calcium uptake into isolated rat mitochondria 
(Kirkland and Baum, 1972). Since the publication of that report 
13 
many studies have been undertaken in attempts to implicate prostaglan-





and its stable analogs U46619 and U44069, 
compare favorably with A23187 in extracting calcium into organic 
solvents under limited conditions (Gerrard and White, 1978; Reed and 
Knapp, 1978). When tested in a mitochondrial system, A23187, PGG
2
, 
and U44069 all stimulated uncoupled oxidation of succinate which was 
+ 
inhibited by ruthenium red, 1a 3 , or EGTA (Reed and Knapp, 1978). 
Further, a number of prostaglandins were found to release calcium 
from isolated mitochondria (Malmstrom and Carafoli, 1975; McNamara 
et al., 1980). In guinea pig myometrium PGE
1 
was found to depolarize 
the plasma membrane, leading to enhanced Ca 2+ influx (Clegg et al., 
1966). In contrast, no natural prostaglandins nor U46619 were able 
to transport calcium into phosphatidylcholine vesicles while A23187 
was readily able to do so (Weissmann et al., 1980). 
In direct studies of calcium binding to membrane preparations, 
several prostaglandins have been reported to inhibit calcium binding 
to a fraction of uterine smooth muscle ascribed to the sarcoplasmic 
reticulum (Carsten and Miller, 1977). In addition, in an intact 
smooth muscle preparation, PGE
1 
has been shown to inhibit calcium 
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binding to a high affinity site presumed to be intracellular in loca-
tion (Wheeler and Weis, 1980). 
Thus, it is not certain whether prostaglandins and thromboxanes 
exert their effects on Ca 2 + by means of a direct ionophoretic action 
or by a receptor-mediated event. These data tend to support a hypoth-
esis wherein the actions of TXA2 and prostaglandins are mediated via 
interactions with receptors. While no receptor has yet been reported 
for TXA
2
, receptors have been characterized for a number of prosta-
glandins (Hammarstrom et al., 1975; Morrell, 1976; Schafer et a1., 
1979). The availability of receptor level antagonists such as trans-
13-azaprostanoic acid and 9,11-epoxyimino-prostanoic acid, TXA2 antag-
onists (LeBreton et al., 1979; Fitzpatrick et al., 1978), and 7-oxa-
13-prostanoic acid, a PGE antagonist (Fried et al., 1969) provide 
useful tools to test which of the possibilities is more tenable. It 
will be important to determine whether the TXA2 and prostaglandin 
antagonists block the TXA
2
- and prostaglandin-mediated calcium move-
ments as well as the physiological responses to the prostaglandins. 
Statement of Specific Aims 
The objective of this study was to further examine the inter-
actions between calcium and arachidonate metabolites in regulating 
the enhancement in permeability to water of the toad urinary bladder 
by vasopressin. This dissertation considers the following specific 
aims: 
1. To determine the effects of vasopressin and its putative 
second messenger calcium on the synthesis of TXA2 in the 
isolated toad urinary bladder and in suspensions of iso-
lated toad urinary bladder epithelial cells. 
2. To determine the effects of vasopressin on 4SCa non-steady 
state influx and efflux, and on 45Ca steady state compart-
mental analysis in suspensions of isolated toad urinary 
bladder epithelial cells. 
3. To determine the effects of the TXA
2
-1ike compound, 
U46619, the effects of the TXA2 synthesis inhibitor, 
7-(1-imidazolyl)-heptanoic acid, and the effects of 
the TXA2 antagonist, trans-13-azaprostanoic acid, on 
45Ca non-steady state influx and efflux, and on 45Ca 
steady state compartmental analysis in suspensions of 
isolated toad urinary bladder epithelial cells. 
4. To determine the role of extracellular and intracellular 
calcium in the antidiuretic response to vasopressin and 
TXA
2
-1ike compounds in the toad urinary bladder. 
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CHAPTER II 
THE EFFECTS OF VASOPRESSIN AND CALCIUM ON THE SYNTHESIS OF 
TXA2 AND PGE IN THE ISOLATED TOAD URINARY BLADDER AND IN 
TOAD BLADDER EPITHELIAL CELLS IN SUSPENSION, AND THE ROLE 
OF TXA2 IN VASOPRESSIN-STIMULATED WATER FLOW 
INTRODUCTION 
Zusman et ale (1977) found that the isolated toad urinary bladder 
synthesized PGE and that vasopressin stimulated the synthesis of PGE 
by enhancing the release of arachidonate from membrane-bound stores 
by a phospholipase. Burch et a1. (1979) confirmed that PGE synthesis 
In the toad bladder was stimulated by vasopressin and, in addition, 
that the toad bladder synthesized TXA
2
, and that the synthesis of 
this metabolite was also stimulated by vasopressin. Bisordi et ale 
(1980) confirmed the observations that the isolated toad urinary 
bladder, and epithelial cells derived from it, synthesize PGE and 
TXA
2
. However, these authors failed to detect any increase in the 
synthesis of either metabolite in the presence of vasopressin or its 
non-pressor analog, 1-deamino-8-D-arginine vasopressin (dDAVP). 
They attributed the earlier reports of Zusman et ale and Burch et 
ale to artifacts obtained through the use of an indirect radioimmuno-
assay for PGB, instead of direct assay for PGE2 . Thus, the objective 
of this study was to confirm that the syntheses of PGE and TXA2 are 
stimulated by vasopressin. Further, since phospholipases are calcium-
requiring enzymes, the effects of altered calcium on PGE and TXA2 
syntheses were also assessed. Since the possible role of TXA2 in 
modulating vasopressin-stimulated water flow has not been described, 
experiments were carried out in an attempt to characterize its effect 
on basal and vasopressin-stimulated water flow. 
MATERIALS AND METHODS 
The following were generous gifts: indomethacin, Merck, Sharp, 




U46619, and U44069, Drs. J. Pike and U. Axen, The Upjohn Co., Kala-
mazoo, MI; trans and cis isomers of the 13-azaprostanoic acid, Drs. 
G. LeBreton and D. Venton, University of Illinois, Chicago, Ill., 
and Drs. R. Broersma, P. Anzenveno, and B. Cregge, Dow Chemical Co., 
Indianapolis, Ind. The following were purchased from commercial 
sources: spectral grade solvents, Burdick-Jackson Co., Muskegon, 
MI; imidazole, Aldrich Chemical Co., Milwaukee, WI; [5,6- 3 H]-PGE
1 
(90-150 Ci/mmol), [5,6,8,11, 14,15- 3 H]-PGE
2 
(90-150 Ci/mmol), and 
3 ® [5,6,8,9,11,12,14,15- H]-TXB2 (60-150 Ci/mmol), and Omnifluor , New 
England Nuclear Corp., Boston, MA; [1- 14C]-arachidonic acid (50-55 
Ci/mmol), Applied Science Laboratories, State College, PA; Silicic 
acid (Biosil A 200-400 mesh), Biorad Laboratories, Richmond, CA; 
Machery-Nagel Sil G-25 thin-layer chromatography plates, Brinkmann 
Instruments, Westbury, NY; charcoal and dextran, Schwarz/Mann, 
Orangeburg, NY; bis(trimethylsilyl)acetamide, and o-methyl-hydroxyl-
amine hydrochloride, Pierce Chemical Co., Rockford, IL; 3' ,5'-cyclic 
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monophosphate, sodium salt, ethylenediamine tetraacetic acid, disodium 
salt, tris(hydroxymethyl) aminomethane-HCl (tris), and indomethacin, 
Sigma Chemical Co., St. Louis, MO; Pitressin, a pituitary extract of 
arginine-vasopressin, Parke Davis and Co., Detroit, MI; deamino-8-D-
arginine-vasopressin, Ferring Pharmaceuticals, New York, NY; colla-
genase, type IV (165-200 U/mg) , Worthington Enzyme Division, Millipore 
Corp., Bedford, ME; Prosil§, peR Chemical Division, SCM Corp., 
Gainesville, FL, Bio-Solv®, Beckman Instruments, Fullerton, CA. 
19 
The Ringer's solutions were of the following compositions, bicar-
bonate buffered: 90 roM NaCl, 3.0 roM KCI, 25 mM NaHC0
3







, 1.0 roM CaCl
2
, and 6.0 roM glucose, pH 7.4; phosphate-
buffered: 110 roM NaCl, 4.0 roM KCl, 0.5 roM CaC1
2
, 1.0 mM NaHP0
4
, 4.0 
roM NaH2P04 , and 6.0 roM glucose, pH 7.4; tris-buffered: 112 mM NaCl, 
5.0 roM Kel, 1.0 roM CaC1
2
, 20 roM tris-HCl, and 6.0 roM glucose, pH 





and the phosphate- and tris-Ringer's solutions were 
constantly aerated with compressed air. All Ringer's solutions used 
for cell suspensions contained penicillin G, 25,000 U/liter, and 
streptomycin sulfate, 0.05 g/liter. 
Indomethacin, 36 mg, was dissolved in 10 ml 0.1 M phosphate 
buffer, pH 8, and diluted into 2 liters Ringer's solution to yield a 
concentration of 50 ~M. Control Ringer's solution contained an equiv-
alent amount of phosphate buffer. Meclofenamate, 7-(I-imidazolyl)-
heptanoic acid, and imidazole were dissolved directly into Ringer's 
solution. U46619, U44069, and TXB
2 
were dissolved in ethanol to 
make stock solutions (10 roM), which were stored at -20°C. When these 
were added to experimental Ringer's solutions, the control media 
contained an equivalent volume of ethanol. 13-Azaprostanoic acid 
(3.2-19 mg) was wetted with 25 ~l of ethanol and dissolved in 10 ml 
of Ringer's solution at pH 9. This solution was diluted into 200 ml 
Ringer's solution at pH 7.4 to obtain concentrations of 50 to 300 
~M. Control media contained the ethanol and pH 9 Ringer's vehicle. 
Radioactivity cou~ting. Radioactivity of 3H and 14C was counted 
in a Beckman LS-355 liquid scintillation counter (Beckman Instruments, 
Fullerton, CA). The scintillation cocktail consisted of 40g Omnifluor® 
20 
(Beckman) and 2 liters Bio-Solv@ (Beckman), in 10 liters of toluene. 
Aqueous samples were dissolved up to 1 ml per 10 ml cocktail. Radio-
activity was counted to an instrumental error of 3% maximum, standar-
dized to an internal standard. In the experiments described no attempt 
was made to correct for the counting efficiency of the instrument 
(ca. 30% for 3H and 75% for 14C). 
Water flow. Water flow was measured gravimetrically by the 
method of Bentley (1958). Hemibladders were mounted with polyester 
thread on glass tubes 6 cm in length, 6 to 8 mm o.d., which had been 
slightly flared on one end, and 3 to 4 ml of one-fifth osmolar Ringer's 
solution (diluted with distilled water) was placed into each bag. 
The serosal bathing chamber consisted of a 40 ml polycarbonate centri-
fuge tube (3 cm in diameter) which had been cut to 8 to 10 em in 
length (Fig. 2). A small hole had been bored through the tube near 
the bottom and a stainless-steel tube of 2 mm o.d. mounted through 
it with an epoxy cement. To the stainless-steel tube was attached 
catheter tubing which was connected in turn to a manifold. By this 
means the serosal bath (15 ml Ringer's solution) was constantly 
aerated. The free end of the glass tube holding the hemibladder was 
placed through a #5 1/2 rubber cork and the whole assembly mounted 
into the polycarbonate tube. Osmotic water flow was measured as the 
weight loss from the hemibladder monitored by removing the rubber 
stopper-glass tube-hemibladder assembly, blotting the hemibladder 3 
times on a Kimwipe®, and suspending it in a Mettler Type H16 balance. 
Generally, hemibladders were allowed to stabilize for at least 2 
hours during which time the serosal media were changed every 30 
Water Flow Chamber 
Hanger 
• • • • • , • • , , • • ,
• • I • 
o 
Hemibladder ---+-+--- o 
Serosal Medium ---+----
Figure 2. Water floy cbamber. The hemibladder was 
mounted in the chamber mucosal surface inward. The 
rubber stopper did not fit tightly to allow air to 
escape from the chamber. 
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minutes and the mucosal media changed twice, before any experimental 
manipulations were commenced. 
Water flow was generally normalized to the mean weight of the hemi-
bladders used in the experiments by use of the following formula: water 
flow = [(mass" - massf)/~t]/(massh "bl dd ) (mass- h "bi dd ) or, 
1· eml a er x, eml a ers 
in units 






are the masses of the hemibladder assembly at 
the beginning of and the end of the time period, respectively, ~t is 
the time interval between the mass determinations, mass h "bl dd is eml a er 
the mass of the hemibladder alone after it has been thoroughly blotted 
on a Kimwipe®, and mass- h "bi dd is the mean mass of all the hemi-x, eml a er 
bladders used in the experiment, usually arbitrarily chosen to be 150 
mg. 
Normalization of water flow to hemibladder surface area. U46619, 
U44069, and TXB
2 
all contracted hemibladders. Therefore, water flow 
was normalized to mean hemibladder surface area in experiments using 
these agents. Water flow was measured as weight loss/minute per hemi-
bladder and expressed as mg/minute/lOcm2 surface area. The mean 
surface area for the hemibladders used in these experiments was 
lO.4±2.8cm2 , n=38. Surface area was calculated assuming the hemibladder 
sacs were spheres where volume = (4/3)nr 3 and surface area = 4nr 2 , 
where r is radius in em. The volume was determined by submerging a 
hemibladder in a beaker of Ringer's solution containing the experi-
mental agent, up to the level of the thread used to secure it to the 
glass tube. The hemibladder was then filled with the usual mucosal 
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solution of diluted Ringer's solution to the point where the bottom of 
the water meniscus was level with the thread on the glass tube. At 
this point the pressure inside the hemibladder equalled the pressure 
outside the hemibladder so no distension occurred due to hydrostatic 
pressure and the hemibladder appeared spherical. The mucosal solution 
was drawn up into a graduated syringe and volume was determined to 
within 0.1 mI. The procedure was then carried out a second time. 
The coefficient of variation of the differences between the two deter-
minations was 1.4% (n=16). In hemibladders treated with U44069, 
U46619 or TXB
2
, after the experiment was completed the volume was 
determined, then the hemibladders were washed three times with Ringer's 
solution at 10 minute intervals to remove the drug, and the procedure 
repeated. 
Since water is assumed to move through pores in the apical 
membrane (Koefoed-Johnsen and Ussing, 1953), a highly folded contrac-
ted hemibladder may impede water flow, leading to an underestimate of 
water flow when compared to a hemibladder of equal weight which is not 
contracted. Determination of surface area, on the other hand, serves 
as an index of the amount of epithelium available for unimpeded flow 
(Kachadorian and Levine, 1979). To test the hypothesis that hemi-
bladder surface area is a valid normalization parameter for water flow, 
one member of each of eight pairs of hemibladders was filled with 3 ml 
of diluted Ringer's solution while the other was fully distended by 
adding mucosal medium over a one hour period, until no more could be 
accomodated, usually 20 to 30 mI. The distended hemibladders were 
emptied and 3 ml diluted Ringer's solution were added. These hemi-
bladders remained distended after emptying. The hemibladders were 
24 
allowed to stabilize 30 minutes, then vasopressin (50 mU/ml) was 
added and water flow was determined for 30 minutes. The weights of 
the hemibladders were not significantly different between the 2 groups 
(149±8 mg in the undistended hemibladders and 133±7 mg in the distended 
hemibladders, n=8 pairs). At the end of the vasopressin treatment 
period, the measured surface areas of the distended hemibladders 
were significantly greater than their paired controls (lO.O±3.0 cm2 
in the undistended hemibladders and 16.1±3.0 cm 2 in the distended 
hemibladders, p<O.Ol, n=8 pairs). Water flows normalized to weight 
were significantly greater in the distended hemibladders than 1n 
their paired undistended controls (O.28±O.04 mg/minute per mg hemi-
bladder in undistended hemibladders and O.SO±0.07 mg/minute per rng 
hemibladder in the distended hemibladders, p<O.Ol, n=8 pairs). 
However, when water flow was normalized to surface area, there was 
no difference between the 2 groups (3.6±O.2 mg/minute per cm2 hemi-
bladder in undistended hemibladders and 3.7±O.2 mg/minute per cm 2 
hemibladder in the distended hemibladders). Similar observations 
have been reported by Kachadorian and Levine (1979). While the data 
demonstrate that normalization of osmotic water flow to surface area 
is preferable in situations where surface areas may be different, 
for several representative experiments, water flow was normalized to 
mean hernibladder wet weight in addition to the normalization to surface 
area. The mean hemibladder wet weight for these experiments was 
164±12 mg (n=38). Since weight was not changed by the agents used 
in these studies, this further confirms that absolute water flow was 
increased by each experimental agent. 
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Collagenase method of cell preparation. The procedure described 
is modified from Gatzy and Berndt (1968) and Wiesmann et ale (1977). 
After double pithing the toad, the abdomen was opened and the abdom-
inal vein leading from the bladder was severed and the bladder was 
perfused through the ventricle antegrade with 50 ml of Ca,Mg-free 
bicarbonate-Ringer's solution. The bladder was then perfused retro-
grade through the abdominal vein with approximately 15-20 ml of 
Ringer's solution, until the perfusate was no longer sanguinous. 
The bladders were excised, cut into quarter bladders, and placed 
into a Ca,Mg-free bicarbonate-Ringer's solution containing type IV 
collagenase (2 mg/ml). Since trypsin damages toad bladder cells 
(Gatzy and Berndt, 1968), type IV collagenase was used since it is 
claimed by the manufacturer to be essentially trypsin-free. The 
bladder pieces were gently agitated with 95% °2:5% CO
2 
for 60 min 
after which the collagenase solution was replaced with bicarbonate-
Ringer's solution containing 1 roM CaC1
2 
and 1 roM MgS0
4 
for 30 min. 
The bladder pieces were removed from the solution and placed mucosal-
side up on a piece of Parafilm®-covered styrofoam. The epithelial 
cells were dislodged by very gently scraping the surface of the bladder 
only once with the edge of a microscope slide. Cells from several 
bladders were pooled in a 40 ml polycarbonate centrifuge tube and 
pelleted at 200 x g at room temperature in a floor model lEC Clin-
ical Centrifuge for 5 min. The supernatant was poured off, replaced, 
and the gelatious pellet resuspended by passing the pellet through a 
plastic Eppendorf pipet tip (2 ml) attached to 1 ml adjustable pipet. 
At times the end of the pipet tip was cut to obtain a wider inside 
diameter for ease in pipeting the initial suspension. The suspension 
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was passed into the pipet several times as necessary to resuspend 
the pellet. Any small pieces of smooth muscle, opaque and white in 
color, were removed from the suspension with the pipet. The centri-
fugation and pipeting procedures were repeated twice more, by which 
time the major portion of mucus had been removed. After the pellet 
had been resuspended a third time, the suspension was passed through 
2 layers of U.S.P. type VII gauze to remove the remaining mucus. 
The suspension was pelleted once more, resuspended, and diluted to 
final volume (3 mg protein/ml). The gelatinous material surrounding 
the cells was probably not DNA released from damaged cells. The 
epithelial surface of toad bladders contains goblet cells, ca. 5% 
total epithelial cells, which secrete a mucus. Upon incubation of 
the intact hemibladder for even a few minutes in Ringer's solution 
mucus can be detected on the epithelial surface. Thus, the gelatinous 
material reported here probably represents secretion from goblet 
cells during the 90 min incubation of the intact hemibladder. Via-
bility of cells prepared by this method was 96±2%, n=4, by trypan 
blue exclusion. 
Scraping method of cell preparation. This method is essentially 
that described by Bisordi et ale (1980). Bladders were perfused as 
described above with phosphate-Ringer's solution containing CaCI2 " 
Bladders were excised and immediately placed mucosal-side up on Para-
film®-covered styrofoam. The epithelial cells were scraped off the 
submucosa with the edge of a microscope slide and placed into phos-
phate-buffered Ringer's solution at 4°C for 60 min. Viability of 
cells prepared by this method was 52±9%, n=4, by trypan blue exclu-
sion. 
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EDTA method of cell preparation. The method was modified from 
Scott and Sapirstein (1974). Bladders were perfused as described 
above with bicarbonate-Ringer's solution or tris-Ringer's solution, 
then excised and cut into small pieces (approximately 3 mm). These 
were placed into a 50 ml Ehrlenmeyer flask (which had been previously 
silanized with Prosil®) containing Ca, Mg-free Ringer's solution 
plus 100 ~M EDTA. The bladder pieces were stirred moderately with a 
teflon-coated magnetic stirbar for 10 min. The medium was decanted 
and discarded. Fresh EDTA-Ringer's solution was added and the bladder 
pieces stirred for 10 min. The medium, containing detached cells, 
was decanted and filtered through 2 layers of gauze into a polycarbo-
nate centrifuge tube. Fresh EDTA-Ringer's solution was added to the 
bladder pieces and the harvesting procedure was repeated, usually 3 
or 4 times in total, until the cells were all collected. The cells 
were centrifuged at 200 x g for 5 min and resuspended to a final 
protein concentration of approximately 3 mg/ml, in either bicarbonate-
Ringer's solution containing 1 roM CaC12 and 1 mM MgS04 or tris-
Ringer's containing varying amounts ~~ calcium. Viability of cells 
prepared by this method was 75±12%, n=4, by trypan blue exclusion. 
Experimental protocol for vasopressin and dDAVP experiments. 
In all experiments, bladders from 6-8 toads were pooled to allow for 
the simultaneous incubation of triplicate samples for controls, vaso-
pressin, dDAVP, and indomethacin or meclofenamate incubates. This 
was considered to be a single experiment with the mean of the 3 
measurements being averaged. Cells prepared by the collagenase or 
EDTA methods were incubated at room temperature (22-25~C) with constant 
gentle agitation from a teflon-coated magnetic stirbar for 60 min 
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under an atmosphere of 95% °2:5% CO2 or compressed air as appropriate. 
Aliquots of 3 ml were placed into 10 ml polycarbonate centrifuge 
tubes. Suspensions were pelleted at high speed in an lEe Model CL 
tabletop clinical centrifuge for 45 sec and resuspended in Ringer's 
solution or Ringer's solution plus indomethacin or meclofenamate for 
15 min with stirring. Then the suspensions were pelleted once again. 
Resllspension was into Ringer's solution or Ringer's solution plus 
vasopressin (5 mU/ml or 10 mU/ml), dDAVP (130 nM), indomethacin (50 
~M), or meclofenamate (10 ~M). Incubation with stirring was continued 
for 15 min after which the suspensions were pelleted, the media saved 
for radioimmunoassay of PGE and TXB
2
, and the pellet retained for 
protein assay by the method of Lowry et ala (1951). Viability at 
the end of the experiment was not reduced from the initial estimate, 
being 94±5%, n=4, and 75±8%, n=4, for cells isolated by the colla-
genase or EDTA methods, respectively. 
After a 60 min incubation at 4°C, cell suspensions prepared by 
the scraping method described by Bisordi et ala (1980) were pelleted 
at 200 x g in a Sorvall RC-2B refrigerated centrifuge for 1 min and 
resuspended in phosphate-Ringer's solution at room temperature. 
Aliquots (1.5 ml) of the gelationous cell mass were placed into 1.5 
ml phosphate-Ringerts solution or phosphate-Ringer's solution plus 
vasopressin, indomethacin, or meclofenamate, at room temperature and 
incubated with stirring for 15 min. The suspensions were pelleted 
as described above, and the media and protein processed as described 
above. 
Protocol for experiments with altered calcium con~entration. 
The cell suspension from a single preparation of 6-8 toads was divided 
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into 10 aliquots in 40 ml polycarbonate centrifuge tubes. The suspen-
sions were pelleted as described above and resuspended in 2 ml Ringer's 
solution containing 0.1, 0.5, 1.0, or 2.0 roM calcium and no magnesium, 
or 0.1 roM calcium plus 0.1 roM EGTA for the 0 calcium point (Blackmore 
et al., 1978). The suspensions were repelleted and resuspended in 
identical Ringer's solutions. The suspensions were incubated with 
gentle agitation by means of teflon-coated magnetic stirbars under 
an atmosphere of 95% °2:5% CO2 or compressed air as appropriate for 
30 min. The suspensions were repelleted, resuspended a final time, 
and incubated for 15 min under the appropriate atmosphere. The 
suspensions were pelleted, the media taken for assay of TXB2 and 
PGE, and the pellet retained for protein determination. 
Radioimmunoassay of immunoreactive (i)PGE. To an aliquot (5 to 
3 
10 ml) of serosal media was added [ H]-PGE 1 (1500 cpm) to account for 
recovery losses. The media were acidified to pH 3.5 with formic 
acid and extracted twice with 2 volumes of ethyl acetate, the ethyl 
acetate then being evaporated under a stream of N2 . In the experi-
ments using cell suspensions an aliquot (0.5 ml) was taken and diluted 
to 2 ml with distilled water to facilitate processing, acidified, 
and extracted once with 20 ml ethyl acetate and the ethyl acetate 
evaporated under a stream of N2 . The dried extract was redissolved 
and applied to a silicic acid column (0.5 g) (Webb et al., 1978). 
The prostaglandin E fraction was eluted (Webb et al., 1978) and con-
verted to PGB using 0.1 N methanolic KOH, then assayed using a pre-
viously described radioimmunoassay procedure (Alexander et al., 1975). 
The term iPGE is used because the antibody cross-reacts· with both 
; 
the 1 and 2 series. The antibody does not significantly cross-react 
with other prostaglandins (Table 1). 
Radioimmunoassay of iTXB2 . To an aliquot of serosal media was 
3 
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added [ H]-TXB2 (1500 cpm) to account for recovery losses. The media 
were acidified to pH 3.5 with formic acid and extracted twice with 2 
volumes of ethyl acetate, the ethyl acetate then being evaporated 
under a stream of N2 . In the experiments using cell suspensions an 
aliquot (0.5-1.0 ml) was taken and diluted to 2 ml with distilled 
3 
water to facilitate processing, [ H]-TXB
2 
was added for recovery, 
the media were acidified and extracted once with 20 ml of ethyl ace-
tate, and the ethyl acetate was evaporated under a stream of NZ. 
The dried extract was redissolved in 50 ~l of methanol and 950 ~l of 
chloroform and applied to a silicic acid column (0.5 g). TXB
2 
was 
eluted and the eluate evaporated under a stream of N2 . The residue 
was dissolved in gelatin phosphate buffer (Alexander et al., 1975) 
and assayed by a previously described radioimmunoassay procedure 
(Burch et al., 1979). The antibody was kindly supplied by Dr. J.B. 
Smith, Cardeza Foundation, Philadelphia, PA. After incubation at 
3 
37°C for 4 hours the free [ H]-TXB2 was separated from the bound 
using a charcoal-dextran solution (Alexander et al., 1975) and the 
3 
bound [ H]-TXB2 was counted in a liquid scintillation spectrometer 
(Beckman). The interassay variability was 17% (n=10). Cross-reac-
tivities of various prostaglandins are shown in Table I. 
Because U44069 and U46619 were found to cross-react with the 
TXB2 antibody, the dried extracts were redissolved in methanol and 
subjected to silica gel thin-layer chromatograpby using the solvent 
system chloroform-methanol-acetic acid-water (90:8:1:0.8) (Moncada 
TABLE 1 
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et al., 1977). The retardation factor (Rf ) for the analogs was 
scraped and TXB2 was eluted from the silica gel using 5% acetic acid 
in methanol (vol/vol) (Green, 1978) and the solvent was evaporated 
under a stream of N2* The residue was subjected to column chromatog-
raphy as described above and assayed. 
[1 4 C]-Arachidonic acid metabolism in toad bladder homogenates. 
Bladders were homogenized in 100 IBM phosphate buffer, pH 7.4 (1 g 
bladder wet weight to 3 ml of buffer) with a Tekmar Model SnT tissue 
homogenizer at medium speed for 30 sec at OoC. [1 4 C]-Arachidonic 
acid (0.3 roM, 0.7 ~Ci) was added to each flask (3 ml) and the homoge-
nates were incubated with shaking under an atmosphere of 95% °2:5% 
CO2 at 25°C for 30 min. The media were acidified to pH 3.5 with 
formic acid and extracted twice with 10 ml ethyl acetate. The ethyl 
acetate was evaporated under a stream of N2* The dried extracts 
were redissolved in methanol and 25 ~g each of PGE2 , PGF2a , and TXB2 
were added as markers. The solution was applied to a silicic acid 
column (0.5 g) and the prostaglandin fraction was eluted (Bills et 
al., 1976). This fraction was evaporated under a stream of N2 and 
subjected to silica-gel thin-layer chromatography as described above. 
The plates were scanned with a Packard Model 7201 radiochromatogram 
scanner. 
Gas chromatographic-mass spectrometric confirmation of TXB2 synthe-
sis from endogenous precursor. Media (2.2 liters) were collected 
from 56 hemibladders which had been incubated in bicarbonate-Ringerts 
solution for 30 min periods. The media were acidified to pH 3.5 
with formic acid and extracted twice with 3 volumes of ?iethyl ether. 
The ether was flash-evaporated and [3H]TXB2 (10,000 cpm) was added 
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to the residue to serve as a marker. A blank was prepared by adding 
[3H]TXB
2 
(10,000 cpm) to another tube and subjecting it to the same 
procedure~ as the sample. The dried extract was redissolved and 
applied to a silicic acid column (0.5 g), 10 ml of chloroform were 
added to elute fatty acids, and 12 ml of chloroform-methanol (95:5) 
were added to elute the TXB
2 
fraction. The eluate was concentrated 
under a stream of nitrogen and subjected to thin-layer chromatography 





was scraped and eluted with methanol, and an aliquot 
was taken to determine radioactivity. Ethereal diazomethane was 
added to the methanolic extract to form the thromboxane methyl ester. 
After 5 min the excess reagent was evaporated under a stream of nitro-
gen and the residue was subjected to thin-layer chromatography as 
described above. The portion of the plate corresponding in R
f 
(0.68) 
to authentic thromboxane methyl ester was scraped and eluted with 
methanol, and an aliquot was taken to determine radioactivity. The 
solvent was evaporated under a stream of nitrogen and the thromboxane 
methyl ester methoxime tritrimethylsilyl (tri-TMS) derivative was 
formed (Fitzpatrick, 1977). The derivative was subjected to combined 
gas chromatography-mass spectrometry using a Finnigan 3200 gas chroma-
tograph-mass spectrometer equipped with a glass column 2 m i.d. x 2 
m coated with 3% OV-l on Supelcoport 80/100, operated isothermally 
at 210°C, with electron energy 70 eV. Carrier gas was helium flowing 
at a rate of 25 ml/min. TXB
2 
levels in the blank were below the 
limits of detectibility by this method. 
~tatistical procedures. Most experiments were defigned such 
that the two hemibladders from a single toad were compared to one 
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another, one serving as a control and the other, an experimental 
hemibladder. Differences between means was assessed using Students 
t-test for unpaired observations (Steel and Torie, 1960). Statis-
tical analysis of the data in Figure 11 was performed by Dr. Boyd 
Loadholt, Department of Biometry, Medical University of South Carolina, 
using an analysis of covariance computer program (Dixon, 1975). 
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RESULTS 
METABOLISM OF ARACHIDONATE IN THE TOAD URINARY BLADDER AND ITS 
MODIFICATION BY VASOPRESSIN 
[ 14Cl-Arachidonate metabolism in toad bladder homogenates. In 
the studies performed prior to these experiments, only PGE had been 
reported to be synthesized by the toad bladder (Zusman et al., 1977). 
Thus, we chose first to establish whether other prostaglandins are 
synthesized by this tissue. In particular, we wished to determine 
whether the toad bladder synthesizes TXA
2
, since Puig Muset et al. 
(1972) had reported that the thromboxane synthetase inhibitor imida-
zole inhibited vasopressin- stimulated water flow. Bladders were 
homogenized to maximally stimulate endogenous phospholipases and to 
minimize acylation of the added [ 14C]-arachidonate into the membrane 
phospholipids~ [ 14C]-Arachidonate was incubated with homogenates of 
toad urinary bladder in 100 mM phosphate buffer, pH 7.4. Radioactive 
products were observed by thin-layer chromatography to comigrate 
with authentic standards: PGF2a (Rf =0.41) , TXB2 (Rf =O.45) , and PGE 2 
(R
f
=O.S8) (Fig. 3)~ Zones (0.5 cm) were scraped from the thin-layer 
plates and radioactivity was eluted from the silicic acid with metha-
nolo Radioactivity was measured by liquid scintillation counting. 
In the control homogenates the product peaks accounted for 15% of 







contained 5~3, 5.5, and 4.2% 
of the total added radioactivity, respectively. After treatment 
with 10 mM indomethacin the product peaks together contained only 
3.2% of the total radioactivity, confirming that the cor,trol peaks 
7 
resulted from enzymatic conversion of the [ 14C]-arachidonic acid. 
.. c 












Figure 3. Products of [14Cl-arachidonic acid in toad urinary bladder 
bomogenates. The upper scan is a radiochromatogram obtained from a 
control homogenate incubated in phosphate buffer for 30 minutes. The 
middle scan 1s of a homogenate incubated with imidazole (1 mM) for 30 
minutes. The lower Bcan is of a homogenate incubated with indomethacin 
(10 ~1) for 30 minutes_ The spots indicate migration of authentic 
samples of arachidonic acid (AA), PGE2' TXB2, and PGFZo -
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Addition of 1.0 ruM imidazole reduced the amount of radioactivity 
contained in the TXB2 peak by 54% compared to the control incubation. 
The decrease in radioactivity associated with the R
f 
of authentic 
TXB2 in the presence of imidazole raised the possibility that the 
isolated toad urinary bladder possesses thromboxane synthetase. 
Therefore, we sought to identify unequivocally the presence of TXB2 
synthesized from endogenous arachidonic acid in the media bathing 
the toad urinary bladders. 
Mass spectral confirmation of TXB2 in the media bathing the hemi-
bladders. A methyl ester methoxime tri-TMS derivative was formed 
from the partially purified ethyl acetate extract of the pooled media 
bathing the hemibladders (see Methods). A single peak corresponding 
in retention time (12 min) to a sample of authentic TXB
2 
methyl ester 
methoxime tri-TMS was eluted (Fig. 4a) and its mass spectrum was 
identical to that obtained using authentic TXB2 (Fig. 4b) to prepare 
the derivative. In addition, these mass spectra contained fragments 
identical to those formed from the same derivative of TXB2 isolated 
from other sources (Chang et a1., 1977; Smith et a1., 1977). 
Time-course of vasopressin-stimulated iTXB2 and iPGE syntheses 
and water flow. In an effort to characterize the role of TXA2 in 
the toad bladder we first determined the effects of vasopressin on 
its synthesis in the isolated toad bladder. Also measured for compar-
ison were iPGE synthesis and osmotic water flow. Within 8 min after 
its addition, vasopressin caused a significant (p < 0.02, n=6) stimu-
lation of iTXB2 synthesis (Fig. 5) .. Maximum rate of synthesis was 
reached by 16 min and fell rapidly thereafter, returnipg to basal 
level by 32 min. Vasopressin-stimulated water flow reached its 
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Figure 4a. Total ion current from the derivatized 
extract obtained from toad bladder incubation media. 
The mass spectrum is contained in the lower trace 
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Figure 4b. Mass spectra of TXB2 methyl ester methoxime tri-THS derivatives. 
The upper Bcan is the mass spectrum of a derivatized sample of authentic 
TXB2- The lower scan is the mass spectrum of a derivatized sample isolated 
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Figure 5. Time course of vasopressin stimulation of water flo~ 
and 1TXB2 and iPGE synthesis. Vasopressin (25 mU/ml) was added 
at time O. At 8 minute intervals the serosal media were collected 
and replaced with fresh serosal media containing vasopressin. The 
upper figure shows vasopressin-stimulated 1TXB2 synthesis and vaso-
pressin-stimulated water flow in the same hemibladders. Media from 
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2 hemibladders (not from the same toad) were pooled for assay of iTXB2. 
Each point represents the synthetic or flow rate of 6 pairs of 
hemibladders. The lower figure shows vasopressin-stimulated water 
flow and vasopressin-stimulated 1PGE synthesis in the same hemibladders. 
Each point represents the flo~ rate of synthetic rate fhr 5 hernibladders. 
41 
maximum during the l6-to 24-min time period. Vasopressin also signif-
icantly stimulated (p < 0.05, n=5) iPGE synthesis within 8 min, but 
the synthesis rate exhibited a prolonged plateau and decreased to 
basal level by 32 min (Fig. 5). 
In one group of hemibladders vasopressin-stimulated water flow 
was compared to vasopressinstimulated iTXB2 and iPGE synthesis. In 
these hemibladders iTXB2 synthesis was positively correlated with 
vasopressin-stimulated water flow (p<O.OOl, n=2l, r=O.7S) (Fig. 6). 
There was no significant correlation between vasopressin-stimulated 
water flow and iPGE synthesis. 
Effects of an osmotic gradient on vasopressin-stimulated iTXB2 
synthesis. To confirm that vasopressin's stimulation of iTXB
2 
syn-
thesis was no~ secondary to the enhancement in water flow, the dilute 
mucosal Ringer's solution was replaced with full-strength Ringer's 
solution. Basal iTXB2 synthesis was identical under the 2 conditions: 
O.OS8±O.OlO pmol/min/hemibladder in the presence of the gradient and 
0.05s±0.006 pmol/min/hemibladder in the absence of a gradient, respec-
tively, n=6 pairs. Vasopressin stimulated iTXB2 synthesis in the 2 
groups of hemibladders to the same extent, to O.087±0.008 and 0.083± 
0.008 pmol/min/ hemibladder, gradient and no gradient, respectively. 
In the absence of the gradient, vasopressin-stimulated water flow 
was almost completely inhibited, being stimulated from 5.8±1.3 to 
47.9±6.7 mg/min/hemibladder in the presence of a gradient and from 
-2.l±O.9 to O.3±O.8 mg/min/hemibladder in the absence of an osmotic 
gradient. 
Effects of exogenous cAMP on iTXB2 synthesis. Exogenous cAMP 
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Figure 6. Correlation of vasopressin-stimulated water flo~ with 
iTXB2 synthesis in the toad urinary bladder. Vasopressin (5 mU/ml) 
was added to the serosal media and water flow and iTXB2 synthesis 
were measured for 30 minutes, beginning 15 minutes after vasopressin 
was added. 
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(Zusman et al., i977). In the present study, cAMP (0.5 mM) increased 
water flow from 1.1±0.7 to 19.2±2.3 mg·min-1·hemibladder- 1 (p<O.Ol, 
0=5), while iTXB2 synthesis was not affected, (being 0.OS4±.006 pmol/ 
min/hemibladder basally and O.056±O.007 pmol/min/hemibladder in the 
presence of cAMP (n=5). 
iPGE and iTXB2 syntheses in toad bladder epithelial cells. The 
toad bladder consists not only of epithelial cells but also suppor-
ting stroma and smooth muscle. Therefore, we prepared suspensions 
of epithelial cells to document that they are responsible for the 
increased synthesis of iPGE and iTXB2 in response to vasopressin. 
Epithelial cells prepared by all three methods synthesized iPGE and 
iTXB2 (Table II). In the cells prepared by the collagenase and EDTA 
methods and incubated in bicarbonate-Ringer's buffer, iPGE syntheses 
were similar, O.27±O.OS and O.25±0.03 pmol/min/mg protein, respec-
tively. However, iPGE synthesis was nearly IO-fold higher (p<O.OOl) 
in the cells prepared by the scraping method (2.02±O.53 pmol/min/mg 
protein) compared to the above methods. iTXB2 synthesis was only 
about one-tenth (O.032± 0.004 pmal/min/mg protein) (p<O.OOI) of iPGE 
synthesis in cells prepared by the collagenase method and one-half 
(1.11±0.39 pmal/min/mg protein) (p<O.05) of iPGE synthesis in the 
scraped cells. In contrast, in cells prepared using the EDTA method, 
iTXB2 synthesis was about two-fold greater (O.59±O.07 pmol/min/mg 
protein (p<O.Ol) than iPGE synthesis. 
Incubation of the cells with indomethacin (50 ~M) or meclofena-
mate (10 ~H) significantly inhibited iPGE and iTXB2 synthesis (Table 
II). iPGE synthesis was inhibited 78±14% (p<0.02), 91+18% (p<O.OOl), 
and 83±6% (p<O.OI) and iTXB2 synthesis was inhibited 53±8% (p<O.02), 
TABLE II 
EFFECTS OF VASOPRESSIN AND dDAVP ON iPGE AND iTXB 2 SYNTHESIS IN ISOLATED TOAD BLADDER EPITHELIAL CELLS 
Basal Vasopressin Basal 
(pmol/min/mg protein) 
Collagenase Method 
iPGE 0.27 (6) 0.53c (6) 0.27 (6) 
to.OS to.lO to.OS 
iTXB 2 0.032 (6) 
0. OS4b (6) 0.034 (6) 
to.OO4 ±O.OOg ±0.O04 
ScraEing Method 
iPGE 2.02 (6) 2.22 (6) 
to.53 to.45 
iTXB2 1.11 
(6) 0.83 (6) 
±0.39 ±0.23 
EDTA Method 
iPGE 0.25 (12) 0.26 (12) 
±0.03 ±0.02 
iTXB2 O.5g



















O.047 c (3) 
±0.004 
a p < 0.05, b p < 0.02, C P < 0.01, d P < 0.001, compared to basal; e p < 
0.01, compared to iPGE; number of observations in each group is given by the 
number in parentheses. 
The medium for the suspensions prepared by the collagenase and EDTA methods 
was bicarbonate-Ringer's containing 1 mM calcium and 1 roM magnesium; the 
medium for the cells prepared by the scraping method was phosphate-Ringer's 
solution containing 0.5 mM calcium. Incubation time was 15 min. 
For isolation procedures) see Methods. 
Concentration of AVP was 5 mU/ml; dDAVP, 130 nH; meclofenamate, 10 ~M; and 
indomethacin) 50 ~M. 
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95±lO% (p<O.OOl, and 92±10% (p<O.Ol) in cells prepared by the colla-
genase, scraping, and EDTA methods, respectively. 
Effects of vasopressin and dDAVP on iPGE and iTXB2 synthesis in 
isolated epithelial cells. In a previous report (Bisordi et aI, 
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1980) vasopressin (5 mU/ml) and dDAVP (130 oM) stimulated hydroosmotic 
water flow to the same extent in isolated toad bladders. Similarly, 
in our laboratory vasopressin (5 mU/ml) stimulated water flow from 
1.2±O.5 to 29.8±2.9 mg/min/hemibladder (n=4) , while dDAVP (130 oM) 
stimulated water flow from 1.4±O.4 to 30.4±2.6 mg/min/hemibladder 
(n=4). In cells prepared via the collagenase method, vasopressin (5 
mD/ml) stimulated iPGE synthesis from O.27±O.05 to 0.53±O.1 pmal/minl 
mg protein (p<O.Ol, n=6) and iTXB2 synthesis from O.032±O.004 to 
O.054±O.009 pmol/min/mg protein (p<O.02, n=6) (Table II). dDAVP 
(130 oM) stimulated iPGE synthesis from O.27±O.OS to O.43±0.09 pmal/ 
min/mg protein (p<O.02, n=6) and iTXB2 synthesis O.034±O.004 to 0.054 
±O.011 pmol/min/mg protein (p<O.05, n=6). dDAVP stimulated iPGE 
synthesis significantly (p<O.OS) less than vasopressin but both stimu-
lated iTXB2 to the same extent. In cells prepared by the scraping 
or EDTA methods, vasopressin failed to stimulate iPGE or iTXB2 syn-
thesis (Table II). 
Effects of extracellular calcium on iPGE and iTXB2 synthesis in 
isolated epithelial cells. In cells prepared via the collagenase 
method, in the absence of exogenously added calcium in the medium 
iPGE synthesis was approximately 35% greater than iTXB2 synthesis. 
Increasing the calcium concentration to 0.1 roM caused an increase in 
iPGE synthesis (Fig. 7), while raising the calcium concentration to 
0.5 or 1.0 mM was without further effect. At the same time that 
,.. 



















Figure 7. Effects of extracellular calcium on iTXB2 and iPGE synthesis 
in toad bladder epithelial cells isolated by the collagenase method. 
See Methods for details of cell preparation and experimental protocol. 
Both iPGE and iTXB 2 were quantitated in the bathing media of the same 
suspensions by radioimmunoassay procedures. Each value represents the 
mean + SEM for 6 suspensions. Synthesis of iPGE was the same in the 
presence of 0.1, 0.5, and 1.0 mM added calcium, but these were sig-
nificantly different from synthesis in the absence of exogenously added 
calcium (p < 0.05) and in the presence of 2.0 mM added calcium (p < 
0.05). Synthesis of iTXB2 was the same in the presence of 0.1, 0.5, 
and 1.0 roM added calcium, but these were significantly different from 
synthesis in the absence of exogenously added calcium (p < 0.02) 
and in the presence of 2.0 mM added calcium (p < 0.05). 
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iPGE synthesis increased, iTXB2 synthesis decreased by the same amount, 
such that the sum of arachidonate metabolism to iPGE plus iTXB2 was 
the same at all calcium concentrations from 0 to 1.0 roM: 0.25 pmol/ 
min/mg protein at no added calcium, 0.24 pmol/min/mg protein at 0.1 
roM calcium, 0.25 pmol/ min/mg protein at 0.5 roM calcium, and 0.25 
pmol/min/mg protein at 1 roM calcium. However, at 2 roM calcium, the 
synthesis of both metabolites was significantly increased (p<O.05) 
such that net conversion of arachidonate to iPGE plus iTXB2 increased 
to 0.35 pmol/min/mg protein. 
In the cells prepared by the EDTA method, a qualitatively 
different effect of calcium was observed. iPGE and iTXB2 syntheses 
were not significantly different in phosphate-Ringer's solution (Fig. 
8a) or bicarbonate-Ringer's solution (Fig. 8b), in the absence of 
exogenously added calcium. Increasing the calcium concentration to 
0.1 roM increased the syntheses of both iPGE and iTXB2 . The increase 
in iTXB
2 
was greater than the increase in iPGE in both buffers and 
the increase in iTXB2 was greater in the phosphate-Ringer's than the 
bicarbonate-Ringer's. Upon raising the concentration of calcium to 
0.5, 1.0, or 2.0 nill the synthesis rates of both iPGE and iTXB2 fell 
compared to the rates in the presence of 0.1 roM calcium. At 0.5 and 
1.0 mM calcium, iTXB2 synthesis remained greater than iPGE synthesis, 
but at 2.0 roM calcium the synthetic rates had returned to the level 
seen in the absence of exogenously added calcium and iPGE and iTXBZ 
syntheses were again identical. 
In the above experiments, the cells incubated in phosphate-Ringer's 
solution (5 mM phosphate) had higher maximum iTXB2 synt;hesis rates 
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Figure 8. Effects of extracellular calcium on iTXB2 and 
iPGE synthesis in toad bladder epithelial cells isolated 
by the EDTA method. See Methods for details of cell 
preparation and experimental protocol. Both iPGE and 
iTXB2 were quantitated in the bathing media of the same 
suspensions by radioimmunoassay procedures. Each value 
represents mean + SEM for 6 suspensions. (a) Cells were 
incubated in phosphate-Ringer's solution. Synthesis of 
iTXB2 was elevated above that in the absence of exogenous-
ly added calcium at 0.1 mM calcium (p < 0.01). 0.5 mM 
calcium (p< 0.02) and 1.0 mM calcium (p <0.05). but was 
not different from that found at 2.0 mM calcium. Synthesis 
of iPGE was elevated above that in the absence of exogen-
ously added calcium at 0.1 and 0.5 mM added calcium (p < 
0.05), but was not at 1.0 mM or 2.0 mM calcium. At 0.1 
mM, 0.5 ~~, and 1.0 mM added calcium, iTXB2 synthesis 
was greater than iPGE synthesis (p < 0.02). (b) Cells 
were incubated in bicarbonate-Ringer's solution. Syn-
thesis of iTXB2 was elevated above that in the absence of 
exogenously added calcium at 0.1 mM, 0.5 mM, and 1.0 mM 
added calcium (p < 0.05), but was not different at 2.0 
roM added calcium. iPGE synthesis was elevated above 
that in the absence of exogenously added calcium at 0.1 
IIL\1 and 0.5 mM added calcium (p < 0.05) but was not differ-
ent at 1.0 mM or 2.0 mM added calcium. At 0.1 mM. 0.5 mM, 
and 1.0 roM calcium, iTXB 2 synthesis was greater than iPGE 
synthesis (p < 0.05). (c) Cells were incubated in tris-
Ringer's solution. iPGE and iTXB2 syntheses were not dif-
ferent from one another at any concentration of added 
calcium. Syntheses of iPGE and iTXB2 were greater at 0.1 mM 
added calcium than in the absence of exogenously added calcium 
(p < 0.05) and the syntheses of iPGE and iTXB2 were greater 
at 0.5 m}1, 1.0 mM, and 2.0 mM calcium than at 0.1 mM calcium 
(p < 0.05). 
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roM phosphate). Extracellular phosphate concentration promotes calcium 
uptake into cells (Borle, 1972). Therefore, cells were incubated 10 
tris-Ringer's solution to minimize the influx of calcium into the 
cells. In these cells iPGE and iTXB2 syntheses were only about one-
half those seen in the bicarbonate-Ringer's and phosphate-Ringer's 
solutions in the absence of exogenously added calcium (Fig. Bc). In 
tris-Ringer's solution raising the calcium concentration from 0 to 2 
roM increased both iPGE and iTXB2 synthesis by identical amounts and 
the absolute amounts synthesized were less than those found in the 
other 2 buffer media containing phosphate. 
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EFFECTS OF THROMBOXANE SYNTHETASE INHIBITORS ON VASOPRESSIN-STIMULATED 
WATER FLOW AND ARACHIDONIC ACID METABOLISM 
Effects of imidazole. Imidazole at low concentrations 1S a 
selective inhibitor of thromboxane synthetase (Moncada et al., 1977; 
Needleman et al., 1977). In addition, imidazole has been shown to 
inhibit vasopressin-stimulated water flow (Puig Huset et al., 1972). 
In the presence of 1 roM imidazole, basal iTXB
2 
synthesis was not 
different from control (Table III). In control hemibladders vaso-
pressin (5 mD/ml) increased iTXB2 synthesis 136.3±lB.4% (p<O.OOl, 
n=12). In imidazole-pretreated hemibladders iTXB
2 
synthesis was 
stimulated by vasopressin 72.8±11.3% (p<O.OOl, n=12), that is, 44±10% 
less (p<O.OOl, n=12 pairs) than the stimulation of control rate. In 
the control hemibladders vasopressin-stimulated water flow was 47.7± 
5.0 mg/min/hemibladder, compared to 37.0±3.5 mg/rnin/hemibladder in 
the imidazole-pretreated hemibladders, an inhibition of 23.2±4.4% (p 
< 0.02, n=12 pairs). Since imidazole has been reported to cause 
shunting of endoperoxide intermediates from TXA2 to other prosta-
glandins (Nijkamp et al., 1977), iPGE synthesis was measured in these 
hemibladders. Basal iPGE synthesis was not affected by imidazole (1 
mM) (Table III). However, vasopressin-stimulated iPGE synthesis was 
0.30±0.04 pmol/min/ hemibladder in control hemibladders compared to 
O.41±0.04 pmol/min/hemibladder in the imidazole pretreated hemibladders 
(p < 0.001, n=11 pairs). Thus, the reduction in vasopressin-stimulated 
water flow observed in this experiment may have been caused, not by 
an inhibition of iTXB
2 
synthesis, but by enhanced iPGE synthesis. 
In further experiments imidazole was found to stimulate vaso-
'1 
pressin-stimulated iPGE synthesis in a dose-dependent manner at 
TABLE III 








































Water flow was measured gravimetrically, iTXB
2 
and iPGE by radioimmunoassay. All values are mean ± S.E.M.; 
n given in parentheses. The experiments carrIed out in the presence of 1 roM imidazole were performed in 
January, those in the presence of 50 mM imidazole, in May. Endogenous steroid levels are considered to be 
high in the winter, resulting in high vasopressin-stimulated water flow (Handler ~!-. ':11., 1969) and these 





concentrations from 0.01 to 1.0 roM (Fig. 9) Imidazole at high concen-
trations has been reported to inhibit cyclooxygenase as well as throm-
boxane synthetase. In toad bladders imidazole (50 roM) inhibited 
vasopressin-stimulated iTXB
2 
and iPGE syntheses (Table III) while 
stimulating vasopressin-stimulated water flow (Table III). Thus, 
imidazole, at a high concentration (50 roM) acted in the same manner 
as other cyclooxygenase inhibitors (Zusman et al., 1977) to enhance 
the response to vasopressin, presumably by inhibiting PGE synthesis. 
Effects of 7-(1-imidazolyl)-heptanoic acid (7IRA). 7IHA has 
been reported to be a specific thromboxane synthetase inhibitor which 
has no effects on cyclooxygenase activity (Yoshimoto et al., 1978). 
7IRA was synthesized by Mr. Tom Eller in the laboratory of Dr. Daniel 
R. Knapp as previollsly described (Burch et al.) 1980). 7IRA caused 
a dose-dependent inhibition of vasopressin-stimulated water flow, 
reaching a maximum inhibition of 30±10% (p < 0.05) at a concentration 
of 50 ~M (Fig. 10). 7IRA also inhibited iTXB2 synthesis in a dose-
dependent manner (Fig. 10). Vasopressin-stimulated iPGE synthesis 
was not affected by 7IRA, even at concentrations as high as 500 ~M 
(Fig. 10). 
To determine whether 7IHA inhibited vasopressin-stimulated water 
flow by a mechanism not related to TXA2 synthesis inhibition, the 
effect of 7IHA on vasopressin-stimulated water flow was assessed in 
the presence of fatty acid cyclooxygenase inhibitors. Hemibladders 
were pretreated with indomethacin (50 ~M) or meclofenamate (1 ~M) 
for 1 hour prior to water flow measurements. Vasopressin was added 
at a low concentration (0.2 mU/ml) since cyclooxygenase inhibitors 
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Figure 9. Effect of imidazole on vasopressin-stimulated iPGE 
synthesis. Hemibladders were incubated in flasks in the pre-
sence of imidazole for 30 minutes. Paired hemibladders were 
used as controls. Vasopressin (5 mU/ml) was added and synthesis 
was measured for 30 minutes. 
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Figure 10. Dose-response relationships for the inhibition of 
vasopressin-stimulated water flow, and iTXB2 and iPGE syntheses 
by 7-(1-imidazolyl)-heptanoic acid. Inhibition of water flo~ 
and iTXB2 synthesis became significant (p < 0.05) at 50 ~M 
7IHA. No significant inhibition of iPGE synthesis occurred. 
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et al., 1978). 7IRA (100 ~M) had no effect on basal or vasopressin-
stimulated water flow in the presence of indomethacin or meclofenamate 
(Table IV). The magnitude of the water flow response to vasopressin 
in the presence of meclofenamate was less (p < 0.02) than the response 
in the presence of indomethacin, a phenomenon often attributed to 
phosphodiesterase inhibition by indomethacin (Flores and Sharp, 1972). 
In addition, the effects of 7IRA in the presence of meclofenamate on 
a high concentration of vasopressin was assessed. Again, 7IRA had 
no effect (Table IV). Exogenous cAMP stimulates water flow across 
the toad urinary bladder but does not affect iTXBZ synthesis. Pre-
treatment of hemibladders with 7IRA (100 ~M) for 1 hour did not 
significantly alter the water flow response to cAMP compared to con-
trol hemibladders (Table IV). 
EFFECTS OF TXA2 ANTAGONISTS ON VASORPESSIN-STlMULATED WATER FLOW 
trans-13-Azaprostanoic acid. LeBreton et a1. (1979) described 
trans-13-azaprostanoic acid (t13APA) as an antagonist of either TXA2 
or PGH
2 
in the platelet, which does not alter arachidonic acid metabo-
lism. Two series of experiments were performed with t13APA. In the 
first, 50 ~M and 100 ~M concentrations of t13APA were found to inhibit 
vasopressin (5 mU/ml)-stimulated water flow in a dose-dependent manner, 
reaching a maximum inhibition of 33±7% (p < 0.05, n=6 pairs) (Fig. 
11). In the second experiment, concentrations of t13APA of 100 ~M 
and 300 ~M also inhibited vasopressin-stimulated water flow in a 
dose-dependent manner, reaching a maximum inhibition of 30±6% (p < 
0.05, n=9 pairs). Two different shipments of toads were used in 
these experiments, consequent~y, the absolute magnitud~s of responses 
in the 2 experiments were different. However, in each experiment 
TABLE IV 
EFFECTS OF 7-(1-IMIDA20LYL)-HEPTANOIC ACID ON PROSTAGLANDIN-









Vasopressin, 0.1 mU/ml 
7IHA Control 7IHA 
3.4±O.6 8.6±1.5 lO.1±1.7(5) 
1.210.3 37 .116.4 34.6±6.2(10) 
Vasopressin, 5 mU/ml 
1.4±O.4 65.9±10.4 63.1±8.6(8) 
cAMP, 0.5 DIM 
1.3±O.6 19.2±2.3 18.6±4.3(5) 
Values are mean ± S.E.M. Number of hemibladders in each group is given in 
parentheses. Concentration of 7IRA was 100 ~M, meclofenamate, 1 ~M, and 
indomethacin, 50 ~M. Preincubation was for 1 hour. The experiments were 





























Figure 11. Dose-response relation for inhibition of 
vasopressin-stimulated water flow by t~ans-13-aza­
prostanoic acid. Slopes obtained for the two series 
of experiments were not significantly different (p > 
0.05). The two series were pooled, yielding a common 
line of inhibition of vasopressin-stimulated water 
flow y = 45.7x - 68.9. Inhibition was significantly 




vasopressin-stimulated water flow was significantly inhibited compared 
to control, and in each experiment a dose-response relationship was 
evident. 
In an effort to determine whether t13APA depends on TXA2 synthesis 
to inhibit vasopressin-stimulated water flow several experiments 
were performed to assess the effects of t13APA (300 ~M) on vasopressin-
stimulated water flow in the presence of indomethacin or meclofenamate. 
Like 7IHA, t13APA did not affect vasopressin-stimulated water flow 
in the absence of TXB2 or PGE synthesis (Table V). Similarly, t13APA 
(300 ~M) did not affect cAMP-stimulated water flow (Table V). 
cis-13-azaprostanoic acid. In the platelet the cis isomer of 
13-azaprostanoic acid is inactive as an antagonist of TXA2 (LeBreton 
et al., 1979). In the toad bladder, at a concentration of 300 ~M, 
c13APA had no effect on water flow stimulated by 1.0 mD/ml vasopressin. 
In the control hemibladders water flow was stimulated from 1.4±O.4 
to 42.5 mg/ min/hemibladder and in the hemibladders pretreated with 
cI3APA (300 ~M) water flow was stimulated from I.S±O.S to 40.3±3.2 
mg/min/hemibladders (n=6 pairs) (difference between stimulated water 
flows not significant). 
EFFECTS OF TXA2 MIMETICS ON WATER FLOW 
Since TXA2 synthesis inhibitors and TXA2 antagonists inhibited 
vasopressin-stimulated water flow it became of interest to assess 
the effects of TXA2 itself on vasopressin's actions. However, the 
extreme lability of TXA2 precluded direct. testing of its effects on 
water flow. Thus, stable corapoundswhich mimic TXA2 's actions were 
sought. The stable prostaglandin endoperoxide analogs (15Z)-hydroxy-
9a,11a-(epoxymethano)prosta-SZ, 13E-dienoic acid (U44069) and its 
TABLE V 
EFFECTS OF trans-13-AZAPROSTANOIC ACID ON PROSTAGLANDIN-





Control t13APA Control 
Meclofenamate 1.8±0.8 2.0±1.1 12.2±2.2 
Indomethacin 2.9±1.0 2.6±0.6 28.6±4.2 
cAMP, 







Values are mean ± S.E.M. Number of hemibladders in each group is given 
in parentheses. Concentration of t13APA was 300 ~M, meclofenamate, 1 ~M, 
and indomethacin, 50 ~M. Preincubation was for 1 hour. The experiments 
were performed in bicarbonate-Ringer's solution. 
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11a,9a-(epoxymethano) analog, U46619, possess biological activity 
that mimic the actions of TXA2 and/or the prostaglandin endoperoxides 
in platelets and aortic strips (Malmsten, 1976). TXB2 , the stable 
metabolite of TXA2 , has also been shown to exhibit actions similar 
to TXA2 in the cardiovascular system (Friedman et al., 1979). 
Effects of U44069 and U46619 on iTXB2 synthesis. U44069, in 
addition to acting as a prostaglandin endoperoxide/TXA2 agonist, has 
been reported to be a thromboxane synthetase inhibitor (Diczfalusy 
and Hammarstrom, 1977). At a concentration of 1 ~M, U44069 had no 
effect on basal iTXB2 synthesis (Table VI). However, U44069 signif-
icantly inhibited vasopressin (5 mU/ml)-stimulated iTXB2 synthesis 
46.8±6.2% (p<O.Ol, n=6) (Table VI). U46619 (1 ~M) had no effect on 




, U44069, and U466I9 on basal water flow. In 
hemibladders not pretreated with indomethacin or meclofenamate, U46619 
(1 ~M) caused a significant increase in basal water flow, from 2.8±O.S 
to S.7± 0.9 mg/min/lOcm2 (p<0.05, n=5) when measured over a 30 min 
period, whereas U44069 tended to increase water flow (3.0±0.6 to 
4.4±1.2 mg/min-10cm2 , 0.10 < P > 0.05, n=5). To reduce the contribu-
tion of variable amounts of endogenous TXA2 to the water flow response, 
hemibladders in the remaining experiments were pretreated with indo-
methacin (50 ~M) or meclofenamate (10 ~M) for 1 hr before the addition 
of the agonists. Both U44069 and U46619 stimulated basal water flow 
in indomethacin-pretreated hemibladders (Fig. 12). U44069 (1 ~M) 
stimulated basal water flow from 4.2±0.B to 12.4±I.2 mg/min/lOcm2 
(p< 0.05, n=5) , or from 4.2±0.8 to 9.1±1.1 mg/min/ISO mg hemibladder 
wet weight (p<O.05, n=5) (Methods). U46619 was more effective than 
U44069, 1 JJH 
Control 
U44069 




EFFECTS OF U44069 AND U46619 ON BASAL AND 














~P < 0.05, compared with basal rate. 
P < 0.01, compared with vasopressin-stimulated controls. 
Vasopressin concentration was 5 rnD/ml. Hemibladders were preincubated 
with U44069 or U46619 for 30 min, n=6 pairs, each group. 
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Figure 12. Stimulation of water flow in response to the endoperoxide/ 
1~~2 agonists U44069 and U466l9. Hemibladders were pretreated with 
indomethacin (50 ~M) for one hour. Basal water flow was measured 
for 30 minutes, then U44069 (filled circles) or U46619 (open circles) 
(1 ~M) was added to the serosal bathing media and water flow ~as 
measured for 30 minutes. Each point represents the mean + SDI for 
5 hemibladders. *p < 0.05, **p < 0.01, compared with basal. 
U44069, increasing water flow from 2.8±1.O to 21.8±2.2 mg/min/lOcm2 
(p<O.Ol, n=5), or from 2.6± 1.0 to 17.1±1.9 mg/min/lS0 mg (p<O.OI, 
n=S). A lower concentration U46619 (0.1 ~M) stimulated basal water 
flow from 2.7± 1.1 to 13.4±1.0 mg/min/lOcm2 (p<O.02, n=S) , or from 
2.5±1.0 to 10.1±O.9 mg/min/lS0 mg (p<O.OS, n=5). 
TXB2 stimulated basal water flow in a dose-dependent manner 
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(Fig. 13). The highest concentration of TXB 2 used, 50 ~M, stimulated 
basal water flow from 2.1±0.3 to IS.9±O.8 mg/min/lOcm2 (p<O.02, n=4) , 
or from 2.1±O.3 to 14.3±O.7 mg/min/ISO mg (p<O.OS, n=4). To determine 
that the stimulation of basal water flow was not due to some nonspecific 
effect of prostanoic acid derivatives, the effect of PGE 1 was assessed 
on basal water flow. PGE 1 (2.5 ~M) caused no change in basal water 
flow (2.1±O.8 to 2.3±O.6 mg/min/lOcm 2 , n=5) , confirming previous 
observations (Lipson and Sharp, 1971). 
Effects of trans and cis-13-azaprostanoic acid on TXB 2- and 
U46619- stimulated water flow. As described above, in the toad bladder, 
t13APA, a TXA2 antagonist (LeBreton et a1., 1979), had no effect on 
basal water flow, but inhibited vasopressin-stimulated water flow. 
Further, t13APA had no effect on vasopressin-stimulated water fow in 
the presence of inhibitors of fatty acid cyclooxygenase. Thus, the 
effects of t13APA on water flow stimulated by TXB2 and U46619 in the 
presence of indomethacin (50 ~M) were assessed. t13APA (300 ~M) 
inhibited TXB2 (25 ~M)- stimulated water flow 79±9% (p<O.02, n=5). 
t13APA also antagonized the effects of U46619 in a dose-dependent 
fashion (Fig. 14). At a concentration of 300 ~M, t13APA completely 
inhibited the water flow response to 0.1 ~M U46619 (Fig. 14). Since 
indomethacin inhibits cyclic nucleotide phosphodiesterase in addition 
---. 
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Figure 13. Dose-response relation for stimulation of 
osmotic water flow by TXB2- Hemibladders were pretreated 
with indomethacin (50 ~) for 1 hour. Basal water flow 
was measured for 30 min (n=10). TXB2 was added to the 
serosal bathing media and water flow was measured for 
three consecutive 10 min periods. Each point represents 
the mean + SEM for 3 or 4 heimibladders during the first 
10 min period. Each point is significant at p < 0.05 or 
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Figure 14. Inhibition of U46619-stimulated water flow by trans-13-aza-
prostanoic acid. The abscissa represents the molar concentration ratio 
of trans-13-azaprostanoic acid (13APA) to U466l9. The filled circles 
represent hemibladders pretreated with indomethacin (50 ~M) and the 
open circle represents hemibladders pretreated with meclofenamic acid 
(1 ~M) for 1 hour. The hemibladders were then preincubated for 10 
minutes with trans-l3-azaprostanoic acid prior to the addition of 
U46619. Each point represents the mean + SEM for 5 hemibladders. 
Inset: Inhibition of U46619 (0.1 ~M)-stimulated water flow by 
trans-13-azaprostanoic acid (300 ~M). 13APA was added to the experi-
mental hemibladders (open circles) and U466l9 (closed circles) was added 
to the control hemibladders. *p < 0.05, n = 5 pairs. 
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to cyclooxygenase (Flores and Sharp, 1972), the effect of t13APA on 
U46619-stimulated water flow was assessed in the presence of another 
cyclooxygenase inhibitor, meclofenamate, which does not inhibit 
phosphodiesterase (Alexander et al., 1975)« At a molar concentration 
ratio of 300:1 t13APA inhibited U46619-stimulated water flow 65±6% 
(p<O.02, n=5) in meclofenamate- (1 ~M) pretreated hemibladders while 
U46619-stimulated water flow was inhibited 64±6% in indomethacin (50 
~M)-pretreated hemibladders (Fig. 14). The absolute levels of TXB
2
-
and U46619-stimulated water flow were significantly (p<O.05) greater 
in the indomethacin-pretreated hemibladders (22.3±1.8 mg/min/IO cm2 
in the presence of U46619) than in the meclofenamate-pretreated hemi-
bladders (12.6± 1.2 mg/min/IO cm2 in the presence of U46619). Since 
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this concentration of indomethacin has been previously shown to inhibit 
cyclic nucleotide phosphodiesterase in the toad bladder (Flores and 
Sharp~ 1972), the increased water flow in the presence of indomethacin 
compared with meclofenamate suggests that these agents could be acti-
vating adenylate cyclase. 
The cis isomer of 13-azaprostanoic acid is inactive as an antag-
onist of TXA2 or the endoperoxide/TXA
2
-1ike agent U46619 (LeBreton 
et al., 1979). Thus, we tested the effects of c13APA on U46619-
stimulated water flow. At a concentration of 300 ~M, c13APA had no 
effect on water flow stimulated by 0.1 ~M U46619. In control hemi-
bladders U46619 stimulated water flow from 2.4±O.S to 14.8±1.3 mg/ 
min/10cm2 , and in the c13APA-pretreated hemibladders, water flow was 
stimulated from 1.7±O.6 to 13.6±3.2 mg/min/10cm2 . 
Effect of phosphodiesterase inhibition on U46619-stirnulated water 
flow. The observation that U46619 elicited a greater water flow 
68 
response in the presence of indomethacin than meclofenarnate suggested 
that U46619 may mimic vasopressin by enhancing the intracellular 
accumulation of cAMP since indomethacin has been shown in the toad 
bladder to be a phosphodiesterase inhibitor (Flores and Sharp, 1972). 
In the mammalian uterus U44069 has been shown to enhance cAMP accumu-
lation (Vesin et al., 1979). To test this hypothesis hemibladders 
were pretreated with meclofenamate, which has been shown to not inhibit 
phosphodiesterase. Three separate experiments were then performed. 
In the first, one hemibladder of each pair was treated with theophyl-
line (0.5 roM), a concentration which only minimally affected water 
flow itself (Table VII). Next, to both hemibladders of each pair 
was added U46619 (1 ~M). By itself, U46619 stimulated water flow 
from 1.8±O.4 to 12.2±O.8 mg/min/IO cm2 (~= 10.2±0.S) in the first 10 
min. In the hemibladders which had been pretreated with theophyl-
line, U466l9 stimulated water flow from 4.0±O.6 to 19.4±1.2 mg/minl 
10 cm2 (~=lS.6±O.8). The ~ in the presence of theophylline was 
statistically different from U46619 alone (p<O.Ol, n=6 pairs). Since 
the possibility remained that the greater response to U46619 in the 
presence of theophylline was due to an effect of theophylline added 
to an effect of U46619, additional experiments were performed. In 
one series of experiments theophylline was added to one hemibladder 
of each pair and U46619 to the other. Theophylline elicited a slight 
water flow response which was maintained (Table VII) while U46619 
elicited its usual transitory response. After 10 min the 6 for water 
flow across the hemibladders pretreated with U46619 was 11.2±0.9 
mg/min/ 10 cm 2 while the 6 for water flow was 2.0±O.9 mg/min/l0 cm2 
in the theophylline-pretreated hemibladders. In another series of 
TABLE VII 
EFFECTS OF PHOSPHODIESTERASE INHIBITION ON U46619-STlMULATED 
WATER FLOW 
Treatment WATER FLOw (mg/min/IO cm2 ) 
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a Basal ± Theopbylline Theophylline n Basal TheoPByl- ±U46 , ±U46d line 10 mine 20 min 
U46619 I.S±0.2 1.B±0.4 12.2:tO.S8 3.2±0.Se 
U466I9 + Theophylline (6) I.3±O.3 4.0±O.6f 19.4±1.2g,l 7.8±1.2g,m 
Theophylline (0.5 mM) 1.9±O.4 4.1±0.ge ,f 4.0±O.g3 3.4±O.6e 
U46619 (1 1-111) (9) 2.l±O.3 2.4±0.4 13.1±0.9g ,h 3.6±O.4e 
Theophylline 1.6±0.3 4.1±1.0e 4.1±1.2e 3.7±0.ge 
U46619 + Theophylline (9 ) 1.7±O.4 4.3±1.0 21.9±3.0 i ,j B. 3±1. 6g , k 
a Basal water flow is the average of two 10 min periods, b theophyl-
line (T) (0.5 mM) was added to the appropriate bemibladders and water 
flow measured for 10 min. c U46619 (1 ~M) was added aO the appropriate 
hemibladders and water flow was measured for 10 min, a second to min 
period of incubation with U46619, e p < 0.05 compared tg Basal, p < 
0.05 compared to U46619, g.p < 0.01 compared to basal, p < 0.02. 
compared to theophylline, 1 p < 0.001, compared to tieophylline, J p < 
0.02 compared to ¥46619, above (unpaired analysis), p < 0.02 compared 
to theophylline, p < 0.02 compared to U46619, m p < 0.05 compared 
to U46619. 
All hemibladders were pretreated with meclofenamate (10 ~M) for 1 hour 
prior to the beginning of the basal periods. Paired hemibladders were 
used. 
experiments run concurrently with the last, theophylline was added 
to both hemibladders of each pair. Then U46619 was added to one 
hemibladder of each pair. Again, theophylline elicited a slight, 
sustained increase in water flow (Table VII) while U46619 elicited a 
transitory increase. After 10 min the ~ for water flow response to 
U46619 plus theophylline was 17.8±3.0 mg/min/IO cm2 while the ~ for 
the response to theophylline alone was 2.4±O.2 mg/ min/IO cm2 . By 
unpaired! analysis, the ~ for U46619 plus theophylline (17.8±3.0) 
was significantly different (p<O.02, n=18) from the ~ for U46619 
alone (11.2±D.9) while ~ for theophylline alone was the same in the 
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2 experiments (2.0±O.9 versus 2.4±O.2) using this protocol. Thus, 
U46619 appeared to have a greater effect in the presence of theophyl-
line, at least when the response is considered as the absolute incre-
ment in water flow. 
Effects of U46619 on vasopressin-stimulated water flow. Because 
TXA2 may be a positive modulator or partial mediator of vasopressin-
stimulated water flow, the effects of the endoperoxide/TXA2 agonist 
U46619 were assessed on vasopressin-stimulated water flow in indometh-
acin-pretreated hemibladders. Vasopressin and U466I9 (1 ~M) were 
added simultaneously to the experimental hemibladders. Water flow 
was determined for 30 min. Vasopressin stimulated water flow in a 
dose-dependent manner from 0.1 to 2.0 mU/ml vasopressin (Fig. 15). 
U46619 (1 ~M) significantly increased water flow in this concentration 
range of vasopressin, but, by paired-t analysis the effect was not 
significant at the 2.0 mU/ml concentration. The dose-response curve 
was significantly shifted to the left (p<O.OOI) in a parallel fashion 
(slopes of 0.64 and 0.62, control and U46619, respectively) suggesting 
100 
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Figure 15. Effects of U46619 on vasopressin-stimulated water flow. 
Hemibladders were pretreated with indomethacin (50 ~M) for 1 hour. 
Vasopressin (closed circles) or vasopressin plus U46619 (1 ~N) 
(open circles) was added to the serosal baths and water flow was 
measured for )0 minutes. After thorough washing to return water 
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flow to basal level and a 30 minute recovery period, a supramaximal 
dose of vasopressin (10 mU/ml) or vasopressin plus U46619 was added 
and water flow was measured for another )0 minutes. Water flow is 
expressed as a percentage of this maximal response (64.3+4.6 mg/minute 
per 10 cm2 , n=72). Each point represents the mean+SEM for 6 hemi-
bladders. U46619 significantly (p<O.OOl) increased vasopressin-
timulated water flow and significantly shifted the dose-response 
curve to the left (p<O.OOl) in a parallel fashion (slopes were 0.64 
for the control hemibladders and 0.62 for the U46619-treated hemi-
bladders). 
that vasopressin and U46619 are acting on the same sequence of events 
to increase water flow. 
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DISCUSSION 
In these studies incubation of toad urinary bladder homogenates 
with [14C]-arachidonic acid resulted in the synthesis of at least 2 
radioactive products corresponding to [ 14C]_PGE and [14C]-TXB
2
. The 
synthesis of PGE by the isolated toad urinary bladder has been 
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described previously (Zusman et al., 1977). In this study, the pres-
ence of TXB2 synthesized from endogenous arachidonic acid was verified 
by gas chromatography-mass spectrometry and quantitated using a specific 
radioimmunoassay. 
In a previous study of [3H]-arachidonic acid metabolism by the 
toad urinary bladder, Zusman et ale (1977) demonstrated an increased 
release of [3H]-arachidonic acid induced by vasopressin and increased 
[3H)-PGE synthesis. However, they did not report any synthesis of 
[3H]-TXB2 . However, the synthesis of TXB2 
by the isolated toad urinary 
bladder and epithelial cells derived from it was recently confirmed 
by another laboratory (Bisordi et al., 1980). This study confirms 
that vasopressin stimulates iPGE synthesis and demonstrates that 
iTXB2 synthesis is also stimulated by vasopressin. Thus, vasopressin, 
by stimulating an acyl hydrolase, resulting in the increased release 
of arachidonate from membrane-ester storage sites, increased the 
synthesis of not only PGE2 , but also TXA2 - In a very recent study 





, and that syntheses of both compounds 
were rapidly stimulated by vasopressin. 
Exogenous cAMP stimulated water flow but did not affect TXA2 
synthesis. Thus, these studies suggest that vasopressin stimulates 
TXA2 synthesis separate from cAMP synthesis, similar to its effect 
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on PGE2 synthesis (Zusman et a1., 1977). TXA2 synthesis was stimu-
lated by vasopressin whether or not an osmotic gradient existed across 
the bladders. Thus, stimulation of TXA2 synthesis appeared to be a 
direct effect of vasopressin and not secondary to enhanced water 
movement. 
Vasopressin-stimulated iPGE synthesis reached a maximum during 
the first 8-min period after the addition of vasopressin (20 mD/ml) 
and remained unchanged until after water flow began to decline toward 
basal rate. This observation is qualitatively similar to the obser-
vations of Zusman et al. (1977) who also reported that vasopressin 
(1 mU/ml) stimulated iPGE synthesis within the first 10 min and 
remained unchanged over a period of 40 min. The vasopressin-stimu-
lated synthetic rate reported by Zusman et al. (1977) was 10 times 
higher than basal, whereas that in the present study was only 2 times 
higher. Although an explanation for the differences is not known, 
geographical source, housing, and season, 3 variables that may influ-
ence synthetic rate, must be considered. However, the observations 
made in the 2 studies are consistent with PGE playing a part in a 
negative feedback loop where vasopressin stimulates PGE synthesis 
which in turn negatively modulates vasopressin's action. 
Vasopressin stimula~ion of iTXB2 synthesis and water flow 
occurred in parallel, but iTXB2 synthesis peaked prior to maximum 
water flow. This is consistent with a positive modulator role for 
TXA2 in vasopressin-stimulated water flow in which stimulation of 
TXA2 synthesis leads to enhanced water flow. Since the bladders 
responded to TXB2 with a water flow response, TXB2 may not be excluded 
as the active metabolite. However, in many systems it is found that 
TXA2 is much more active than TXB2 (Friedman et a1., 1977). In the 
present studies high concentrations of TXB
2 
were required to elicit 
the water flow response. 
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Epithelial cells isolated from toad urinary bladders via several 
methods synthesize iPGE and iTXB2 and the rates of synthesis of these 
substances vary with respect to the method of isolation and the extra-
cellular calcium concentration. The collagenase method for isolating 
epithelial cells from toad bladders was described by Gatzy and Berndt 
(1968) who compared it to an EDTA method. They found that cells 
isolated using collagenase retained vasopressin responsiveness as 
judged by enhanced oxygen consumption and that the cells appeared to 
be anatomically intact as judged by electron microscopy. Modifica-
tions of this method have been widely used to prepare toad bladder 
epithelial cells which respond to vasopressin (Wiesmann et al., 1977; 
MacKnight et al., 1971) and other agents (Arruda and Sabatini, 1980a,b). -. -
Using this isolation technique, we found that vasopressin as well as 
its non-pressor-antidiuretic analog, dDAVP (Zaoral et al., 1967; 
Vavra et al., 1968; Sawyer et al., 1974), stimulate iPGE and iTXB2 
synthesis in epithelial cells, confirming previous observations in 
intact hemibladders (Zusman et al., 1977; Burch et al., 1979). 
Vasopressin increases urinary excretion of PGE in normal rats 
and in rats with congenital diabetes insipidus (Walker et a1., 1978; 
Dunn et al., 1978); vasopressin also stimulates PGE2 synthesis in 
cultured renomedullary intersitial cells and isolated perfused rabbit 
kidneys, but, in contrast, dDAVP does not (Beck et al., 1980; Zipser 
et a1., 1981). This has led to the hypothesis that enhanced urinary 
PGEZ excretion is associated only with the pressor component of 
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vasopressin and is unrelated to its antidiuretic action (Beck et 
a1., 1980). However, it has been shown that Y 'p enhances iPGE 
excretion in rats with congenital diabetes ~idus (Dunn et al., 
1980; Walker & Frolich, 1980; Walker & Frc ,1981) and in human 
patients with central diabetes insipidus (I 19 e~ a~., 1980). The 
previous observations, coupled with the pre~ ~tudy demonstrating 
that vasopressin and dDAVP stimulate iPGE and ~ synthesis in 
toad bladder epithelial cells, are consistent with the notion that 
in vivo the antidiuretic component of these peptides is associated 
with stimulation of the synthesis of prostaglandins and thromboxanes 
in collecting tubules. 
It was reported in a previous study that vasopressin did not 
stimulate iPGE or iTXB2 synthesis in scraped epithelial cells (Bisordi 
et a1., 1980). Utilizing the same procedure, basal synthesis rates 
for iPGE and iTXB2 similar to that study were obtained, and no stimu-
latory effect of vasopressin was observed. The basal synthetic rates 
of iPGE and iTXB2 in the scraped cells were 10- and 30-fold greater 
than those observed in the cells prepared by using collagenase. 
Scraping the bladders to prepare the cells is clearly deleterious as 
evidenced by the much lower viability, i.e. 52% trypan blue exclusion. 
Trauma is an effective nonspecific stimulus for activating phospholi-
pase (McMurray ,and MaGee, 1972) and since vasopressin appears to 
stimulate PGE and TXB2 synthesis via activation of this group of 
enzymes trauma may mask vasopressints effect. Thus, it would appear 
that isolating cells via a scraping procedure is not suitable either 
for studying the effects of vasopressin and dDAVP or other hormones 
on endogenous arachidonic acid metabolism or studies on the effects 
of prostaglandins and thromboxanes on cellular functions. 
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Using the EDTA technique to prepare cell suspensions, we observed 
no stimulation of iPGE or iTXB2 synthesis with AVP. Gatzy and Berndt 
(1968) found this technique to damage toad bladder cells anatomically 
and to render them insensitive to vasopressin or other agents as 
assessed by a failure of these agents to alter oxygen consumption. 
Scott and Sapirstein (1974) reported that vasopressin caused enhanced 
accumulation of cAMP in toad bladder epithelial cells prepared by 
this method, but Handler and Preston (1976) were unable to confirm 
those observations. Thus, it appears that the EDTA technique is 
associated with irreproducible results and may not be appropriate 
for use in obtaining consistently viable cells. 
iTXB2 synthesis was nearly 20-fold greater in the cells pre-
pared by the EDTA method compared to the collagenase method when 
incubated in bicarbonate-Ringer's solution with 1 roM calcium. In 
contrast, iPGE synthesis was similar in the cells prepared via either 
method. The reason for the reversal in the ratio of these 2 arachi-
donic acid products, produced by the preparative methods, is unknown. 
EDTA does not appear to have an effect on the catalysis of the endo-
peroxide intermediates to TXA2 by a purified thromboxane synthetase 
(Hammarstrom and Falardeau, 1977). Since EDTA is a commonly-used 
agent for preparing cell suspensions from a variety of tissues, the 
potential interactions between EDTA and arachidonic acid metabolism 
should be more carefully evaluated. 
Many phospholipases, the rate-limiting enzymes in prostaglandin 
and thromboxane synthesis, which catalyze the release of arachidonic 
acid from various membrane storage sites, require calcium (Kunze and 
Vogt, 1971). Not surprisingly, in the present study iPGE and iTXB
2 
syntheses in toad bladder epithelial cells were influenced by the 
calcium concentration in the bathing media. Previous studies of the 
effect of calcium on the metabolism of arachidonic acid by renal 
tissue have usually measured only a single end product. Therefore, 
a possible dual effect of calcium on arachidonate metabolism would 
not have been discovered. In rat inner medullary kidney slices, 
preincubation with calcium-free media and EGTA reduced PGE synthesis 
compared with control media (2.5 ruM Ca 2+) while the addition of the 
calcium ionophore A23187 to the control media enhanced arachidonate 
release and PGE synthesis (Zenser and Davis, 1978; Zenser et al., 
1980). When, the formation of two products was monitored 10 minced 
renal papillae, addition of A23187 enhanced PGE synthesis 5-fold 
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while PGF2a synthesis was enhanced only 2-fold (Oelz et al., 1978). 
Thus, when A23187 was used as the means to alter intracellular calcium, 
the synthesis of both PGE2 and PGF2a were increased. Surprisingly, 
in the cells isolated by the collagenase technique, increasing the 
calcium concentration from 0 to 1 roM did not alter the net amount of 
arachidonate metabolized to iPGE plus iTXB
2
, but rather resulted in 
enhanced iPGE synthesis at the expense of iTXB
2
. This unique effect 
of calcium on arachidonic acid metabolism has not been previously 
reported. 
This effect of calcium on arachidonic acid metabolism is consis-
tent with several possibilities. A single source of arachidonate 
may have been released by two different phospholipases, one control-
ling the release of arachidonate and coupled to the enzymatic pathway 
to PGE, and the other coupled to the pathway to TXB
Z
' Alternatively, 
the availability of the prostaglandin endoperoxide intermediates to 
the enzymes thromboxane synthetase and prostaglandin endoperoxide E 
isomerase may be influenced by the intracellular calcium content. 
While to our knowledge no precedent for the latter possibility has 
been reported, the recent work of Billah et ala (1980) demonstrates 
that multiple phospholipases may differentially control arachidonate 
release within a single cell. Obviously, additional explanations 
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for the present observations are tenable. Clearly, additional studies 
are necessary to determine if calcium can produce this unique effect 
on arachidonic acid metabolism in other intact cell systems. 
In the cells prepared by the EDTA method and incubated in bicar-
bonate- or phosphate-Ringer's solution, increasing the calcium concen-
tration from 0 to 0.1 ruM increased iPGE and iTXBZ syntheses, but 
further increasing the calcium concentration was associated with a 
decline of iPGE and iTXBZ syntheses toward the rates seen in the 
media with no added calcium. The cyclooxygenase has been reported 
to be localized to the endoplasmic reticulum and nuclear membranes 
(Rollins and Smith, 1980). Black et ale (1981) have reported that 
endoplasmic reticulum vesicles isolated from adipocytes and incubated 
in extracellular media containing varying amounts of calcium, sequester 
more calcium when the cells were incubated in media containing moder-
ately low concentrations of calcium compared to no added calcium. 
However, when extracellular calcium was raised to several mM, calcium 
sequestration by the subsequently isolated endoplasmic reticulum 
vesicles was inhibited toward the zero-calcium level. Similarly, 
Waite and Sisson (1972) found that increasing calcium concentration 
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from 0 to 1.0 roM was associated with an enhanced phospholipase A2 
activity in isolated rat liver mitochondrial membranes; however, 
increasing the calcium concentration further to as high as 5 roM caused 
a progressive inhibition of the phospholipase A2 activity. Thus, 
the present findings may be rationalized by suggesting that altered 
extracellular calcium concentration may modify intracellular calcium 
metabolism. This suggestion is strengthened by the observation that 
the calcium-induced increases in iPGE and iTXB2 synthesis in the 
phosphate-Ringer's solution were much greater than the increases in 
the bicarbonate-Ringer's solution. This phenomenon may be explained 
by the well-established effect of phosphate to increase intracellular 
calcium concentrations (Borle, 1972). That enhanced cellular calcium 
uptake may be involved is further supported indirectly by the present 
observation that in tris-Ringer's solution, which contains no anion 
to complex calcium, increasing extracellular calcium was associated 
with only a slight increase in iPGE and iTXB2 syntheses compared to 
the other 2 buffer media. That the large increases in synthetic 
rates were observed in the cells prepared by the EDTA method but not 
the collagenase method is consistent with the notion that the EDTA 
method produces cells which are damaged (Grenier and Smith, 1978) 
compared to the cells isolated by the collagenase method, damage 
which may be reflected by increased calcium permeability of the plasma 
membrane. 
It has been demonstrated previously that exogenously administered 
PGE inhibits vasopressin-stimulated water flow (Orloff et al., 1965) 
while administration of any of a number of cyclooxygenase inhibitors 
results in potentiation of vasopressin-stimulated water flow (Ozer 
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and Sharp, 1972; Zusman et al., 1977). Puig Huset et ale (1972) 
found that imidazole caused an inhibition of vasopressin-stimulated 
water flow in isolated urinary bladders of Bufo bufo. We have con-
firmed their observation using urinary bladders of B. marinus. 
Concentrations of imidazole (1 mM) which increased iPGE synthesis 
inhibited vasopressin-stimulated water flow and iTXB
2 
synthesis. 
Imidazole, 50 roM, a concentration which inhibited iPGE and iTXB
2 
synthesis by 88% and 84%, respectively, acted as a typical cyclooxy-
genase inhibitor to potentiate vasopressin-stimulated water flow. 
The biphasic action of imidazole on vasopressin-stimulated water 
flow is consistent with the accepted mechanism of PGE modulation of 
the permeability response to vasopressin (Orloff et al., 1965; Zusman 
et al., 1977). However, the possibility that TXA2 may be playing a 
role opposite to that of PGE
2 
in affecting vasopressin-stimulated 
water flow could not be ruled out. This proposal was attractive 
since Samuelsson et ale (1978) proposed that thomboxanes and prosta-
gland ins may act antagonistically toward one another as modulators 
of hormone action. 
Imidazole inhibited vasopressin-stimulated water flow. While 
this effect is consistent with a positive modulatory role for TXA2 
on vasopressin-stimulated water flow, the results could easily be 
accounted for by the enhanced iPGE synthesis caused by imidazole. 
In addition, imidazole has a variety of effects other than throm-
boxane synthetase inhibition. Imidazole activates phosphodiesterase 
(Butcher et a1., 1962). Imidazole is also known to reduce intracell-
ular mobilization of calcium (Yu et al., 1967) while vasopressin 
increases the release of 45Ca from prelabelled hemibladders (Thorn 
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and Schwartz, 1968). Thus, imidazole may have antagonized the action 
of vasopressin by decreasing the mobilization of intracellular calcium 
by a direct effect on calcium stores. The potential decreased avail-
ability of calcium at high concentrations of imidazole may play a 
role in the decreased synthesis of both PGE and TXB
2
, since phospho-
lipases, the enzymes catalyzing the rate-limiting step in prosta-
glandin and thromboxane synthesis (Kunze and Vogt, 1971) are often 
calcium-requiring enzymes (McMurray and Magee, 1972). Imidazole is 
also known to inhibit cyclooxygenase at high concentrations (Moncada 
et al., 1977). Thus, decreased activity of a phospholipase(s) or 
cyclooxygenase may account for the decreased synthesis of TXB2 and 
PGE found with imidazole (50 roM) in these studies. 
In an attempt to clarify any role for TXA2 in the action of 
vasopressin on water permeability in the toad urinary bladder, another 
~ 
thromboxane synthetase inhibitor, 7-(1-imidazolyl)-heptanoic acid 
(7IRA) was used. 7IRA, at concentrations of 10 ~M to 100 ~M, inhib-
ited vasopressin-stimulated iTXB2 synthesis and water flow, but did 
not affect iPGE synthesis. This is in contrast to imidazole, which 
caused increased iPGE synthesis at the same time that iTXB2 and water 
flow were inhibited. However, at a concentration of 500 ~M, 7IHA, 
while further inhibiting iTXB2 synthesis, did not further inhibit 
vasopressin-stimulated water flow. 
'In contrast to 7IRA, t13APA does not affect arachidonic acid 
metabolism (LeBreton et al., 1979). Furthermore, in several different 
tissues previously examined, t13APA only antagonized the actions of 
TXA2 or PGH2 , and not PGE2 or PGI Z (LeBreton et al., 1979). Thus, 
the use of t13APA, a TXA2 or PGH2 antagonist, which does not alter 
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arachidonic acid metabolism yet 1S dependent upon it to exert its 
antagonistic actions, permitted a further assessment of the role of 
TXA2 in vasopressin-stimulated water flow. t13APA inhibited vaso-
pressin-stimulated water flow in a dose-dependent manner. That TXA2 
is the active arachidonate metabolite and that PGH2 is not, is suppor-
ted by the observations that imidazole and 7IHA, agents that reduce 
the synthesis of TXA2 inhibited vasopressin-stimulated water flow, 
which would not be expected if PGH2 were the active compound. While 
PGH2 was not measured no evidence has been presented to suggest that 
imidazole or 7IRA affected PGH2 synthesis. The observations that 
imidazole increased PGE syntbesis and that 7IRA had no effect on 
iPGE synthesis suggest that PGH2 synthesis was not altered. That 
TXA2 is not an absolute requirement for vasopressin-stimulated water 
flow is supported by the observations that a high concentration of 
imidazole (50 mM) almost completely inhibited iTXB2 synthesis but 
increased vasopressin-stimulated water flow, and that fatty acid 
cyclooxygenase inhibitors also enhance vasopressin-stimulated water 
flow (Flores and Sharp, 1972; Zusman et al., 1977). The enhancement 
of vasopressin-stimulated water flow by imidazole (50 mM) and fatty 
acid cyclooxygenase inhibitors is presumably due to inhibition of 
PGE synthesis. 
To further assess the specificity of their action, the effects 
of 7IRA and t13APA were assessed on cAMP-stimulated water flow. 
cAMP does not affect the synthesis of PGE (Zusman et al., 1977) or 
iTXB2 - Neither 7IRA nor t13APA affected cAMP-stimulated water flow, 
further attesting to the specificity of the actions of these agents. 
84 
TXA2 is a short-lived intermediate of arachidonic acid metabo-
lism; therefore, direct demonstration of its effects in the toad 
bladder is technically difficult. Although TXB
2 
is generally cGnsid-
ered to be an inactive product of hydrolysis of TXA
2
, at higher con-
centrations it has been shown to exhibit actions similar to TXA2 
(Friedman et al., 1979). Thus, in the present studies, the effects 
of TXB2 and the stable endoperoxide/TXAi-like agonists U44069 and 
U46619 were assessed on the water flow response of the toad bladder. 
U46619 stimulated water flow in bladders that were not pretreated 
with cyclooxygenase inhibitors, while U44069 did not. The failure 
of U44069 to stimulate water flow may have been due to its simultan-
eous inhibition of TXA2 synthesis, which would perhaps, negate its 
agonistic properties. All three of these compounds stimulated basal 
water flow in indomethacin- or meclofenamate-pretreated hemibladders. 
The relative order of potency for the three compounds was similar to 
that which has previously been reported (Malmsten, 1976; Friedman et 
al., 1979). U46619 was two fold more potent than U44069, an observa-
tion that has been previously made in aortic strips (Malmsten, 1976). 
That the stimulation of water flow was not a nonspecific effect of 
prostanoic acid derivatives is borne out by the observation that 
PGE
1 
did not stimulate water flow. 
These compounds may be mimicking the action of either the prosta-
glandin endoperoxides or TXA
2
. That the active metabolite in the 
toad bladder is TXA2 and not the endoperoxide was discussed above. 
The complete pharmacology of these agents is not known. We have 
attempted to characterize some of their actions in the isolated toad 
bladder. U46619, U44069, and TXB2 three compounds of different 
structure, but which in a variety of tissues have similar actions 
(Malmsten, 1976; Friedman et al., 1979), all exhibited similar 
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actions in the toad bladder, at concentration ratios similar to those 
used in other tissues (Malmsten, 1976; Friedman et a1., 1979). These 
actions have been assumed in the past to mimic TXA2" However, defini-
tive evidence supporting this notion is lacking, and other actions 
of these compounds may exist. The effects of these compounds are 
antagonized by t13APA, but not by c13APA, properties consistent with 
specific receptor agonist activity (LeBreton et a1., 1979). Finally, 
these agents were studied in the absence of endogenous arachidonic 
acid metabolism to avoid the influence of possible alterations in 
the cellular actions of endogenous prostaglandins. Thus, while alter-
native explanations may exist for the observations reported herein, 
the data are consistent with the hypothesis that TXA2 may partially 
mediate the water flow response to vasopressin in the toad bladder. 
U46619 enhanced vasopressin-stimulated water flow to submaximal 
concentrations of vasopressin, resulting in a parallel shift in the 
dose-response curve. The parallel shift, while not ruling out other 
possibilities, supports the notion that vasopressin and U44619 are 
acting on the same pathway(s) leading to increased water flow. Since 
the response to vasopressin is enhanced, the step affected by the 
agonist may be rate-limiting at low doses. However, this step is 
not rate-limiting at high concentrations of vasopressin since the 
agonist did not enhance water flow to supramaximal doses of vaso-
pressin. 
In contrast to these observations, in a preliminary study, Ludens 
and Taylor (1979) found that U44069 and U46619 inhibited vasopressin-
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stimulated water flow in hemibladders not pretreated with cycloox~­
genase inhibitors. Their findings may be reconciled with ours in 
part, since U44069 inhibited vasopressin-stimulated iTXB
2 
synthesis 
(vide supra), which may account for the decrease in the vasopressin-
stimulated water flow response. However, TXB
2
, and U44069 and U46619 
also cause marked, sustained contraction of the hemibladders that 
reduced their surface areas ca. 5% and 25%, respectively. Therefore, 
simply weighing the empty hemibladder at the end of the experiment 
leads to a substantial overestimate of transporting surface in the 
agonist-treated hemibladders, with concomitant underestimation of 
water flow. Indeed, in preliminary experiments using the conditions 
of Ludens and Taylor (1979), without correcting for the decrease in 
surface area, we also observed a reduction in vasopressin-stimulated 
water flow in the presence of U44069 and U46619, compared with control 
hemibladders. However, in'these experiments, TXB
2
, U44069, and U46619 
all increased the absolute magnitude of basal water flow. 
In indomethacin- or meclofenamate-pretreated hemibladders, t13APA 
antagonized the increase in water flow due to U46619 or TXB
2
. In 
contrast, the inactive c13APA had no effect on U46619-stimulated 
water flow. Thus, these studies support the concept that t13APA 
specifically antagonizes a site of action common to both vasopressin 
and U46619. 
The significance of TXA2 as a mediator or modulator of vaso-
pressin-stimulated water flow is presently unknown. TXA2 synthesis 
inhibition or antagonism inhibit vasopressin-stimulated water flow 
to approximately 30%. Fatty acid cyclooxygenase inhibitors such as 
meclofenamate inhibit the synthesis of both PGE2 and TXA2 in the 
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toad bladder and augment vasopressin-stimulated water flow 40% (Bisordi 
et al., 1980) to approximately 100% (Zusman et al., 1977). In the 
toad bladder the synthesis rate of PGE is generally greater than 
that of TXA2 . Thus, the net result of complete inhibition of fatty 
acid cyclooxygenase would be expected to be augmentation of vaso-
pressin-stimulated water flow. The studies with fatty acid cyclo-
oxygenase inhibitors also point out that TXA2 synthesis is not an 
absolute requirement for vasopressin-stimulated water flow in the 
toad urinary bladder. 
Figure 16 summarizes the hypothesis constructed from the data 
which have been described. Vasopressin increases a phospholipase 
activity (Zusman and Keiser, 1977) in the epithelial cells of the 
toad bladder, resulting in the release of arachidonate from its 
storage pool in membrane phospholipids. Fatty acid cyclooxygenase 
catalyzes the conversion of arachidonate into the prostaglandin endo-
peroxides which have at least two possible fates, conversion to either 
PGE2 or TXA2" PGE2 acts as a negative modulator of vasopressin-
stimulated water flow (Orloff et al., 1965), and the present studies 
provide evidence consistent with a positive modulator role for TXA2 . 
Inhibition of prostaglandin synthesis by mepacrine, a phospholipase 
inhibitor (Zusman and Keiser, 1977), or by inhibitors of cyclooxy-
genase (Flores and Sharp, 1972; Zusman et al., 1977), result in 
increased vasopressin-stimulated water flow because of the removal 
of the negative modulator, PGE
2
. Inhibition of thromhoxane synthesis 
by imidazole or 7IHA, or thromboxane antagonism by t13APA, inhibit 
vasopressin-stimulated water flow. 
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Figure 16. Vasopressin-stimulated arachidonic acid metabolism and 
its modulation of vasopressin-stimulated water flow. Vasopressin 
stimulates (+) phospholipase activity and water permeability. The 
released arachidonic acid is converted to TXA2 which acts as a 
positive modulator (+) or to PGE which acts as a negative modulat~r 
(-) of vasopressin-stimulated water flow. Agents which inhibit each 
enzyme are denoted by dashed arrows directed toward the enzyme; 
llAPA 1s an antagonist of TXA2'S action. 
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CHAPTER III 
THE EFFECTS OF VASOPRESSIN AND TXA2-LlKE COMPOUNDS 
ON 45 Ca EFFLUX FROM ISOLATED TOAD URINARY 
BLADDER EPITHELIAL CELLS IN SUSPENSION 
INTRODUCTION 
45 Vasopressin has been shown to enhance Ca efflux from preloaded 
intact toad urinary bladders (Thorn and Schwartz, 1965; Schwartz and 
Walter, 1969; Cuthbert and Wong, 1974). This chapter describes experi-
ments examining 45 Ca efflux from isolated toad urinary bladder epithe-
lial cells. Epithelial cell suspensions were used instead of intact 
bladders because the agents which were to be tested are known to 
have effects on smooth muscle as well as epithelial cells in the 
toad bladder. Vasopressin is known to cause relaxation of toad 
bladder smooth muscle (Dibona and Civan, 1970) while U46619 was shown 
(Chapter II) to cause a marked contraction of smooth muscle in the 
toad bladder. Thus, use of isolated epithelial cells allowed any 
effects of the agents on 45Ca fluxes to be attributed soley to the 
epithelial cells, the presumed target for vasopressin's antidiuretic 
effect. 
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MATERIALS AND METHODS 
The following were purchased from commercial sources: 45CaC12 
(0.65-0.77 Ci!mmole), and Na 1251 (17 Ci!mg), The Radiochemical Center, 
Amersham, England; [methoxy- 3H]-inulin (14 mCi/g), New England Nuc-
lear Corp., Boston, MA; bovine serum albumin, RIA grade, and anti-
mycin A, Type III, isolated from Streptomyces kitazawaensis mycellia, 
KeN, and sodium metabisulfite, Sigma Chemical Co., St. Louis, MO; 
chloramine T, Eastman Kodak Co., Rochester, NY; other chemicals and 
reagents were supplied by the sources listed in Chapter II, Materials 
and Methods. 
[ 125 I]-Albumin was prepared by the chloramine T method: 2 ~g 
bovine serum albumin was dissolved in 20 ~l of 0.5 M phosphate buffer 
(pH 7.4) and 5 ~l (100 ~ Ci/~l) of Na 1251 solution was added directly 
from the shipping container. Chloramine T (17.5 mg chloramine T in 
5 ml of 0.05 M phosphate buffer (pH 7.4) in a light-tight container), 
5 ~l, was added and the solution was allowed to incubate for 60 sec. 
Stop solution ( 12 mg sodium metabisulfite in 5 ml of 0.5 M phosphate 
buffer), 40 ~l, was added and the tube shaken for 15 sec. The reac-
tion mixture was poured over a column (30 cm x 1 cm) of Sephadex 
GIOO which had been equilibrated with 0.05 M phosphate buffer (pH 
7.4) containing 2 ~g!ml bovine serum albumin and fractions collected 
at 1 ml/tube. The labelled albumin was collected in fraction 8. 
The nominal activity of [ 125I]-albumin was 200 mCi/g. The author 
wishes to thank Dr. Alfred Crosswell for the chloramine T methodology. 
Perturbation of 45Ca efflux. To each of 2 polycarbonate centri-
fuge tubes (15 ml) were added 3 ml of suspended cells (approximately 
2-3 mg protein) which had been isolated by the collagenase method. 
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The suspensions were placed into a water bath maintained constantly 
at 25°C. and stirred with teflon-coated magnetic stirbars under an 
atmosphere of 95% 02' 5% CO2 - To each suspension was added 10 ~Ci 
45Ca. Uptake of 45Ca label proceeded for 90 min (Fig. 17). At this 
time the suspensions were centrifuged in an IEC Model CL tabletop 
clinical centrifuge at high speed for 35 sec. The supernatant was 
decanted and retained for specific activity determination. The 
pellets were resuspended in nonradioactive media and centrifuged 
again to clear the intercellular spaces of trapped 4 5 Ca. The cells 
were centrifuged, the media collected, and the pellets resuspended 
at the end of 1,5,10 and each 10 min thereafter in a protocol 
suggested by Borle (1975). At the end of the experiment the pellet 
was dissolved in 0.1 N NaOH for several hours and aliquots were taken 
for 45Ca and protein determinations. Use of the Biosolve@-liquid 
scintillation cocktail (Chapter II) with the Beckman L8-355 counter 
was not associated with any quench, even in the presence of the 
unneutralized NaOH (cpm=9B±2% of predicted dpm at a range of 50 cpm 
to 200,000 cpm per vial). 4 5Ca remaining in the cells at each time 
point was determined by summing the radioactivity in the pellet with 
the radioactivity lost to the bathing media over each period. Experi-
mental manipulations were performed by adding the agents to one of 
the suspensions after efflux had been carried out for a specific 
period of time. The rate of 45Ca efflux was monitored as the percent 
45Ca remaining in the cells which has been lost per time period, or 
"instantaneous" first order rate constant (Butcher, 1980), as follows: 
kapp = cpmw/[(cpmcell(t) + cpmce1l (t+8t))/2]8t 








IOl ... IUII 
LA" CELL 
PlLLI' 

























IOl ... LIII 
LAST CILL 
PILLIT 















Figure 17. Flow scheme for the two types of 45Ca experiments. Experimental details 
are contained in the Methods. 
\.0 
W 
interval ~t, and [(cpmcell(t) + cpmcell(t+~t))/2] is the mean amount 
of radioactivity remaining in the cells during ~t. Usually the 
results are expressed as the ratio k . t l/k t l' app,experlmen a app,con ro 
but referred to as efflux . t l/efflux t 1· experlmen a con ro 
Steady state 4 SCa content. Cell suspensions were labelled for 
90 min with 4 SCa (10 ~Ci/4 ml suspension). Suspensions were then 
centrifuged in the table top centrifuge at high speed for 45 sec and 
resuspended in bicarbonate-Ringer ' s solution containing 4SCa of the 
same specific activity. Each suspension was then divided into four 
1 ml aliquots, one served as control, the remainder were exposed to 
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vasopressin (0 .. 1, 1.0, or 20 roD/rol). The "lanthanum method ff described 
by van Breeman et al. (1972) was used to separate extracellular 4SCa. 
The procedure described here is quite similar to that modification 
described by Lee and Auersperg (1980) for isolated fibroblasts. 
After vasopressin was added to the experimental suspensions, 300 ~l 
aliquots were taken from each suspension after 1, 5, or 15 min and 
injected into a 40 ml polycarbonate centrifuge tube containing 30 ml 
of ice-cold La-Ringer's solution (90 roM NaCl, 10 roM tris-Hel, 10 m}1 
LaCl 3 , pH 7.4), and centrifuged at 500 x g for 1 min at 4°C in a 
Sorvail IC-2B centrifuge. The supernatant was decanted, the pellets 
were resuspended in 30 ml La-Ringer's solution and the suspensions 
placed into an ice bucket for 30 min. The suspensions were recen-
trifuged, the pellets dissolved in 0.1 N NaOH, and aliquots were 
taken for determination of 4SCa and protein. 
Compartmental analysis of 4SCa efflux. The suspensions were 
labelled with 4SCa and desaturated as described above (Fig. 17). In 
these experiments experimental agents were always added to one of 
the suspensions before uptake of the label and the suspensions were 
incubated for a period of time which would be sufficient for estab-
lishment of a stable physiological response in intact hemibladders. 
This last condition was required since after 90 minutes of uptake 
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the slow compartment of efflux to be described was not loaded to 
equilibrium specific activity. Equilibration of specific activity 
would require at least 14 hours in these cells, a condition which 
clearly could not be tolerated by isolated cells without subjection 
to temporary culture. Thus, by assuring equilibrium to be achieved 
in response to experimental agents, reasonable assurance was obtained 
that calcium pools and fluxes into and out of the pools would also 
be in equilibrium. From the rate coefficients of efflux, the mathe-
matical models could then correct the measured pool sizes to those 
which would have been measured if equilibrium specific activity had 
been reached. The amount of 45Ca remaining in the cells was calcu-
lated for each time during desaturation as described above and the 
data were further analyzed by the mathematical models to be presently 
described. 
Compartmental models. The equations for calculating the 
kinetic parameters will be presented for a parallel system where 
each compartment independently exchanges with the bathing medium 
., 
compartment (Fig. l8 t a-c). The derivations necessitate that the 
system be in a steady state. Thus, the respective fluxes, com-
partment sizes, and rate constants of transfer are considered to 
be constant and equal during the uptake of isotope and during 
desaturation. During the labelling period the system can be 
considered to be closed. That is, all compartments are of finite 
size and no calcium is added or subtracted from the system con-
sisting of the bathing medium and the various cellular compartments. 
During the labelling period the change in specific activity ai' 
in each compartment i can be described by 
daildt = kOiai(oo) 
or, rearranging and taking the Laplace transform (Robertson t 1957) 
(1) 
where t 1s labelling tfme 1n minutes, Ai is the exponential 
constant of calcium influx into the ith compartment during the 
labelling period, and ai(~) is the specific activity of compartment 
i at infinite time, or, equilibrium specific activity. 
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Since the bathing medium compartment in these experiments is very 
large, fluxes into and out of the medium are so small as to be neg-
ligihle (in the experiments described here the cell exchangeable calcium 
is approximately 2 x 10-8 mole and the bathing medium pool is 3 x 10-6 
mole, or, the cellular pool is 0.7% of the bathing medium pool). Thus, 
the specific activity of the medium is constant during the labelling 
phase and can be accepted to be equal to ai(oo)-
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Figure 18. Models used in the compartmental analyses of 45Ca efflux from prelabe~led 
isolated toad urinary bladder epithelial cells. a) 2-compartment parallel model (Sl 
and 52) plus the bathing medium compartment (SO), b) 3-compartment parallel model, 
c) 4-compartment parallel model, and d) a modified series 3-compartment model. Exper-
imental data were fitted to the 4-compartment parallel model, the most rapidly 
exchanging compartment was discarded, and the constants for the modified series 




where R. is the radioactivity in compartment i, and S. is the 
~ ~ 
amount of traced substance, here calcium, in compartment i. 
Substituting Equation (1) into Equation (2) 




During desaturation the system can be described as a linear 
combination of exponentials (Sheppard, 1962) 
~ = X1e-Al t + X2e- A2t + •.. (5) 
where X. are coefficients of the exponential terms, in these 
1.-
experiments equivalent to Ri - To graphically determine Xl through 
Xn and Al through An the natural logarithm is taken from each 
side of Equation (5) 
One may plot In XT versus time and obtain a series of linear func-
tions each with slope Ai and y-intercept In Xi- Alternatively, 
the method used in these experiments was a reiterative nonlinear 
least squares program (NeIder and Mead, 1965) to obtain the exper-
imental intercepts and slopes_ 
Experimentally, the amounts of 45Ca released into the medium 
during each time period, Rmt , during desaturation are summed and 
to this is added the amount of 45Ca remaining in the cells at the 
end of desaturation, Re , or 
Rm,t(O) = Rml + Rro + ... + Rm,t(160) + Rc = 1\0 + Rcells (6) 
where ~,(160) is the amount of radioactivity lost into the medium 
98 
during the period from 150 to 160 minutes. 
A value R
t 
is calculated to represent total exchangeable 
calcium remaining in the cells at any time during the desaturation 
R
t 
= [(~t/mg cell protein)]/ai(oc) (7) 
Each ~t is obtained by subtracting from Rmt(O) the total amount 
of 45Ca released into the medium up to time t. Thus, R t is XT 
normalized to specific activity and cell protein, having the units 
cpm or moles, if the specific activity of the medium ai(oc) is 
known. 
The following demonstration that Ai = k£o is adapted from 
Borle (1975). During the desaturation the system is said to be 
open, that is, the medium compartment, since it is periodically 
renewed, can be considered to be infinite in size. Thus, the 
slope Ai of each kinetic phase represents the rate constant of 
efflux kiD from compartment i to medium 0, or 
(8) 
where PiO is the rate of exchange or flux from compartment i to 
medium O. 
Since 
ai = Ri/Si 





At time 0 of desaturation all radioactivity is in compartment 
i and is equal to Ri(O)t and, at infinite time Hi = O. Thus 
~ = Ri(o)exp[-(PiO/Si)t] (11) 




Plotting In ~ versus time the slope is -(OiO/5i) and the y-inter-
cept is Ri(O) (the Xi of Equation (5». 
Since 
(13) 
the slope of component i represents the rate constant of efflux 
from compartment i to medium O. Equation (4) is an expression of 
the labelling period occurring in a closed system and the expo-
nential constant Ai is not a rate constant. The equation describing 
45Ca uptake in such a closed system can be developed as follows 
for a medium compartment So and a cellular compartment 
Since So and Si 
Also 
Since the system 
Therefore 
Ri = aiSi 
are constant 
dRO/dt = SO(daO/dt) 
dR£/dt = Si(dai/dt ) 
dRo/dt = PiOai - POiaa 
dRi/dt = POiaa - p·oa· -z., 'l-
is in steady state 
dRO/dt = SO(dao/dt) = p(ai - aO) 
d~/dt = Si(daildt) = p(ao - ai) 
Combining Equations (18a) and (18b) 











Since ai ultimately approaches aO' the terminal value of (aO - ai) 
approaches zero. Moreover, since all the radioactivity is initially 
in compartment 0 with specific activity aO(O), the initial 
(aO - ail - aO(O). The solution is then 
80 - Bi = aO(O)exp -p[(SO + Si)/(SOSi t )] 
From Equation (lSb) 
ao - 8i = (d~z/dt)/p 
and combining Equations (20) and (21) 
(20) 
(21) 
(d~/dt)/O = aO(O)exp -p[(SO + Si)/(SOSi t )] (22) 
Since aO(O) = 8i(oo) 
(dRi/dt)/ai (00) = pexp -p[ (SO + Sill (SoSit)] (23) 
or, in logarithmic form 
In (dRi/dt)/ai(oo) = In p - p[(SO + Si)/(SOSi)]t 
The slope of the semilogarithmic plot of Equation (23) versus time 
1s equal to Ai or 
Therefore 
Since at steady state 
PiO = kiOSi = P 
Equations (25) and (26) give 









In the experiments performed in this dissertation So is more than 
100 times larger than Si (see the second paragraph of this section). 
Thus 
(So + 5i)/SO = (>100 + 1)/(>100) ~ 1 (30) 
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Therefore, under the conditions of the present experiments 
(31) 
Thus, the size, Si' of each compartment can be calculated 
from Equation (4), and since Ai is also ~O' the exchange.rate 
(flux) into and out of the compartment is 
(32) 
The equations above describe the kinetics of a parallel 
system. If, instead, the system is in series (Fig. 17d) the 
specific activity in the more slowly exchanging compartments 
will rise due to influx from the more rapidly exchanging compart-
ments (due to P12 and 023) during the initial portion of desatur-
ation~ that is, until the specific activity in the more rapidly 
exchanging compartments falls to that in the more slowly exchanging 
compartments (Uchikawa and Borle (1978) for a discussion of this 
phenomenon and derivation of equations to quantitate it). Thus, 
analyzing the system as if it were in parallel would overestimate 
the sizes of the slowly exchanging compartments and underestimate 
the sizes of the rapidly exchanging compartments. The error 
incurred from such an analysis may be calculated according to 
Huxley (1960) 
where the subscripts sand f refer to the more slowly exchanging 
compartment and the more rapidly exchanging compartment, respec-
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tively. In the present experiments the 2 more slowly exchanging 
compartments have the characteristics Rf = 1.2, Rs = 6.1, Af = 0.06, 
and As = 0.006. If these 2 compartments are actually in series, 
then Rs,true = O.7aRs ' or, an error of 22% exists. Thus, equations 
will next be presented by which the kinetic parameters for a modified 
series case may be calculated. 
The following derivations are taken directly from Uchika~a 
and Borle (1978), being modified only to use of the same symbols 
which have already been described. 
The system of exchangeable calcium compartments in isolated 
cells is represented as follows 
where So is the medium compartment, 51 is calcium bound to the 
glycocalyx, and 52 and 83 are the two intracellular pools. 
1. Labelling period. 
According to the general kinetic equation, one can write 
al-3,t' = Kal-3,t' + I (34) 
lO~ 
where Bl-3,t' is the specific activity of SI' S2' and S3 at a time, 
t', during labelling, t' is any time during the labelling period 
t, and I is tracer input into the system, where 
- klO 0 0 
K = 0 - k20 + k23 k23 (35) 
0 k32 - k32 
aO,t' = [al. t ' a2,t' a3,t,]t (36) 
and 
I = k 20 (37) 
At the beginning of the labelling period, the system contains 
no tracer so that 
(38) 
Assuming that K has three distinct eigen values, - Ai' where 










(A3 - k20)/(A3 - A2) 
A3/(A3 - ).2) 
Al = klD 
A2 A3 = k32k20 
A2 + A3 = k20 + k23 +k32 
2. Transition period 
(39) 
o 
(A2 - k20)L(A2 - A3) 
A2/(A2 - A3) 
(40) 





The specific activity of the cells at the end of the labelling 
period is the same as their specific activity at the beginning of 




3. Desaturation period 
During desaturation, tracer input I into the system is zero. 
The differential equation describing it is 
and 
AO = al-3,t 
The solution to these equations is 




[exp(- Alt - l)]exp(- Alt') 
[exp(- A2t - l)]exp(- A2t') 
[exp(- A3t - l)]exp(- A3t') 
4. Relative radioactivity of the system 
Let ~t be the amount of tracer in compartment i, Rt the 
sum of ~t where i = 1, 2, 3. 





= ~ Bi(oo)Ci[exp(- Ait - 1)][exp(- Ai t ')] 
i=1 
(51) 
where Ci has the same meaning as Si in the previous parallel case. 
Thus, the values Si derived here will have the "same" meaning as 
Si in the parallel case, that is, amount of traced substance in 
compartment i. Thus, 
C1 = SI 
C2 = [(S2 + S3)A3 - k20S2]/(A3 - A2) 
C3 = [(S2 + S3)A2 - k20S2]/A2 - A3) 
Let RiO = Ci[exp(-Ai t ' - 1)], then 
3 






The solutions for equations (52 through (54) are as follows 
kl0 = Al 






S2 + S3 c C2 + C3 (59) 
P20 - C2A2 + C3A3 (60) 
S2 - (P20)2/(C2A~ + C3A~) (61) 
S3 e (C2 + C3) - S2 (62) 
P23 c S2S3(A 2A3/ P20) (63) 
~. == p. ·/s-J 1.,.J 1.,. (64) 
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Data fitting. A reiterative least squares program (NeIder and 
Mead, 1965) was used to obtain the kinetic parameters A. and R .. The 
1 1 
fitting procedures were executed on a Hewlett-Packard HP 2IODA computer 
with 32K memory. The models used were series of 2, 3 or 4 exponentials 
(Equation 5). An estimate of error, Itfunctional error," was obtained 
for each model 
t=n 
[(observed Rt - predicted Rt)/(observed Rt )]2 
functional error = 
t=O 
For the 12 experiments reported in Table VIII, the functional errors 
were O.040021±O.000057, O.003402±O.000008, and O.OOIOI4±O.000003, for 
the 2, 3, and 4 component models, respectively (Fig. 18). An F-ratio 
test (Boxenbaum et al., 1974) to determine whether the reduced func-
tional errors obtained when the model was expanded were statistically 
different was performed. The use of a 3-compartment model was signifi-
cantly better than a 2-compartment model (p<O.OI). However, a 4-com-
partment model was nearly statistically significantly better than a 
3-compartment model (p<O.07). Based on washout data to be described 
below, a 4-compartment model was chosen, only the 3 more slowly 
exchanging compartments being attributed to the cells. The author 
wishes to acknowledge the invaluable aid rendered by Ms. Martha Stroud 
who programmed the computer and offered instruction in the use of the 
programs. 
Statistics. Most experiments were performed in such a manner 
that a single cell suspension was divided into 2 equal volumes and 
used for control and experimental measurements. In these experiments 
differences between means was tested with Student's t-test for paired 
observations (Steel and Torrie, 1960) using either a Texas Instruments 
TABLE VITI 
KINETICS OF THE CELLULAR CALCIUM POOLS 
Parallel Case Series Case 
Fast Pool (SI) Fast Pool (5)) 
SI PI0 kID SI PIO k iO 
1.52 0.364 0.226 1.52 0.364 0.226 
±0.16 ±O.O62 ±0.020 ±0.16 ±0.062 ±O.OlO 
Intermediate Pool (52) Intermediate Pool (52) 
-- .... ~--- ----
52 P20 k20 52 P20 P23 k20 
1. }6 0.080 0.073 2.35 0.123 0.042 0.055 
±O.06 ±O.OOl ±0.O06 ±o .16 ±O.OIO ±O.004 ±O.006 
Slow Pool (S3) 5low Pool (83) 
-----~~~~~ ----
S3 ]0 k30 S 3 P32 k32 
6.01 0.038 0.0065 4.78 0.042 0.0092 
±O.60 ±O.O04 ±0.OOO4 ±O.SO ±0.O04 ±0.OOI0 
0=12. All results are expressed as mean ± 5.E.M. S. = pool size, nmol/mg protein; p .. = 
exchange rat~ (flux) from pool i to pool j, nmol/min7mg proteIn; k .. = rate constant IJ 








TI-59 calculator with statistics chip or a Monroe Statistician@ 
preprogrammed calculator. Several limitations are inherent in the 
methods used to analyze the data. The cumulative amount of 4 SCa in 
the cells was obtained by summing the individual media measurements. 
Thus, each point contains not only its own experimental error but 
also the error from each of the other points. Thus, the least 
squares program is not strictly appropraite for analysis of the data 
(Boxenbaum et a1., 1974). Boxenbaum et a1. (1974) have pointed out 
that comparisons between fitted parameters using a !-test may not be 
reliable, especially when more than one model may be fitted to the 
data. 
In several of the 4SCa efflux experiments the data were analyzed 
as ln4sCa remaining versus time and the several components of efflux 
were separated by "curve peeling" (Casteels and Droogmans, 1975). 
The linear portion of the slowest component (from 110 minutes to the 
end of the experiment) was analyzed with the linear regression 
program of the TI-59 calculator and residuals calculated from the 
best-fit line. The linear portion of the next component (50-110 
minutes) was then analyzed similarly. The values for the control 
and experimental suspensions for each component were then subjected 
to analyses of covariance to determine whether the lines were different 
(Dixon and Massey, 1969). 
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RESULTS 
EFFECTS OF VASOPRESSIN AND cAMP ON 45Ca EFFLUX FROM PRELABELLED 
EPITHELIAL CELLS 
Effects of vasopressin on 4 S Ca efflux from isolated toad bladder 
epithelial cells in suspension. Thorn and Schwartz (1965), Schwartz and 
Walter (1969), and Cuthbert and Wong (1974) have shown that vasopressin 
causes an enhancement of 45Ca release from prelabelled intact hemi-
bladders. To determine whether epithelial cells isolated by the colla-
genase method responded to vasopressin in the same manner an attempt was 
made to reproduce those results. Desaturation was commenced simultan-
eously in 2 aliquots of a cell suspension which had been labelled with 
45Ca. After the 10 min decanting vasopressin (10 mU/ml) was added to 
one tube of each pair of aliquots and remained for three 10 min periods. 
As shown in Fig. 19, vasopressin elicited an enhancement in 45Ca efflux 
which lasted as long as vasopressin was present in the bathing media. 
Maximum enhancement was 39±11%. Efflux returned toward control rate 
after the removal of vasopressin. Efflux of 45Ca from the isolated 
cells was from 3 compartments (to be discussed below). The rate con-
stants of efflux were such that by 90 min the first 2 compartments were 
completely desaturated. In an additional series of experiments, vaso-
pressin was added after 120 min of desaturation. Vasopressin (10 mU/ml) 
enhanced 45Ca efflux to 28±8% after 20 min (Fig 20). Efflux returned to 
basal rate after vasopressin was removed. Thus, vasopressin appeared to 
elicit enhanced 4SCa efflux from at least the third, most slowly exchan-
ging compartment. 
Effects of vasopressin on steady state 45Ca efflux. The enhance-
ment in 4SCa efflux observed when vasopressin was added to cells already 



















Figure 20. Effect of vasopressin on 45Ca efflux from 
pool S3· The protocol was that described in the legend 
to Figure 19 except that vasopressin (10 mD/m1) was added 



















Figure 19. 'E'ffect of vasopressin on 45Ca efflux 
from epithelial cells isolated from toad urinary 
bladder. Cell suspensions were labelled for 90 
minutes with 45Ca. Each suspension was then 
divided into 2 aliquots and desaturated simultan-
eously. To one of each pair of aliquots was added 
vasopressin (10 mU/ml) after 30 minutes of desaturation. 
Data are plotted as the ratio of efflux from cells 
incubated with vasopressin to control (see METHODS). 
The values are expressed as mean (circles) + SEM 
(bracketing lines). *p <0.05, **p <0.02, n = 6 pairs. 
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undergoing desaturation may be accounted for by at least 2 processes. 
Vasopressin may have caused a net efflux of calcium from the cells, 
or, the rate of calcium exchange may have increased. In an attempt 
to distinguish between these 2 possibilities, the following experiment 
was performed. Suspensions were labelled with 45Ca for 90 min. The 
suspensions were then divided into 4 aliquots, one served as control, 
the remainder received vasopressin (0.1, 1.0, or 20.0 roD/ml). 
Aliquots were taken from these suspensions 1, 5, and 15 minutes 
after the addition of vasopressin and the 45Ca content of the cells 
determined (see Methods). In these experiments 45Ca was present in 
the bathing media at all times. Therefore, any decrease in 45Ca 
content of the cells would represent net calcium efflux while simple 
enhancement in calcium-calcium exchange would cause no change in 
45Ca content. As shown in Fig. 21 vasopressin elicited a net loss 
of 45Ca at concentrations of 1 and 20 mU/ml, concentrations which 
are physiologically active, while vasopressin, 0.1 mU/ml, a concentra-
tion which only rarely causes an enhancement in water permeability 
in intact toad bladders, did not elicit any change in 45Ca content 
of the cells. These experiments suggested that the enhanced 4SCa 
efflux observed in the perturbation experiments described previously 
was due to net efflux of calcium. 
Effects of preincubation with vasopressin on 4 SCa content and 
efflux. Fig. 22 demonstrates that 45Ca exchange in the cells is 
best described by a series of exponential components. The steady 
state experiment just described cannot distinquish the effects of 
vasopressin on any particular component of 45Ca exchange. Thus, 
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Figure 21. Effect of vasopressin on steady state 45Ca content of iso-
!ated toad urinary bladder epithelial cells. Cells were labelled with 
5eafor 90 minutes. Vasopressin (0.1, 1, or 20 mU/ml) was then added 
to the experimental suspensions (time a 0 on the graph) and at various 
times afterward aliquots were taken from both the experimental and ~on­
trol suspensions and 45Ca content of the cells was determined by the 
lanthanum method. 45Ca concentration in the control cells was 2.87 + 
0.42, 2.90 ± 0.33, 2.97 + 0.38, and 3.10 + 0.26 nmo1/mg protein at time 
= 0, 1, 5, and 15 ,minutes. (*p < 0.05, **p < 0.02, compared to control, 
n = 5 for each point). 
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Figur~ 22, 45Ca efflux from epithelial cells isolated from the toad urinary 
bladder'. Points represent the actual data for a single experiment. The curves 
were generated by computer and are the best fits for each case (see Methods). 
Estimates of the relative differences, functional error, of the fitted curves 
to the actual data were calculated (see Methods) for each case: 0.040134, 
0.004212, and 0.000983, for the 2, ), and 4 compartment cases, respectively, 





estimate of the effect of vasopressin on calcium content of the 
several components of calcium exchange in the cells. 
In these experiments vasopressin was added to the experimental 
aliquots of the suspensions before the addition of the 4 5 Ca label. 
After 15 min preincubation the control and experimental aliquots 
were simultaneously labelled with 4SCa for 90 min. Vasopressin 
remained in the experimental aliquots during the labelling and 
desaturation periods. The effects of preincubation of the cells 
with vasopressin (10 mU/ml) are shown in Fig. 23. Preincubation 
with vasopressin (10 mD/ml) resulted in significantly less total 
uptake of 4SCa during the labelling period, 7.76±O.62 nmol/mg protein, 
compared to the paired control suspensions, 9.9S±0.S8 nmol/mg protein 
(p<O.OS, n=6 pairs). Fig. 23 demonstrates that the efflux of 4 SCa 
from the cells can be well described by a series of 4 exponential 
components. Vasopressin decreased the time-O intercepts of 2 of the 
4 components. The intercept of the most rapidly exchanging component, 
here called Xo (Xi refers to the actual intercepts of each component 
while S. is the pool size calculated from X.), was not affected by 
1 1 
vasopressin (3.77±O.49 nmol/mg protein in the control suspensions 
compared to 3.52± 0.52 nmol/mg protein in the suspensions incubated 
in vasopressin). The intercept of the second component, Xl' was 
reduced in size from 2.03± 0.47 to O.96±0.14 nmol/mg protein (p< 
0.025, n=6 pairs). The intercept of the third component, X2 , was 
not affected by vasopressin (1.38±O.28 versus 1.43±O.34 nmol/mg 
protein in controls). The size of the fourth component, X3 , was 
decreased by vasopressin from 2.72±O.26 to 1.90±O.34 ~pl/mg protein 
1 







































Figure 23. 45Ca efflux from isolated toad bladder epithelial cells 
pre1ncubated with vasopressin (10 mU/ml). Cell suspensions were 
divided into 2 aliquots, 1 of which was incubated for 15 minutes 
with vasopressin (10 mU/ml). Then both aliquots were labelled with 
45Ca for 90 minutes and desaturated. The experimental aliquots 
contained vasopressin during the labelling and desaturation periods. 
Each vasopressin point is different from the respective control 
point (p < 0.02 - 0.05, .n ~ 6 pairs). 45Ca content at time = 0, 
not shown for the sake of clarity, were 9.95 + 0.58 and 7.76 + 
0.62 nmol/mg protein, control and vasopressin~ respectively. -
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constant of efflux of 4SCa from cells undergoing desaturation (Fig. 
19), it did not significantly change the steady state rate constants 
of 4SCa efflux of any of the components (Table XIII). In the experi-
ments of Cuthbert and Wong (1974), the enhancement rate constant of 
efflux was transitory, supporting the present observations. 
In a separate series of experiments the effects of a lower 
concentration of vasopressin (1 mD/ml) were assessed on steady state 
45Ca efflux. In these experiments vasopressin (1 mD/ml) reduced the 
size of Xl from 1.64±0.30 to 1.14±0.23 nmol/mg/protein (p<O.05, n=6 
pairs), and X3 was reduced in size from 2.48±0.22 to 2.06±O.28 
nrnol/mg protein (p<0.05, n=6 pairs). Neither Xo nor X3 were affected. 
Effects of exogenous cAMP on 45Ca efflux from prelabelled cells. 
cAMP is generally considered to be the second messenger for vasopressin-
stimulated water permeability (Orloff and Handler, 1967), and exogenous 
cAMP and several of its analogs mimic the effect of vasopressin on 
water permeability (Orloff and Handler, 1962). However, Cuthbert 
and Wong (1974) found that in intact hemibladders, exogenous cAMP 
actually inhibited 4SCa efflux from preloaded hemibladders. To 
determine whether exogenous cAMP mimicks vasopressin in isolated 
epithelial cells, pertubation and steady state experiments were 
performed. 
Fig. 24 shows the effect of adding cAMP (10 mM) to cells already 
undergoing desaturation. During the first 10 min cAMP caused a 
slight inhibition of 4SCa efflux, 16±4% (p<O.OS, n=6). This inhibi-
tion was not exhibited at 20 or 30 min after the addition of cAMP. 
Upon the removal of cAMP from the bathing media, 4SCa efflux trans-
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Figure 24. Effect of cAMP on 45Ca efflux from isolated 
toad bladder epithelial cells. Suspensions were labelled 
with 45Ca for 90 minutes. Each suspension was divided into 
2 aliquots and desaturated simultaneously.' After 40 min-
utes of desaturation exogenous cAMP (10 mM) was added to 




and 111±5% (p<O.05, n=5 pairs) of control at 20 min after the removal 
of cAMP. This effect of cAMP to enhance 4SCa efflux after its 
removal was also observed in the figures published by Cuthbert and 
Wong (1974). 
In an additional series of experiments, cAMP was added to the 
cells for 15 min prior to the prelabelling period with 45Ca. Analysis 
of the desaturation curves (Fig. 25) showed that in contrast to 
vasopressin, cAMP did not affect total uptake of 4SCa (9.32±O.62 
rumol/mg protein versus B.97±0.72 nmol/mg protein in control aliquots). 
However, the intercepts of the third, X
2
, and fourth, X
3
, components 
of efflux were affected by cAMP. In contrast to vasopressin, cAMP 
increased the intercept of the third component to 2.04±O.41 nmol/mg 
protein compared to I.30± 0.32 nmol/mg protein in the control suspen-
sions (p< 0.05, n=5 pairs) while, like vasopressin, cAMP decreased 
the intercept of the fourth component from 2.68±0.28 nmol/mg protein 
in the control suspensions to 2.21±O.26 nmol/mg protein in the 
suspensions preincubated with cAMP (p< 0.05, n=5 pairs). 
COMPARTMENTAL ANALYSIS OF 4SCa IN ISOLATED TOAD BLADDER EPITHELIAL 
CELLS AND THE EFFECTS OF VASOPRESSIN AND cAMP 
Characteristics of the steady state 4SCa efflux curve. The 
efflux of 4 SCa from toad bladder epithelial cells labelled for 90 
min with 4SCa was measured for 140-160 min. Fig. 22 shows a typical 
efflux curve. Graphical analysis yielded 4 calcium pools. The most 
t 
rapidly exchanging pool, termed S , was assigned as extracellular 
o 
4SCa trapped in the bathing medium remaining with the cell pellet 
after the initial washing. This assignment was made ba~ed on the 
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Figure 25. 45Ca efflux from isolated toad bladder epithelial 
cells preincubated with exogenous cAMP (10 mM). Cell suspen~ 
sions were divided into 2 aliquots, 1 of which was incubated 
for 15 minutes with cAMP (10 mM). Then both aliquots were 
labelled with 45Ca for 90 minutes and desaturated. The exper-
imental aliquots contained cAMP during the labelling and 
desaturation periods. Curves were analyzed as In 45Ca remain-
ing versus time and divided into linear components (see Methods). 
Analysis of covariance revealed significant differences between 
the control and experimental values for components S2 (p' < 
0.01, n - 5 pairs) and 53 (p < 0.02, n & 5 pairs). ~5Ca content 
at time - 0 were 8.79 + 0.72 and 9.32 + 0.62 nmol/mg protein, 
control and cAMP, respectively. 
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similarities in both rate constant of exchange and in the "space" 
occupied by this 45Ca pool and those for [3H]-inulin and [ 125I]-bovine 
serum albumin. Thus, the rate constant of exchange for 4SCa was 
2.60±O.42 min- 1 (n=12), for [3H]-inulin 2.5S±O.56 min- 1 (n=4) , and 
for [ 125 I]-albumin 2.86±O.48 min- 1 (n=4). Similarly, 4SCa space for 
pool 8 was 28±5 ~l (n=12), for [3H]-inulin 21±4 ~l (n=4) , and for 
o 
[ 125 I]-albumin 23±6 ~l (n=4). 
The remaining 3 exchangeable calcium pools had time constants 
[1/k .. , that is, average "residence time" in the pool (Atkins, 
1J 
1974)] of 4.4, 14, and 154 min, and contained 1.52, 1.16, and 6.01 
nmol calcium/ mg protein, respectively (Table VIII). Thus, in the 
present experiments where uptake time was 90 min, the most rapidly 
exchanging pool, SI' and the intermediate pool, 8 2 , were 100% loaded 
before commencement of desaturation, and the slowly exchanging pool, 
S3' was 44% loaded. Thus, the 90 min labelling period was chosen 
since it is the minimum time required to reach 100% loading of pool 
52. Upon commencement of desaturation, the calculated time taken to 
reach 1% of initial radioactivity was 20 min for 8 1 , 63 min 
for 8 2 , 
and 710 min for 8
3
, and to reach 0.1% of initial radioactivity, 30 
min for 8 1 , 95 min for 52' 
and 1050 min for 8 3 " 
Arrangement of the Calcium Pools. As demonstrated in the 
Methods, the calculations for the actual rate constants of desatur-
ation and pool sizes from the apparent values obtained from the 
desaturations depend upon whether the calcium pools are arranged in 
parallel without interconnections, or in series, such that the 
calcium contained in the more slowly exchanging pools must pass 
successively through the more rapidly exchanging pools to reach the 
123 
bathing medium. Thus, several experiments were performed in an 
effort to gain some insight into the structural identities of the 
exchangeable calcium pools, so that inference might be made concer-
ning arrangement of the pools. 
Effects of lanthanum on 45Ca efflux. 
+ 
La 3 has greater affinity 
for membrane Ca 2 +-binding sites than does Ca 2 + (Sanborn and Langer, 
1970). Thus, La 3 + is often used to displace Ca 2 + from membrane 
binding sites (Sanborn and Langer, 1970; van Breeman et a1., 1972). 
+ Further, La 3 does not penetrate most biological membranes (Langer 
and Frank, 1972) and has been shown by electron microscopy to not 
cross the plasma membrane of toad urinary bladder epithelial cells 
(Davis, 1981). Thus, La 3 + was used in an attempt to displace any 
45Ca bound to the extracellular surface of the epithelial cells. In 
3+ . physiological experiments, it was found that 1 roM La 1n tris-Ringer's 
solution containing 1 roM Ca 2 +, completely inhibited vasopressin-
stimulated water flow. Thus, 1 mM La 3 + was used in the present 
experiments. In 4 experiments, simultaneous desaturation was commenced 
in 2 aliquots of a single cell suspension which had been prelabelled 
with 45Ca for 90 min. After the 1 min decanting, the Ringer's 
solution added to the experimental suspension contained 1 roM La 3 + in 
addition to 1 ruM Ca 2 +. This resulted in an enhanced efflux to 
182%±24 (p< 0.01, n=4) of control (Fig. 26). Upon removal of the 
+ 
La 3 at the 10 min decanting, efflux returned toward the control 
rate. In 4 similar experiments La 3 + was added after the 50 min 
decanting, when only pools 8
2 
and S3 were still labelled. In these 
experiments 45Ca was not displaced, instead 4 5Ca efflu~<was inhibited 
i 
to 21±4% (p<O.Ol, n=4) of control (Fig 26). These results suggest 
L 
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Figure 26. Effect of La 3+ on 45Ca efflux from isolated 
toad bladder epithelial cells. Suspensions were labelled 
with 45Ca for 90 mdnutes. Each suspension was divided 
into 2 aliquots which were desaturated simultaneously. 
After 1 minute or 50 minutes of desaturation La 3+ (1 mM) 
was added to 1 of each pair of aliquots (*p < 0.05, 
**p < 0.01, n = 4 pairs). 
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that pool S1 consists, at least partly, of superficially bound 45Ca 
and that 45Ca efflux from pool 8
2 
or S3 consists, at least in part, 
of 45Ca which must cross the plasma membrane from inside the cells 
to reach the bathing medium, and that this transport is blocked by 1 
roM La 3 +. 
In an additional 4 experiments the effects of La 3 + on 4SCa 
compartmental analysis were studied. Claret-Bethon et al. (1977) 
f d h h d ' 1 f 45C f 1 8 b L 3+ . , oun t at t e 1SP acement 0 a rom poo 1 y a 1S trans1ent, 
being complete within only 30 sec. In the present experiments 
labelling with 4 S Ca took place for the usual 90 min. The cells were 
pelleted, and to the wash solution of the experimental suspensions 
was added 1 roM La 3 +. The suspensions were stirred for 30 sec, 
pelleted, and normal Ringer's solution was added to both control and 
experimental suspensions and desaturation was commenced in the usual 
fashion. La 3+ displaced 48% of the 4 SCa in pool 81 (Table IX). The 
absolute decrement calculated from these experiments is somewhat 
suspect since the rate constant of efflux from pool Sl was greatly 
increased; thus, the rate constants of efflux from pools S~ and Sl 
were within 3-fold of one another. Myhill (1967) has calculated 
that if only 5% error exists in the experimental data, then 2 rate 
constants of efflux can be resolved if only they differ by a factor 
of 4. In the present experiments the experimental error is probably 
greater than 5%, since, for example, the radioactivity was determined 
to a precision of only 3%. In these experiments the sizes of pools 
+ 82 and 83 were not affected by La
3 (Table IX). However, even 
though La 3 + was not nominally present during the desaturations, the 
rate constants of efflux from these compartments were significantly 
TABLE IX 
EFFECTS OF RINSING WITH LJ 3 + ON 4SCa KINETICS 
-------~~~~-~ -~-~-- - ---_ ... _._- .. _-----"--
Parallel Case 
~-~~~-,---------------.---. 
Fast Pool (SI) 
s} P10 kIO 
Control 1.64
a 0.398a 0.248 
to.18 ±0.047 ±0.OJ1 
La 3+ 0.82 0.728 0.903 
±O.10 ±O.033 ±O.044 
Intermediate Pool (52) 
52 P20 k20 
Control 1. 01 0.079 0.077
a 
±0.21 ±O.006 ±O.O07 
La 3+ 1. 22 0.055 0.045 
to.30 ±O.OOB ±0.OO6 
Slow Pool (5)) 
---------
53 P30 k30 
Control 4.38 0.029
a 0.0062a 
±0.37 ±0.OO4 ±O.0007 
La 3+ 4.40 0.018 0.0044 
±0.44 ±0.003 ±O.OOO9 
ries Case 
~~~----~-~~-~~-- _. 
Fast Pool (51) 
--~------
SI PIO k IO 
1.34a 0.3983 0.248 
to.18 ±0.O47 ±0.031 
0.82 0.228 0.263 
±0.10 ±0.OJ3 ±0.044 
Inlermediate Pool (S2) 
S2 P20 


























n=4. All results are expressed as mean ± S.E.H. S. = pool size, nmol/mg protein; p .. = exchange rate 
(flux)_from pool i to pool j, nmol/min/mg pr~tein; i .. = rate constant of efflux fro~Jpool i to pool 
j, min 1. Bathing media calcium = 1 mM, La 3 = 1 mM~J 





decreased. Thus, these "steady stateH experiments tend to confirm 
the results obtained with the perturbation experiments, that pool Sl 
represents, at least in part, calcium bound to extracellular sites 
and that pools 82 and 83 represent calcium which is located inside 
the cells, or at least, which is bound to sites not accessable to 
lanthanum. 
In another series of experiments La 3 + (1 mM) remained in the 
experimental suspensions for the entire desaturation. In these 
suspensions S2 was undetectable while 83 was significantly larger 
+ than in control suspensions (Table X). Thus, the effects of La 3 on 
4SCa efflux in these experiments was similar to that which was noted 
by Langer and Frank (1972) in fibroblasts and myoblasts in culture, 
where La 3+ slowed efflux of 45Ca from one compartment to a rate only 
about 10% as rapid. 
Effects of EGTA on 4SCa efflux. In several other tissues a 
slowly exchanging calcium pool is observed with a time constant of 
efflux similar to that of the slowly exchanging pool, 83 , observed 
in the present experiments (Sanborn and Langer, 1970; Claret-Berton 
et aI, 1977). The latter have concluded that this slowly exchanging 
pool represents extracellular calcium based on displacement by the 
calcium-chelating agent, EGTA. Indeed, in intact isolated toad 
bladders, Cuthbert and Wong (1974) concluded that a slowly exchanging 
calcium pool which may be identical to the pool S3 in the present 
experiments, is extracellular in location based on displacement by 
EGTA. Thus, several perturbation experiments were performed using 
EGTA. Simultaneous desaturation was commenced in 2 aliAuots from 
prelabelled cell suspensions. After the 100 min decanting, a time 
TABLE X 
EFFECTS OF La 3 + ON 45Ca KINETICS 
Control 
Parallel Case 













































n=4. All results are expressed as mean ~ 
S.E.M. S. = pool size, nmol/mg protein; 
p .. = excflange rate (flux) from pool i to 
pb~l j, nmol/min/mg protein; k .. = rate 
constant of efflux from pool i 1 lo pool 
j, ~in-l. Bathing media calcium = 1 mM, 
La 3 = 1 roM. 
a 3+ P < 0.05 compared to La . 
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at which only pool S3 contained 45Ca, the Ringer's solution added to 
the experimental suspensions contained no added calcium and 2 roM 
EGTA. This resulted in an enhanced efflux to 340±46% of control 
efflux (Fig. 27). EGTA was allowed to remain for only one time 
period since other experiments have demonstrated that toad bladder 
epithelial cells do not appear viable after prolonged incubation 
with EGTA in the absence of calcium. These experiments suggest that 
S3 may represent slowly exchanging extracellular calcium. 
In additional experiments, the effects of EGTA on "steady 
state" 45Ca efflux was studied. Suspensions were labelled for 90 
min. The cells were pelleted, and the rinsing Ringer's solution for 
the experimental suspensions contained no added Ca 2+ and 2 roM EGTA. 
The suspensions were pelleted again and normal Ringer's solution was 
added to both control and experimental suspensions and desaturation 
was commenced as usual. EGTA displaced essentially all the 45Ca in 
pool SI (Table XI). The size of pool S2 was not significantly 
affected, while the size of pool S3 was decreased by 56-70% (Table 
XI). Similarly, the time constants of efflux were lowered from 4.3 
to 1.0 min, 14 to 11 min, and 150 to 74 min, for pools SI' S2' and 
S3' respectively. 
Intracellular calcium. The data obtained with La 3 + and EGTA 
suggest that calcium pool Sl is completely extracellular. Neither 
La 3 + nor EGTA affected the size of pool S2. This suggests that pool 
S2 may represent intracellular calcium. Borle (1972) and Borle and 
Uchikawa (1978) have evidence to suggest that at least part of S3 
can be attributed to mitochondria. In the present experiments EGTA 
decreased the size of S3 by about 60% while La 3 + was without any 
.. .. .. 
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Figure 27. Effect of EGTA on 45Ca efflux from isolated 
toad bladder epithelial cells. Suspensions were labelled 
with 45Ca for 90 minutes. Each suspension was divided 
into 2 aliquots which were desaturated simultaneously. 
After 100 minutes of desaturation Ca2+-free Ringer's 
solution containing EGTA (2 mM) was added to 1 of each 
pair of aliquots (*p < 0.01, **p < 0.001, n = 4 pairs). 
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TABLE Xl 
EFFECTS OF HI NS J NG W I TIl EGTA ON 4 Sed K I NET I CS 
---- ----. Par aTr~ CC';se- ----- ... ------ -----
- ... .--~ -.,---- -- -~.-,- -~------
Fast Pool (S I) 
----------- - --"--~ --" .- ,-
SI PIO kIO 
Control 1.83
c 0.372 0.206b 
to.18 to.059 ±0.021 
EGTA 0.34 0.360 1.06 
to.02 ±0.040 to.042 
Intermediate Pool (S2) 
_ .. - -, - -.- ---.~. -_._--> 
S2 P20 k20 
1. 17 c 0.064c Control 0.075 ±0.31 to.OO7 to.OO4 
EGTA 1.26 0.312 0.248 
to.31 ±0.042 to.025 
Slow Pool (S) 
S3 P30 k30 
Control 6.23
c 0.038 0.0061 b 
to.49 to.004 ±0.0004 
EGTA 2.30 0.0]3 0.0143 
±0.23 to.002 ±0.0009 
--------
$f'ries Case 

















Intermediate Pool (S2) 
S2 P20 
2.36 0.118b 
10. II to.009 
2.30 0.456 
±0.]7 ±0.120 
























n=4. All results are expressed as mean ± S.E.M. S. = pool size, runol/mg protein. p .. = exchange rate 
(flux)_from pool i to pool j, runol/min/mg protein; t .. = rate constant of efflux fro~Jpool i to pool 
j, min . Bathing media calcium = 1 mM, EGTA = 2 mM~J 





effect. Since mitochondria are considered to play an .imp6ru<;lnt role 
... ,,--" ... < 
in buffering intracellular calcium, the effects of>.two"{n·hititors of 
mitochondrial function, antimycin A and cyani~e, wete assessed on ..... 
" 
steady state calcium metabolism. The effects pf these 2 agents were 
similar and the data from the 2 were pooled (Table XII). The mito-
chondrial inhibitors decreased the size of pool S3 ca. 40%. At the 
same time the size of pool S2 tended to be increased. This effect 
is similar to that described for the effect of mitochondrial inhib-
itors on calcium metabolism in whole liver (Carafoli, 1967). In 
that tissue inhibition of mitochondrial function was associated with 
decreased stores of calcium in the mitochondria, while microsomal 
calcium was increased. 
Effects of vasopressin on 4SCa compartmental analysis. While 
most of the data gathered on the arrangement of the exchangeable 
calcium compartments in the isolated toad bladder epithelial cells 
are consistent with pool S2 and at least part of S3 being internal 
and thus probably in series with one another, the possibility that 
the compartments may actually be in parallel cannot be ignored. 
Therefore, all compartmental analyses were performed for both a 
modified series and parallel cases. The modified series case of 
Uchikawa and Borle (1978) was used. In this model the most rapidly 
exchanging compartment, Sl' is not considered to be in series with 
compartments S2 and S3 since it appears to be composed of loosely 
associated extracellular calcium. The present data with EGTA treat-
ment supports the use of this model_ EGTA displaced Sl without 
affecting the size of S2- Further, the first component, SO' was not 
" , 
TABLE XII 
EFFECTS OF MITOCHONDRIAL INHIBITORS ON 4 5Ca KINETICS 
-------~--
Parallel Case ------SerTes Case 
Fast Pool (51) Fast Pool (51) 
---------
5) PlO klO 51 PlO kiO 
Control 1.83 0.430 0.247 1.83 0.430 0.247 :to.20 ±0.OS8 ±0.025 ±0.20 ±0.OS8 ±0.02S 
Inhibitors 1.72 0.444 0.283 1.72 0.444 0.283 
±0.18 ±0.060 ±0.03} :to. 18 ±0.060 ±O.O)} 
Intermediate Pool (52) Intermediate Pool (S2) 
---. __ . 
52 P20 k10 S2 P20 P23 k20 k23 
Control 1.42
a 0.094a 0.064a 2.42a 0.143 0.042 0.042a O.Oll 
±0.28 ±O.OIS ±O.OOB ±0.26 ±0.048 ±0.008 ±0.004 ±O.OOI 
Inhibitors 1. 90 0.142 0.105 ).18 0.201 0.034 0.106 0.014 
±0.32 ±0.035 ±0.029 ±0.41 ±0.040 :to.OOB ±O.022 ±0.O02 
Slow Pool (S)) Slow Pool (53) 
--~------- --------
53 P30 k30 S3 P32 k32 
Control S.31
b 0.034 0.007Sa 3.9Sc 0.042 0.0101a 
±O.68 ±O.004 ±O.OOOS ±0.52 ±0.008 ±O.OOIO 
Inhibitors 3.15 0.039 0.0111 2.35 0.034 0.0141 
±0.72 ±O.OlO ±O.OO12 ±0.50 ±O.OOB ±O.OOll 
n=6. 3 KCN, and 3 antimycin A. All results are expressed as mean ± S.E.M. S. = pool size, nmol/mg 
protein; p .. = exchange rate (flux) from pool i to pool j, nmol/min/mg protein! k .. = rate constant 
of efflux flam pool i to pool j, min-to Bathing media calcium = 1 mM, KCN = 2 mM!Jantimycin A = 10 ~M. 





considered since it appeared to represent trapped bathing media 
calcium. 
As shown previously, incubation of the cells with vasopressin 
prior to 4SCa labelling caused a reduction in the total 4SCa uptake 
into the cells (Fig 23). When these data were subjected to compart-
mental analysis vasopressin was seen to greatly reduce the amount of 
4SCa binding in 2 pools, 51 and 8
3
, while analysis of the series 
case also suggested a small reduction in the size of pool S2 (Table 
XIII). This observation is consistent with that reported in Fig. 
21, which also demonstrated a reduction in cellular 4SCa in response 
to vasopressin. The rate constants of 4SCa flux were not different 
from control with the exception of k23 (Table XIII) in the series 
model, which was reduced in size (p<O.02, n=6 pairs), suggesting 
that the permeability of a membrane controlling flux from 82 into 53 
was reduced by vasopressin. The fluxes of 4SCa were reduced between 
all compartments except P20 in the parallel model (Table XIII). 
Reduction in steady state fluxes was not surprising in view of the 
reduced compartment sizes. In additional experiments, a lower 
concentration of vasopressin (1 roD/ml) was also found to signi-
ficantly reduce the size of pool S3 (Table XIV). 
Effects of cAMP on 4SCa compartmental analysis. Compartmental 
analysis of the 4SCa efflux curves in Fig 24 demonstrate that cAMP 
(10 mM) did not affect the kinetic parameters of 81 ; however, 83 was 
significantly reduced in size (p<O.OS) (Table XV). The flux of 4SCa 
from 82 to So (P20) was significantly (p<0.02-0.0S) increased in 
both the parallel and series cases, while k20 was sli~htly elevated 
in both cases, but not significantly. The enhanced size of 82 
TABLE XIII 
EFFECTS OF VASOPRESSIN (10 mU/ml) ON 4SCa KINETICS 
Parallel Case 





Vasopressin 0.86 0.194 
±0.12 ±O.028 
Intermediate Pool (S2) 
S2 P20 
Control 1. II 0.071 ±0.O6 ±0.O09 
Vasopressin 1. 21 0.052 
±O. II ±O.OI2 




























Fast Pool (5]) 
51 PI0 k 10 
1. 67 a 0.42gb 0.254 
±0.20 ±0.067 ±O.OID 
0.86 0.194 0.230 
±O.12 ±O.02B ±O.033 



























0=6. All results are expressed as mean ± 5.E.M. S. = pool size, nmol/mg protein; p .. = exchange rate 
(flux) from pool i to pool j, nmol/min/mg protein; k .. = rate constant of efflux fro&Jpool i to pool j, 
min-to Bathing media calcium = 1 mH. 1J 





EFFECTS OF VASOPRESSIN (1 mU/ml) ON 45Ca KINETICS 
PararfeT(:as~e------'-~-~'----"-~------'-------~-~feries-C-aSe----~ 
-~~~~- -~-----------..-............-~------.- ---~ -- ---- _. ~ .. -~---
Fast Pool (51) 
___ ~_~_._v_~. ____ ~ __ 
SI PI0 
Control 1.64a 0.384a 
±0.29 ±0.042 






Control 1.28 0.089 
to.18 ±0.010 






Control 5.943 0.036 
±O.52 ±O.OO4 




























































___ ~~~ ___ ~_~~ __________ v. __ r_r __ ~~_. __ ~ __ ~ __ _
n=6. All results are expressed as mean ± S.E.M. S. = pool size, nmol/mg protein; p .. = exchange rate 
(flux) from pool i to pool j, nrnol/min/mg protein; i .. = rate constant of efflux fro~Jpool j to pool j, 
min-t. Bathing media calcium = 1 mM. 1J 





EFFECTS OF cAMP ON 45Ca KINETICS 
Parallel Case Series Case 
"-
Fast Pool (51) Fast Pool (Sl) 
Sl PIO k10 Sl PIO k IO 
Control 2.02 0.447 0.223 2.02 0.447 0.223 ±O.30 ±0.O73 ±O.OlB ±O.30 ±0.073 ±O.OIB 
cAMP 1. 83 0.373 0.234 1.83 0.373 0.234 ±0.17 ±O.062 ±0.O23 to.17 ±0.O62 ±O.O23 
Intermediate Pool (S2) Intermediate Pool (52) 
S2 P20 k20 52 P20 P23 k20 k23 
Control 1.30
a 
O. ]04a 0.078 2.42a 0.144a 0.042 0.058 0.017 a 
±0.32 ±O.012 ±0.009 ±0.32 ±0.O12 ±O.006 ±O.OO7 ±0.002 
cAMP 2.04 0.226 0.112 3.24 0.264 0.036 0.07B 0.011 ±0.41 ±0.018 ±O.Ol3 ±O.45 ±0.O22 ±O.OOS ±O.OO6 ±O.OO2 
Slow Pool (S3) Slow Pool (S3) 
.-~---
S3 P30 k30 S3 P32 k32 
Control 5.41
a 0.043 0.0078 4.238 0.042 0.0096 
±0.63 ±0.004 ±0.0005 ±O.63 ±0.O06 ±O.OOIO 
cAMP 
4.62 0.036 0.0082 3.41 0.036 0.0101 
iO.54 ±0.OO4 ±O.0009 ±O.52 ±O.OOS ±O.OO14 
n=5. All results are expressed as mean ± S.E.M. S. = pool size, nmol/mg protein; p .. = exchange rate 
(fl~) from pool i to pool j, nmol/min/mg protein; 1 .. = rate constant of efflux froffiJpool i to pool j, 
min 1. Bathing media calcium = 1 mH, cAMP = 10 mH. IJ 





coupled with enhanced P20 suggested that cAMP induced a net uptake 
of extracellular calcium into 52' This may account for the reduction 
in 45Ca efflux when exogenous cAMP was added to prelabelled cells 
(Fig. 24). However, since pool S3 was reduced in size, the enhance-
ment in size of 82 may merely represent transfer of 4
5Ca from 83 to 
S2 and the increased P20 may be a reflection of enhanced permeability 
of the membrane. The rate constants of exchange and fluxes into and 
out of 83 while reduced, were not changed significantly by cAMP 
(Table XV). 
EFFECTS OF TXA2 SYNTHESIS INHIBITORS, ANTAGONISTS, AND MIMETICS ON 
45Ca EFFLUX FROM TOAD BLADDER EPITHELIAL CELLS 
Effect of 7IRA on 4 S Ca efflux in the presence of vasopressin. 
7IRA was shown (Fig 10) to inhibit vasopressin-stimulated water flow 
and TXA2 synthesis. To determine whether 7IRA also inhibited vaso-
pressin-induced alterations in 45Ca metabolism the following experi-
ments were performed. As would be predicted from the water flow 
experiments, control experiments showed that 7IRA (100 ~M), by 
itself, had no effect on 4 5Ca compartmental analysis (Table XVI). 
Thus, cells were preincubated with 7IRA (100 ~M) for 30 min, followed 
by addition of vasopressin (1 mU/ml) for 15 min. The cells were 
labelled with 45Ca for 90 min still in the presence of both 7IRA and 
vasopressin. 7IRA blocked the alteration in 45Ca metabolism in 
response to vasopressin (Fig 28). Specifically, it increased the 
4SCa content at time = 0 and increased the size of pool S3' Upon 
performance of compartmental analysis, 7IHA was found to not affect 








EFFECTS OF 7-(l-IMIDAZOLYL)-HEPTANOIC ACID ON 45Ca KINETICS 
Parallel Case 
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n=6. All resuJts are expressed as mpan ± S.E.M. S. = pool size, nrnol/mg protein; p .. ::: exchange rate 
(fl~x) from pooL i to pool j, nmol/min/mg protein; k .. = ralf' constant of efflux fro~Jpool i to pool j, 
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Figure 28. 45Ca efflux from isolated toad bladder epithelial cells 
preincubated with vasopressin (1 mU/ml) or vasopressin plus 7-(1-
imidazolyl)-heptanoic acid (100 ~M). Cell suspensions were divided 
into 2 aliquots, 1 of which was incubated for 15 minutes with 7IRA 
140 
(100 ~M). Then both aliquots were incubated with vasopressin (1 mU/ml) 
for 15 minutes. Both aliquots were labelled with 45Ca for 90 minutes 
and desaturated. The aliquots contained the experimental agents 
during the labelling and subsequent desaturation periods. Each vaso-
pressin plus 7IHA point is significantly different from the respective 
vasopressin point (p < 0.02-0.0S, n - 6 pairs). 45Ca content at time 
= 0 were 8.44 + 0.68 and 11.86 ± 1.13 nmol/mg protein (p < 0.05), 
vasopressin and vasopressin plus 7IHA, respectively. 
TABLE XVII 
EFFECTS OF 7-(I-IMIDAZOLYL)-HEPTANOIC ACID ON 
VASOPRESSIN-INDUCED ALTERATIONS IN 45Ca KINETICS 























1. 66 0.096 
to.28 ±0.03I 


























_. -- - - ~~--- - - - - --- .. -.---... - --'" _ .. - '" - -.-. 
Series Case -----
Fast Pool (5}) 
SI PIO kID 
1.12a 0.345a 0.208 
to.17 ±0.O43 ±O.027 
1.09 0.278 0.261 
±0.26 ±0.037 ±0.021 
Intermediate Pool (S2) 
52 P20 P23 k20 
1. 83 0.132 0.066 0.073 
to.S8 ±O.OIS ±0.006 ±0.015 
1.56 0.152 0.070 0.097 
±0.49 ±0.028 to.OOl ±0.013 
Slow Pool (53) 
53 P32 k32 
4.62a 0.066 0.0140
a 
±O.SI ±0.006 ±0.OOI8 
8.0B 0.070 0.0089 






0=6. All results are ~xpress~d as mean ± S.E.M. S. = pool sjz~, omol/mg protein; p .. = exchange rate 
(fl~x) from pool i to pool j, nmol/min/mg protein; ~ .. = rdte constant of efflux fro~Jpool i to pool j, 
min 1 Bathing media calrium = 1 roM vasopressin = 11 rlJU/ml, 7IHA = 100 ~M. 
a 




effect of vasopressin to reduce the size of pool S3 was completely 
blocked by 7IRA (Table XVII). 
Effects of cis- and trans-13APA on 4SCa efflux. t13APA, but 
142 
not c13APA was shown to inhibit vasopressin-stimulated water flow in 
the isolated, intact toad bladder (Chapter II). The effect of 
t13APA appeared to be antagonism of the action of TXA
2
, since t13APA, 
but not c13APA, also antagonized the water flow response to U46619 
(Fig. 14). Therefore, the effects of t13APA and c13APA on 4SCa 
efflux were assessed. In the initial experiments the concentration 
of 13APA was 300 ~M, the maximum concentration which had been used 
in the water flow experiments. This concentration of either isomer 
of 13APA was associated with massive uptake of 4SCa into the isolated 
cells (Table XVIII). Either isomer of 13APA, when dissolved in the 
Ringer's solution at a concentration of 300 ~M, was observed to 
cause a great amount of foaming when the solution was aerated. 
Thus, the massive 4SCa uptake observed in the presence of 13APA was 
assumed to be caused by a detergent-like degradation of cell membranes. 
Lower concentrations of 13APA were tested on 4 SCa efflux. 





(Table XVIII). However, 13APA (50 ~M), while enhancing 
45Ca uptake into pool 8
2
, had no effect on pool S3 (Table XIX and 
XX). 
Effects of cis- and trans-13APA on 4SCa efflux in the presence of 
vasopressin. Since t13APA (50 ~M) had caused only a small inhibition 
of water flow in response to vasopressin (5 mU/ml) (Chapter II) a 
pilot experiment was performed to assess the effects of t13APA (50 
~M) on water flow stimulated by a lower dose of vasopressin (1 
TABLE XVII I 
EFFECTS OF cis- AND trans-13-AZAPROSTANOIC ACID ON 4 5Ca KINETICS 
13APA (300 jJM)a 
52 k20 S3 k30 
Control 1 . 121:0. 14 0.084±0.007 5.84±0.42 0.0075±0.0006 
c13APA 1B.73±4.21 O. 148±0. 018 46.82±7.82 0.0143±0.0016 
Control 1. 24±0. 13 0.078±0.006 6.23±0.58 0.0082±0.0008 
t13APA 12.47±3.92 0.134±0.023 31.76±4.95 0.0148±0.0017 
13APA (100 IJM)b 
Control 1. 06±0. 12 0.072±0.007 6.24±0.42 0.0076±0.0006 
c13APA 2.42±0.42 0.122±0.024 18.74±3.24 0.0102±0.0011 
Control 1.12±0.14 0.068±0.007 5.98±0.38 0.0069±0.0006 
t13APA 2.65±0.82 O.lIO±O.OIB 14.37±2.87 0.0098±0.0012 
Suspensions were incubated with 13APA or vehicle for 30 minutes prior to 
labelling with 45Ca. 
a ~ . b 3 . n=. pa1rs, n= palrs. 
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TABLE XIX 
EFFECTS OF trans-13-AZAPROSTANO[C ACID ON 4SCa KINETICS 
---------Pa-ra Ife-(-Case~-~-----~---~---~-~-- ---~------------- ~;;-eri-es-Ca~s-e--------------- - ------- -- -----
-----~ --- ~-- ~-~~---~---~--- __________ .• _____ . __ 0_-. __ . ____ .. _. _____ 
Fast Pool (51) Fast Pool (51) 
-.---.-~ .. ---- ... _ .. _-_. ---------
SI P10 k10 SI PIO k 10 
Control 1. 58 0.327 0.231 1. 58 0.372 0.231 to.23 ±O.090 ±0.O34 ±O.23 ±O.090 ±0.OJ4 
t13APA 1. 83 0.428 0.242 1. 83 0.428 0.242 ±0.28 ±O.IIB ±0.028 ±0.2B ±O.118 ±O.02B 
Intermediate Pool (S2) Intermediate Pool (S2) 
S2 P20 k20 S2 P20 P2] k20 k23 
Control I.IB
a 0.084a 0.072 2.33a 0.128a 0.051 0.055 0.019 
to. ]2 ±O.OOB ±0.007 ±0.22 ±O.O14 ±0.OO4 ±0.006 ±0.OO4 
t13APA 1.52 0.149 0.098 2.83 0.198 0.053 0.070 0.019 ±O.14 ±O.OI2 ±O.O07 ±O.25 ±0.016 ±O.OO4 ±O.009 ±O.003 
Slow Pool (S3) Slow Pool (53) 
-----~ .. ~ ~.----~----,--- -
S3 P30 k30 53 P32 k32 
Control 5.82 0.041 0.0073 4.73 0.051 0.0094 ±0.62 ±O.OO4 ±0.OOO7 ±0.38 ±O.OO4 ±O.OOOS 
t13APA 5.92 0.044 0.0082 4.65 0.053 0.0114 ±O.60 ±O.OO3 ±0.OO08 ±O.41 ±0.004 ±O.DOI2 
n=6. All results are expressed as mean ± S.E.M. S. = pool size, nmol/mg protein; p .. = exchange rate 
(flux) from pool i to pool j, nmol/min/mg protein; i_. = rate constant of efflux froffiJpool i to pool j, 
min-I. Bathing media calcium = 1 mM, t13APA = 50 ~M~J 





EFFECTS OF cis-lJ-AZAPROSTANOIC ACID ON 45Ca KINETICS 




























































Fast Pool (S]) 
-------
51 PIO k]O 
1 .82 0.413 0.242 
±O.32 to. ] 23 to.031 
1. 73 0.370 0.219 
±0.24 ±0.078 ±0.028 
Intermediate Pool (S2) 




±0.24 ±0.012 ±0.004 
2.72 0.152 0.52 
±0.29 to.018 to.004 
Slow Pool (53) 
S3 P32 k32 
4.92 0.046 0.0091 
±0.42 to.004 ±0.0013 
4.84 0.052 0.0120 







0=6. All results are expressed as mean ± S.E.M. S. = pool size, nmol/mg protein; p .. = exchange rate 
(fl~x) from pool i to pool j, nmol/min/mg protein; R .. =- rdte constdnt of efflux fro~.Ipool i to pool j, 
min 1. Bathing medid calcium = 1 mM, c13APA :::: 50 ~M~J 
a 





mU/ml). The control hemibladders were incubated with c13APA (50 
~M). In the control hemibladders vasopressin stimulated water flow 
from 1.2±0.s to 50.4±10.1 mg/min/hemibladder, while in the hemi-
bladders preincubated with t13APA for 30 min vasopressin stimulated 
water flow from 1.4±O.1 to 42.0±8.8 mg/min/hemibladder. Thus, in 
the control hemibladders, the increment in water flow due to vaso-
pressin was 49.2±lO.2 mg/min/hemibladder, and in the hemibladders 
preincubated with t13APA the increment in water flow due to vaso-
pressin was 40.6±8.7 mg/min/hemibladder, an inhibition of 16.9±3.8 % 
(p<0.02, n=6 pairs). 
In the 45Ca efflux experiments the cells were incubated with 
t13APA (50 ~M) for 30 min, then vasopressin (1 mD/ml) was added for 
an additional 15 min. The cells were labelled with 45Ca for 90 min 
still in the presence of t13APA and vasopressin, then desaturated. 
Control suspensions contained c13APA (50 ~M). No significant differ-
ence was found in 4SCa efflux between control suspensions (cI3APA 
plus vasopressin) and those preincubated with t13APA and vasopressin 
(Fig 29). Compartmental analysis revealed no significant differences 
between control and t13APA-pretreated suspensions, although the size 
of pool 8
3 
tended to be increased in the presence of t13APA (0.10>p> 
0.05, n=6 pairs) (Table XXI). This trend was confirmed by analysis 
of covariance of the In 4SCa content versus time lines for pool S3. 
When analysis of covariance was performed pool 83 in the presence of 
vasopressin plus t13APA was significantly larger (p<O.OS) than in 
the presence of vasopressin plus c13APA. However, it must be re-
emphasized that the differences were quite small. 
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Figure 29. 45Ca efflux from isolated toad bladder epi-
thelial cells preincubated with vasopressin (1 mU/ml) 
pius tpans-13-azaprostanoic acid (50 ~M) or vasopressin 
plus cis-13-azaprostanoic acid. Cell suspensions were 
divided into 2 aliquots, 1 of which was incubated for 30 
minutes with t13APA (50 ~M) and the other with c13APA 
(50 ~M). Then both aliquots were incubated with vaso-
pressin (1 mU/ml) for 15 minutes. Both aliquots were 
labelled for 90 minutes and desaturated. The aliquots 
contained the experimental agents during the labelling 
and desaturation periods. When the data were analyzed 
as In 45Ca remaining versus time and analysis of covar-
iance performed for each component, pool S3 was found to 
be significantly larger in the presence of vasopressin 
plus t13APA than in the presence of vasopressin plus 
c13APA (p < 0.05 for 6 pairs of aliquots). Also shown 
is the effect of vasopressin (1 mU/ml) on 45Ca efflux. 
Each vasopressin point shown is significantly different 
from the respective control point (p < 0.05, n = 6 pairs). 
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TABLE XXI 
EFFECTS OF trans-13-AZAPROSTANOIC ACID ON VASOPRESSIN-
INDu'cEn ALTERATIONS IN 45Ca KINETICS 
·.----Par-aTTe i--C-ase- --------~------,-.-------....-------.---~--.---,-------.- -~---- .... --"-------.------.,~--~ 
------,- - -_.--------_.-
Fast Pool (SI) 
S1 PI0 k10 
Vasopressin 1. 64 0.438 0.257 
plus c13APA ±O.34 ±O.052 to.030 
Vasopressin 1.42 0.372 0.248 
plus t13APA ±0.41 ±0.043 to.027 
Intermediate Pool (52) 
S2 P20 k20 
Vasopressin 1.48 0.164 0.114 
plus c13APA ±0.2S ±0.012 to.OIO 
Vasopressin ] .37 0.168 0.122 
plus t13APA ±0.34 ±0.O14 ±O.012 
Slow Pool (S3) 
~ ... --.....-..~~-.---~-~ ~ 
S3 P30 k30 
Vasopressin 4.98a 0.044 0.0088 
plus c13APA ±0.44 ±0.OO4 to.OOO7 
Vasopressin 5.24 0.041 0.0082 
plus tl:3APA ±0.40 ±O.OO] to.OOO7 
--- ... - _., ~~ - .-.-~-~ ______ 0 ••• - "_., ___ 
Series Case 
~------.---~----
Fast Pool (51) 
~------------.----... -.-
S1 P IO kID 
1. 64 0.438 0.257 
±O.34 to.OS2 ±0.030 
1.42 0.372 0.248 
±O.41 ±0.043 ±O.Ol7 





























n=6. All results are expressed as mean ± S.E.~1. S. = pool size, mnol/mg protein; p . = exchange rate 
(flux) from pool i to pool j, nmol/min/mg protein; ~. ratp constant of t'1 t lux fro~Jpool i to pool j, 
min-I. Bathing media l'alcium = 1 mN, vasopressin = tJmU/ml, clJAPA = SO ~M, t13APA = :)0 IJH. 





Effects of U46619 on 45Ca efflux from prelabelled cells. 
U46619 (0.1-1 ~M) was shown to mimic the water permeability response 
to vasoprssin (Fig. 12). U46619 appeared to act by mimicking TXA2 
since the effect was blocked by t13APA (Fig 14). The present experi-
ments were performed to determine whether U46619 also mimicked 
vasopressin's effect on 4SCa fluxes. When U46619 (1 ~M) was added 
to suspensions already undergoing desaturation, no effect on 45Ca 
efflux was noted (Fig. 30). However, after U46619 was removed from 
the bathing media 45Ca efflux transiently increased. This effect 
was similar to that observed when exogenous cAMP was added to the 
cells during desaturation (Fig. 24). 
Effects of U46619 on 45Ca compartmental analysis. In suspen-
sions which had been preincubated with U46619 (1 ~M) for 15 min 
prior to labelling with 45Ca for 90 min, uptake of 4SCa into the 
cells was identical to uptake into control cells (lO.62±O.80 nmol/mg 
protein compared to 10.72±O.97 nmol/mg protein in the controls). 
However, by 70 min after commencement of desaturation the cells 
incubated with U46619 contained significantly less 4 5 Ca than did the 
control cells (Fig 31). When these curves were analyzed by compart-
mental analysis, it was found that U46619 (1 ~M) had increased the 
size of pool S2 while decreasing the size of pool S3 (Table XXII). 
In addition to increasing the size of S2' the flux of calcium into 
and out of S2 (P20) was increased, as well as the rate constant of 
efflux from 8
2 
(Table XXII). These effects are similar to those 
observed with cAMP (Table XIII). A lower concentration of U46619 
(0.1 ~M) was observed to cause similar alterations in 4SCa metabolism 
(Table XXIII), although of lower magnitude. 
It 
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Figure 30. Effect of U46619 on 45Ca efflux from isolated 
toad bladder epithelial cells. Suspensions were labelled 
with 45Ca for 90 minutes. Each suspension was divided 
into 2 aliquots which were desaturated simultaneously. 
After 30 minutes of desaturation U466l9 (1 ~) was added 
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Figure 31. 45 Ca efflux from isolated toad 
bladder epithelial cells preincubated with 
U46619 (1 ~M). Cell suspensions were div-
ided into 2 a1iquots, 1 of which was incu-
bated for 15 minutes with U46619 (1 ~M). 
Then both a1iquots were labelled for 90 
minutes with 45Ca and desaturated. The 
experimental aliquots contained U46619 during 
the labelling and desaturation periods. 
Curves were analyzed as In 45Ca remaining 
versus time and divided into linear compo-
nents (see Methods). Analysis of covariance 
revealed that in the presence of U466l9 
component S2 was larger (p < 0.01 for 6 pairs 
of aliquots) and component S3 was smaller 
(p < 0.02 for 6 pairs of aliquots) than con-
trol. 45Ca content at time = 0 were 10.62 
+ 0.80 and 10.72 + 0.97 nmol/mg protein, 
control and U46619 t respectively. 
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TABLE XXII 
EFFECTS OF U466I9 (1 ~M) ON 45Ca KINETICS 
-~~-.---- ---~-- ~------~--------------~----- - --_ .. _-------- __ ~~ ___ .L ___ ~ __ ._.~_~ ___ ~~ ____ _ 
Parallel Case Series Case 
Fast Pool (SI) Fast Pool (SI) 
S1 PI0 kID SI PIO kID 
Control 1.40 0.371 0.214 1.40 0.371 0.214 to.2S ±0.109 ±0.030 iO.25 ±0.109 ±O.030 
U46619 
1.83 0.304 0.173 1.83 0.304 0.173 
±0.42 ±0.090 ±0.032 ±0.42 ±O.O90 ±O.032 
Intermediate Pool (S2) lntermediate Pool (S2) 





2.38 3 0.139a 0.048 0.063 0.017 
±0.09 ±0.009 ±O.007 ±0.20 ±0.009 ±0.009 ±0.008 ±0.003 
U46619 2.27 0.230 0.120 3.36 0.268 
0.038 0.091 0.013 
±0.32 ±0.054 ±O.OII ±0.33 ±0.059 ±0.005 ±0.018 ±0.O03 
Slow Pool (S3) Slow Pool (83
) 
__ . ___ . ~_'L__ _ 
53 P30 k30 S3 P32 k32 
Control 6.40
a 0.043 0.0071 5.15
3 0.048 0.0101 
±0.72 ±0.003 ±0.0003 ±0.58 ±0.009 ±O.OOOI 
U46619 
5.34 0.038 0.0080 4.23 0.038 0.0082 
±0.4] ±0.005 ±0.0007 ±0.40 ±0.005 ±O.OOIO 
n=6. All results are expressed as mean ± S.E.M. S. = pool size, nmol/mg protein; p. = exchange rate 
(flux) from pool i to pool j, nmol/min/mg protein; ft .. = ratt' constant of efflux froJ.J pool i to pool j, 
min-t. Bathing media calcium = 1 mM, U46619 = 1 ~M. IJ 











EFFECTS Of U46619 (0.1 ~M) ON 4 5Ca KINETICS 
~------~.-.-- --.-~-----.-... ----.~----- ---.-.----~~-~-.-- .. ----.. ---~. 
Parallel Case 
~---.--.-=----~-~--
Fast Pool (SI) 
--------------
51 PI0 k IO 
2.05 0.418a 0.242 
±0.24 ±0.058 ±0.028 
2.53 0.584 0.237 
±0.38 ±0.071 ±0.026 
Intermediate Pool (S2) 
---.-~ ~-------
52 P20 k20 
1.28a 0.091 a 0.073a 
±0.09 ±O. 0 11 ±0.006 
I .52 0.138 0.091 
±0.I3 ±0.018 to.012 
Slow Pool (53) 
~ .. ----
53 P30 k30 
6.32a 0.049 0.0082 
±0.62 ±0.003 ±0.0007 
5.94 0.039 0.0078 
±0.48 ±0.004 ±0.0006 
Series Case 
Fast Pool (S1) 
SI PIO k l0 
2.05 0.418a 0.242 
±0.24 ±0.058 ±0.028 
2.S3 0.584 0.237 
±0.38 ±0.072 ±0.026 

































n=6. All results are expressed as mean ± S.E.M. S. = pool size, nmol/mg protein; p .. = exchange rate 
(fl~x) from pool i to pool j, nmol/min/mg protein; l .. = rate constant of efflux froffiJpool i to pool j, 
min 1. Bathing media calcium = 1 mM. U46619 = 0.1 ~A~ 





Effects of t13APA on 4SCa efflux in the presence of U46619. 
Because of the effect of high concentrations of t13APA to markedly 
enhance 4SCa uptake into the cells (Table XVI), a low concentration 
of t13APA, 50 ~M, was used in these experiments. Since the concen-
tration ratio of t13APA to U46619 must be quite high to achieve 
blockade of U46619-stimulated water flow (Chapter II), a low concen-
tration of U46619 (0.1 ~M) was used. Examination of Fig. 14 suggested 
that at this concentration ratio (SOD) t13APA should inhibit U46619-
stimulated water flow ca. 70%. The cell suspensions were incubated 
with t13APA (50 ~M) (c13APA in controls) for 30 min. U46619 (0.1 
~M) was added to the suspensions and 15 min later labelling with 
4SCa began. After 90 min labelling, desaturation of the suspensions 
was commenced. The total uptake of 45Ca was not different between 
control suspensions (c13APA plus U46619) and those preincubated with 
t13APA plus U46619 (9.87±O.54 nmol/mg protein versus 9.72±O.68 
nmol/mg protein in the control suspensions). However, by 80 min of 
desaturation the control suspensions contained significantly less 
45Ca (Fig. 32). Compartmental analysis of the curves revealed that 
preincubation with t13APA increased the size of S2 (p<O.05, n=6) and 
t13APA tended to increase the size of pool 53 (0.10>p>O.OS, n=6 
pairs) (Table XXIV). When the data were analyzed using the modified 
series case the size of pool S3 was significantly (p<O.05, n=6 
pairs) increased in the suspensions incubated with t13APA (Table 
XXIV). When the data for the parallel and series cases were analyzed 
as In 4SCa content versus time and analysis of covariance performed 
on each component pool 53 was found to be significantly larger in 
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Figure 32. 45Ca efflux from isolated toad 
bladder epithelial cells preincubated with 
U46619 (0.1 ~M) plus trans-13-azaprostanoic 
acid (50 ~M) or U46619 plus cis-13-azapros-
tanoic acid. Cell suspensions were divided 
into 2 aliquots, 1 of which was incubated for 
30 minutes with t13APA (50 ~M) and the other 
with c13APA (50 ~M). Then both aliquots were 
incubated with U46619 (0.1 ~) for 15 minutes. 
Both aliquots were labelled with 45Ca for 90 
minutes and desaturated. The aliquots con-
tained the experimental agents during the 
labelling and desaturation periods. When the 
data were analyzed as In 45Ca remaining versus 
time and analysis of covariance performed, 
pool 53 was found to be significantly larger 
in the presence of U46619 plus t13APA than 
in the presence of U46619 plus c13APA (p < 
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TABLE XXIV 
EFFECTS OF trans-13-AZAPROSTANOIC ACID ON 
U46619-INDLJCEDALTERATIONS IN 4SCa KINETICS 
,- _ --- '. -----.--_.. ------. -.-~-- - -- ~-- - ~ - .~-~----- ,------- .. - ~ .-- - - ~~--- --.,----...---..-"""'----~- - ----- . 
Parallel Case Series Case 
-~-.---~----.~~--~~-. 
Fast Pool (SI) Fast Pool (SI) 
-~.-----
51 P I0 kIO SI PIa kIo 
2.22 0.472 0.216 2.22 0.472 0.2]6 
±O.24 ±0.058 ±O.022 ±0.24 ±O.OSB ±0.022 
2.14 0.494 0.230 2.14 0.494 0.230 
±0.32 ±O.062 ±0.02B ±0.32 ±O.062 ±0.02B 
Intermediate Pool (52) Intermediate Pool (S2) 
. ___ ~~. __ ~ __ ~~ __ ~~ __ .,n __ "_ ------ .. - .. ----.-~~~--
52 P20 k20 52 PzO P23 
1. 41 a O.094a 0.092 3.87 0.148 0.070 
±O.12 ±0.007 ±O.D06 ±0.32 ±O.O]B ±O.007 
1. 87 0.128 0.088 4.24 0.164 0.076 
±0.20 ±0.012 ±O.OOB ±D.46 ±0.O16 ±O.OOl 
Slow Pool (8)) Slow Pool (S)) 
~----~----~-. 
S3 P30 k30 53 P32 k32 
6.90 0.052 0.0081 4.4Sa 0.070 0.0104 
±0.68 ±0.006 iO.OOOS ±0.46 ±0.007 ±0.0012 
7.21 0.056 0.0078 4.96 0.080 0.0114 
±0.74 ±O.OO5 ±0.OO06 ±O.48 ±0.007 ±0.0010 






n=6. All results are expressed as mean ± S.E.M. S. = pool size, nmol/mg protein; p .. = exchange rate 
(fl~x) from pooJ i to pooJ j, nmal/min/mR protein; ~ .. :::: rate constant of efflux froJ1Jpooi i to pool j, 
min 1 Bathing media calcium = 1 rnM, U466J<:l =: 0.1 J.1R'! cl3APA = 50 J,JM, t13APA =: 50 ~M. 




the presence of U46619 plus t13APA than in the presence of U46619 




The present studies demonstrate that vasopressin, exogenous 
cAMP, and U46619, all of which enhance water permeability of the 
intact, isolated toad urinary bladder, all affect 45Ca metabolism in 
epithelial cells isolated from the toad bladder. Further, several 
agents which inhibit water permeability also block the alterations 
in 45Ca metabolism in response to vasopressin and U46619. 
Effects of vasopressin on 45Ca efflux 
Vasopressin enhanced the instantaneous rate constant of efflux 
from cells undergoing 45Ca desaturation. In this regard, the isolated 
cells behaved in a manner qualitatively similar to intact hemibladders 
(Thorn and Schwartz, 1968). In the cell suspensions vasopressin 
caused a peak enhancement of 39±11% in the rate of efflux during the 
first 20 min in which it was present. In the experiments of Cuthbert 
and Wong (1974), using intact hemibladders, the maximal enhancement 
in 45Ca efflux due to vasopressin was approximately 150%, and in the 
experiments of Schwartz and Walter (1969) vasopressin elicited an 
enhancement in 45Ca efflux of somewhat less than 100%. The sampling 
frequency used by these 2 groups was much greater and the peak 
enhancement in 45Ca efflux was observed only 1-3 minutes after 
vasopressin addition. Thus, the quantitative differences between 
the present experiments and those in which intact hemibladders were 
used may be partially accounted for by the sampling frequencies, or 
they may result from alterations to the plasma membranes of the 
isolated cells caused by collagenase or the absence of extracellular 
calcium during the isolation procedure. 
159 
The enhanced 45Ca efflux observed when vasopressin was added to 
suspensions already undergoing desaturation may be explained by at 
least 2 processes. Vasopressin may have caused a net efflux of 
calcium from the cells, or, the rate of exchange of calcium may have 
been increased. In addition, the size of the exchangeable pool may 
have been increased (Sha'afi et al., 1981). The latter possibility 
may be less likely since the bathing medium was unlabelled, and the 
effect was seen when vasopressin was added late in the desaturation 
when only pool 53 was labelled. Thus, any calcium entering a larger 
exchangeable pool would be 40Ca and dilute the specific activity of 
the exchanging pool, making it less likely that enhanced efflux of 
4 5 Ca would be observed, even if exchange with the bathing medium 
increased. 
The experiments which examined the effect of vasopressin on the 
steady state concentration of 45Ca in the cells support the explana-
tion that the effect of vasopressin is to cause a net extrusion of 
calcium from the cells. The cells lost a maximum of O.90±O.11 
nmoles of calcium per mg cell protein after exposure to 20 mU/ml 
vasopressin based on the specific activity of the bathing medium. 
This loss was largely complete within 1 min (O.63±O.09 nmol/mg 
protein), confirming the observation of Cuthbert and Wong (1974). 
Vasopressin (0.1 mU/ml), a concentration which does not enhance 
osmotic water flow, did not have any effect on the amount of 45Ca in 
the cells. Vasopressin (1 mU/ml), which in separate experiments 
elicited a water flow response of about 70% that seen in the presence 
of a supramaximal concentration, 20 mU/ml, caused a reduction in 
45Ca content (O.67±O.10 nmol/mg protein) 76% of that observed in the 
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presence of vasopressin at 20 mU/ml (O.90±0.11 nmol/mg protein), 
suggesting parallel responsiveness of the 2 effects to vasopressin. 
When the cells were incubated with vasopressin (10 mU/ml) and 
subsequently labelled with 4SCa and desaturated, 3 components of 
efflux were observed. Vasopressin enhanced efflux from 2 of these, 
causing a net decrease in cellular calcium of 1.89 nmol/mg protein, 
(Legend to Fig. 23) much more than observed in the steady-state 
experiment (0.90 nmol/ mg protein). However, the most rapid component 
of efflux may be calcium bound to the external surface of the plasma 
membrane. In the steady state experiments where lanthanum was used 
to displace extracellular calcium this first component would not 
have been detectable due to displacement by lanthanum. When the 
first component is ignored, preincubation with vasopressin (10 
mU/ml) was found to cause a reduction in cellular calcium of 0.82 
rumol/mg protein, quite similar to the 0.90 nmol/mg protein observed 
in the steady state experiments. 
Compartmental Analysis 
Several experiments were performed in an attempt to identify 
the structural correlates of the several components of 4 5Ca efflux. 
Efflux was observed to occur from four pools. The most rapidly 
exchanging pool was assigned as that residual 45Ca contained in the 
bathing media which was trapped between the cells in the first 
pellet. This assignment was based on the observation that this pool 
exchanged with the same rate and occupied the same space as the 
extracellular markers inulin and bovine serum albumin. 
The rate constant for exchange from pool SI (0.2 min-I) was in 
the range usually considered to be the 45Ca bound to the extracellular 
surface of the plasma membrane (Borle, 1970; Sandborn and Langer, 
1972). Predictably La 3 + (1 mM) displaced about 50% of this pool. 
This displacement was quite similar in magnitude to that reported 
3+ . 45 for La d1splacement of Ca from the glycocalices of cultured 
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heart cells and fibroblasts (Langer and Frank, 1972). EGTA displaced 
essentially all of the 45Ca in this pool. Thus, "pool" 8
1 
appeared 
to be composed of 2 pools of extracellular membrane-bound 4SCa which 
exchanged with similar time constants which, due to the poor resolu-
tion of the present method, were not able to be dissociated kinetic-
ally_ 
In the experiments in which the cells were incubated with La 3 + 
the rate of efflux from pool 8
2 
slowed to a rate similar to that for 
efflux from pool S3' This suggests that the 4SCa from pool 52 and 
perhaps pool S3 must cross the plasma membrane to reach the bathing 
medium. Langer and Frank (1972) observed in heart cells and in 
fibroblasts that incubation with high concentrations of La 3 + reduced 
the rate of efflux from a pool with characteristics similar to S2 to 
a rate which is similar to that of 8
3 
in these experiments. Further 
suggesting that 8
2 
was intracellular in location was the observation 
that EGTA did not affect the size of pool S2. 
Pool 8
3 
exchanged only slowly with bathing medium calcium. 
Borle has suggested that pools with characteristics similar to pool 
8
3 
in a variety of cells are mitochondrial in origin. In the present 
experiments mitochondrial inhibitors were observed to reduce the 
size of pool 8
3 
by about 40%. At the same time the size of pool S2 
was increased. A similar effect of mitochondrial inhibitors was 
noted by Carafoli (1967) in liver. Uncoupling of mitochondrial 
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function reduced mitochondrial calcium content while enhancing 
microsomal calcium content, presumably by allowing the microsomal 
calcium uptake systems to compete more favorably with the mitochondria 
for available calcium. However, in the present experiments EGTA 
displaced about 70% of 45Ca from pool S30 However, EGTA increased 
the rate constants of efflux from pools S2 and 8
3 
from 0.064 and 
0.0061 min- 1 to 0.248 and 0.0143 min- 1 so that the enhanced efflux 
observed in the perturbation experiment may represent the enhanced 
rate constants. However, the possibility cannot be excluded that up 
to 70% of pool 8
3 
may be extracellular in location. 
In preliminary experiments not reported in this dissertation, 
an attempt was made to determine the Q10's of efflux from pools 52 
and 8
3
. The Q10 of efflux from pool 52 was 2.88 in one experiment 
and 3.24 in another, suggesting that a membrane must be crossed by 
an energy-requiring process. The Q10 for pool 8
3 
was apparently 
higher since little efflux was observed from this pool under the 
conditions of the experiment. 
The model derived from the foregoing data may be summarized as 
follows. The bathing medium, pool SO' may be considered of infinite 
size since it is periodically changed. Another bathing medium, pool 
So represents that bathing medium which remains with the cell pellet 
on centrifugation of the suspensions. 
pools of extracellular bound calcium. 
may be displaced by La 3 + and represents 




Pool 8 1 L 
is , 
about 50% of 
EGTA but not 
composed of 2 




by L 3+ a . 
8
2 
is considered to be the cytoplasmic pool except for a possible 
mitochondrial component. Thus, calcium extrusion from the cell must 
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take place only via flux from 8
2 
into the bathing media, 8 0 , For a 
large variety of isolated cells the plasma membrane surface area is 
about 30 cm2 /mg protein (Borle, 1970; Claret-Berthon et al., 1977). 
Thus, calcium flux across the plasma membrane, S2~SO' amounts to 
some 44 femptomol/cm 2 /sec in these cells, well within the range of 
14-76 fentomol/ cm2 /sec published for transport of calcium across 
the plasma membranes of a wide variety of cells (Borle and Anderson, 
1976, for a review). Further, the rate constant of efflux from pool 
S2 was also virtually identical to those from "cytoplasmic pools" 
from a variety of cell types (Hodgkin and Keynes, 1957; Blaustein 
and Hodgkin, 1969; Borle, 1970; Sanborn and Langer, 1970; Langer and 
Frank, 1972; Claret-Berthon et al., 1977). The isolated toad bladder 
epithelial cells are spherical (Eggena, 1978), thus their volume is 
about 15.3 ~l/mg protein. If the free ionized calcium concentration 
in the cytoplasm is assumed to be 0.1 ~M, then the portion of 82 
which may be accounted for by free ionized calcium is 0.0015 nmol/mg 
protein or less than 0.1% of 820 Thus, S2 must consist primarily of 
sites such as endoplasmic reticulum and binding proteins. Pietras 
et al. (1976) found that total cellular calcium in bullfrog bladder 
epithelial cells was 3.7 mH. Their method of determination would 
presumably have included pools S1' S2' and 8 3 , In this study, 
exchangeable calcium in all 3 pools would amount to about 0.6 mM 
calcium. Thus, one may expect that a large non-exchanging or very 
slowly-exchanging calcium fraction exists in these cells, perhaps 
amounting to 80% of total cellular calcium. 
"Pool" S3' like pool 52 appears to be composed of 2 pools. 
Pool S3 E is the 60-70% of 8
3 
which may be displaceable by EGTA and , 
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which 1S not affected by mitochondrial inhibitors. It appears to be 
close to the extracellular space since it is displaced by EGTA, but 
since La 3 + did not affect it, it must be on the inside of the cells. 
Perhaps binding to the inside surface of the plasma membrane to 
phospholipid head-groups would satisfy the requirement of close 
association to the extracellular space and inaccessibility to 1a 3 +. 
Pool 5 3 ,M is that 30-40% of pool S3 which is affected by mitochondrial 
+ 
inhibitors and which is not displaced by La 3 . Presumably, it 
represents mitochondrial calcium. 
Effects of cAMP and U46619 on 45Ca Efflux 
Unlike vasopressin, exogenous cAMP caused a transient inhibition 
of 4 5Ca efflux. This effect of cAMP is similar to that reported by 
Cuthbert and Wong (1974) except that in their studies, using intact 
hemibladders, the inhibition of 4 5 Ca efflux in response to cAMP was 
about 75%, and lasted as long as cAMP was present in the bathing 
media. While the effect of cAMP on 45Ca efflux was different from 
that seen in response to vasopressin, compartmental analysis revealed 
that cAMP, like vasopressin, caused a significant reduction in the 
size of the calcium pool 8
3
. The decrease in the size of pool 8
3 
(O.82±O.13 nmol/mg protein) was accompanied by a similar increase in 
the size of pool S2 (O.73±O.10 nmol/mg protein), consistent with the 
notion that calcium was transferred from pool S3 to pool 52 in 
response to cAMP. However, in these experiments cAMP was present 
for 15 min plus 90 min during labelling of the cells. Thus, the 
alteration in pool S2 may not have occurred simultaneously with the 
alteration in 8
3
, and the changes may not be associated. In fact, 




and the bathing medium was enhanced by cAMP. This type of biphasc 
effect of agents on 4 SCa flux has been observed in pancreatic acinar 
cels (Schulz, 1980) and appears to be common to many agents. 
Like cAMP, U46619 also did not enhance 4SCa efflux from the 
cells undergoing desaturation. The effects of U46619 on 4SCa compart-
mental analysis were quite similar to those seen in response to 
cAMP. Pool S3 was decreased in size and pool 82 was increased in 
size by a similar amount. A similar effect of U46619 to enhance the 
size of one cellular calcium pool by shifting from another pool 
without affecting net efflux has be~n observed by LeBreton (personal 
communication, in press in Am. J. Physiol.). Further, calcium 
exchange between pool 82 and bathing medium was enhanced by U46619. 
The similarities in the effects of U46619 and cAMP on 45Ca compart-
mental analysis suggests that U46619 may act to increase water 
permeability across the toad bladder and alter 4 5 Ca metabolism by 
enhancing the cellular accumulation of cAMP. In support of this 
notion is the observation that U44069 enhances cAMP accumulation in 
the uterus (Vesin et al., 1979). Further, experiments described in 
Chapter II suggest that the magnitude of the water flow response to 
U46619 may be increased by inhibition of cyclic nucleotide phosphodi-
esterase. 
Effects of 7IHA and 13APA on the 4SCa Response of Vasopressin and 
U46619. 
In order to explore the role of TXA2 in vasopressin's stimulation 
of water permeability the effects of 7IRA, a TXA2 synthesis inhibitor, 
and t13APA, a TXA2 antagonist, were assessed on vasopressin-induced 
alterations in 4SCa metabolism. 7IRA (100 ~M) blocked the effect of 
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vasopressin to reduce the size of pool S3. While vasopressin (1 
mU/ml) decreased the size of S3 by 1.14±O.28 pmol/mg protein. 7IRA 
blocked the effect of vasopressin completely, the size of pool 53 in 
the presence of 7IRA plus vasopressin was 2.97±O.62 pmol/mg protein 
greater than 1n the presence of 7IRA alone. Since at this concentra-
tion 7IRA (100 ~M) inhibits vasopressin-stimulated water flow only 
20-25% no direct correlation appears to exist between the inhibition 
of 4SCa efflux brought about by 7IRA and its inhibition of vasopressin-
stimulated water flow. However, experiments to be described in the 
next chapter suggest that the "extra" increase in size of S3 in 
response to 7IRA may be mediated by PGE
2 
acting unopposed by TXA
2
. 
t13APA is a TXA2 antagonist which inhibited vasopressin-stimu-
lated water flow, while its cis isomer, which is inactive as a TXA2 
antagonist, had no effect on vasopressin-stimulated water flow. 
Preliminary experiments showed that at the concentration (300 ~M) 
used in the water flow studies both trans- and cis-13APA acid caused 
a massive uptake of 45Ca into the isolated epithelial cells. When 
the Ringer's solutions containing the compounds were aerated a large 
amount of foaming occurred. Thus, the massive 4SCa uptake observed 
in response to these compounds was assumed to be due to enhanced 
permeability of the cells to calcium caused by a non-specific deter-
gent effect. Similar results have been obtained when isolated cells 
have been incubated with other detergents (Murphy et al., 1980). At 
a concentration of 50 ~M neither isomer of 13APA affected the size 
of pool 8
3
" However, both compounds did increase the size of pool 
S2 significantly. In spite of this nonspecific effect of these 
compounds, an attempt was made to characterize the effect of t13APA 
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on vasopressin-induced alterations in calcium metabolism. To control 
for the independent effect of the compounds on pool 8
2
, the control 
suspensions contained c13APA. In preliminary experiments t13APA (50 
~M) inhibited vasopressin (1 mU/ml)-stimulated water flow only 17±4% 
(p<0.02, n=6 pairs). In the isolated cells vasopressin (1 mU/ml) 
decreased the size of pool S3 by 1.1±0.2B nmol/mg protein. Incubation 
of the cells with t13APA in addition to vasopressin blocked the 
effect of vasopressin by 0.28±0.OB nmol/mg protein (26% reduction). 
While this amount corresponded to the 17% inhibition of vasopressin-
stimulated water flow, the effect was not statistically significant. 
Perhaps placing the cells into temporary culture and labelling with 
45Ca to isotopic equilibrium would allow an effect of t13APA to be 
discerned. In the present experiments pool S3 was labelled only to 
about 40% of equilibrium, thus, a small error in measurement would 
produce a large error in the estimate of pool size, especially when 
the expected change is of the order of 15-25%. 
U46619 is thought to enhance water permeability by acting as a 
TXA2 mimetic. This assumption based in part on the observation that 
the water permeability effect could be antagonized by trans- but not 
cis-13APA. Further, the action of U46619 was enhanced by phosphodi-
esterase inhibtors, an effect also observed for vasopressin-stimulated 
water flow. Thus, the effect of t13APA (50 ~M) was determined on 
U46619 (0.1 ~M)-stimulated water flow. Interpolation of the dose-
response curve for inhibition of U46619-stimulated water flow by 
t13APA suggested that at the stated concentrations of each agent, 
water flow might be inhibited about 70%. U46619 (0.1 ~M) decreased 
the size of pool S3 by 0.46±0.12 nmol/mg protein (p<O.OS) when the 
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data were analyzed using the series case. In the presence of t13APA 
the effect of U46619 was blocked by O.S2±O.21 nmol/mg protein (p<O.05), 
or t13APA blocked the effect of U46619 to reduce the size of pool 
8
3
, The 100% blockade of the effect of U46619 on the size of pool 
8
3 
is somewhat greater than would be predicted on the basis of the 
water flow studies (70%). However, the inprecision of the method 
may well account for the differences. 
The experiments described in this study suggest that vasopressin, 
cAMP, and U46619, agents which enhance water permeability across the 
toad bladder, all reduce the size of an intracellular calcium pool, 
8
3
. This pool may be mitocondrial in location. Vasopressin in the 
liver is thought to release calcium from mitochondria as part of its 
action in that tissue (e.g., Babcock et al., 1979). It is also 
interesting to note that U46619 has been shown to release calcium 
from mitochondria isolated from liver (Reed and Knapp, 1978) and 
from mitochondria isolated from smooth muscle (McNamara et al., 
1980). Exogenous cAMP has been shown to release calcium from mito-
chondria isolated from several sources (Borle, 1974; Mattib and 
O'Brien, 1974). Other physiological data supporting the notion that 
release of mitochondrial calcium may playa role in the antidiuretic 
response to vasopressin is the observation that mitochondrial inhib-
itors greatly prolong the action of vasopressin in the toad bladder 
(Masters and Fanestil, 1976). 
cAMP and U46619 also caused uptake of calcium into another 
pool, 8
2
, which may represent endoplasmic reticulum and other cyto-
plasmic sites. Thus, these two agents decrease the size of 8
3 
and 
increase the size of 8
2 
without affecting 45Ca efflux. LeBreton et 
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a1. (1981) have in press a manuscript describing an identical action 
of U46619 on blood platelets, to a cause shift of calcium from one 
pool into the dense tubular system of the platelet without affecting 
calcium efflux. The uptake of calcium into pool S2 caused by cAMP 
and U46619 may be similar to the cAMP-dependent uptake into sarco-
plasmic reticulum (Tada et a1., 1974). 
Thus, the present data tend to support the hypothesis that 
vasopressin may alter water permeability across the toad bladder by 
a mechanism that includes release of membrane-bound calcium. Further, 
other agents that enhance the water permeability of the toad bladder 
may also act to release calcium from the same site. Finally, the 
source of the released calcium may be mitochondria. 
CHAPTER IV 
THE ROLE OF EXTRACELLULAR CALCIUM IN THE ANTIDIURETIC RESPONSE TO 
VASOPRESSIN AND TXA2-LIKE COMPOUNDS IN THE TOAD URINARY BLADDER 
INTRODUCTION 
The role of extracellular calcium in vasopressin's antidiuretic 
effect is unclear. + La 3 blocks vasopressin-stimulated water flow 
(Weitzerbin et al., 1974) as do several divalent cations which may 
substitute for calcium at its binding site(s) and block its effect 
(Bentley, 1959). The organic calcium uptake blocker, verapamil, 
blocks vasopressin's antidiuretic effect in vivo in the dog (Berl, 
1981) and one report suggested that verapamil also inhibited vaso-
pressin-stimulated water flow in the toad bladder (Humes et al., 
1980). However, in another report (Bentley, 1974) verapamil was 
found to have no effect on vasopressin-stimulated water flow in the 
toad bladder. Increasing extracellular calcium in the presence of 
A23187 mimics the water flow response to vasopressin in the toad 
bladder (Hardy, 1978) although this observation has not been confirmed 
(Taylor et al., 1979). However, high serosal calcium concentration 
inhibits vasopressin-stimulated water flow (Petersen and Edelman, 
1964). Since the experiments with cAMP and U46619 demonstrated that 
these compounds may significantly increase the size of one intra-
cellular 45Ca pool in toad bladder epithelial cells, it became of 
interest to determine the role of extracellular calcium in vasopressin 
and U46619's antidiuretic effects. 
In the initial experiments designed to examine the effect of 
vasopressin on 4SCa metabolism, it was found that vasopressin, when 
added to cells previously loaded with 45Ca, caused a marked increase 
in the fraction of 45 Ca which appeared in the bathing medium (Fig. 
19, Chapter III). This increase in 4SCa could have represented an 
enhancement in net calcium extrusion from the cells or, sinc'e the 
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4SCa efflux is representative in these experiments of calcium-calcium 
exchange across the plasma membrane, could have represented an 1ncrease 
in cytosolic calcium concentration from either internal stores or 
from enhanced rate of exchange into the bathing medium. The experi-
ments which examined 4SCa compartmental analysis suggested that vaso-
pressin caused a decrease in cellular exchangeable calcium. However, 
as noted previously, intracellular free ionized calcium could change 
dramatically but not be apparent from the compartmental analysis. 
Thus, to answer the question of whether the action of vasopressin 
requires an extracellular source of calcium, several groups of 
experiments were performed: 1) physiological, in which extracellular 
calcium was modified and resultant effects on vasopressin-stimulated 
water flow determined, 2) biochemical, in which the effects of vaso-
pressin on 4SCa movement were assessed, and 3) studies of the effects 
of inhibitors of vasopressin-stimulated water flow on 4SCa influx. 
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MATERIALS AND METHODS 
Verapamil and D-600 were the generous gifts of ,J(nol:'l" PhArmaceu-
ticals; the following were purchased from commercial sources: ion-
ophore A23187, Calbiochem Corp., San Diego, CA;.carbamylcholine 
(carbachol) and quinidine, Sigma Chemical Co., St. Louis, MO. Other 
chemicals and reagents were described in previous chapters. 
4 5Ca uptake into epithelial cells isolated from toad urinary 
bladders. Epithelial cells were prepared by the collagenase method. 
The method to be described is similar to that described by Wiesmann 
et al. (1977). Cells were finally suspended to a concentration of 1 
mg cell protein/ml Ringer's solution. The suspensons were incubated 
with stirring in 15 ml polycarbonate centrifuge tubes at 25°C under 
an atmosphere of 95% °2:5% CO 2 , Experimental manipulations were 
performed as described in the text. Aliquots of cells from the same 
suspensions were always run in parallel as controls. The controls 
always contained any vehicle used. 45Ca equivalent to 0.5 ~Ci/ml 
Ringer's solution was added to each tube and incubation was continued 
for 5, 10, 30, 60, or 90 min. Aliquots of 1 ml were taken and injec~ 
ted into 20 ml of ice-cold Ca-free Ringer's solution containing 10 
roM EGTA and centrifuged for 2 min at 4°C. The supernatants were 
decanted and the pellet resuspended and washed twice more with 20 ml 
aliquots of ice-cold Ca-free-EGTA Ringer's solution. The pellets 
were dissolved in 0.1 N NaOH and aliquots taken for measurement of 
45Ca radioactivity and cell protein. 
Water flow studies were performed by the method of Bentley (1958) 
as described in Chapter II. 
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Extracellular calcium was measured by the titrametric method of 
Borle and Briggs (1968). 
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RESULTS 
Effects of altered mucosal calcium concentration on vasopressin-
stimulated water flow. In these experiments serosal calcium concentra-
tion was maintained at 1 mM while the mucosal bathing solution was 1 
+ 
roM Ca 2 in 1:5 Ringer's solution in the controls or no added calcium 
in the experimental hemibladders. After incubation for 1 hour and 
changing the mucosal baths every 20 min, neither basal nor vasopressin 
(1 mU/ml)-stimulated water flow was affected by the lack of calcium 
in the mucosal bathing media. In the control hemibladders vasopressin 
stimulated water flow from 1.6±O.7 to 66.7±6.0 mg/min/hemibladder 
and in the experimental hemibladders vasopressin stimulated water 
flow from 1.6±O.5 to 66.9±6.3 mg/min/ hemibladders, n=4 pairs. 
Effects of altered serosal calcium concentration on vasopressin-
stimulated water flow. In these experiments one hemibladder of each 
pair was bathed in a bicarbonate-Ringer's solution containing no 
Mg 2+ and 1 mM Ca 2 +. The experimental hemibladder was bathed in a 
bicarbonate-Ringerts solution containing a different concentration 
of calcium. In all cases, mucosal calcium concentration was main-
tained at 0.2 roM for both control and experimental hemibladders to 
assure that the epithelial cells would not become detached. In these 
experiments both high and low calcium concentrations were found to 
inhibit vasopressin-stimulated water flow. The response to vasopressin 
in the presence of 10 mM calcium was only 65±8% of that in the pres-
ence of 1 roM calcium (p<O.02, n=5 pairs) (Fig. 33). The response in 
the presence of 0.2 mM calcium was not depressed. However, in the 
presence of 0.025 mM calcium, the response was only 73±12% (p<O.05, 
n=5 pairs) and in the presence of 10 ~M calcium, i.e., in the absence 
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Figure 33. E~fects of altered serosal calcium 
concentration on vasopressin-stimulated water ~lo~. 
One member of each pair of hemibladders was incu-
bated in the presence of an altered serosal calcium 
concentration while the contralateral hemibladder 
was incubated in 1 mM serosal calcium. Incubation 
was for 60 minutes with serosal calcium being changed 
every 20 minutes. All hemibladders were bathed 
with 0.2 mM calcium in the mucosal bath. Vaso-
pressin (1 mU/ml)-stimulated water ~low was measured 
for 30 minutes (*p < 0.05, **p < O.02,and ***p < 0.01, 
compared to 1 roM calcium, n = 5 pairs, each point). 
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of exogenously-added calcium, the response was only 24±2% (p<O.Ol, 
5 . ) f th b d' h f 1 roM Ca 2 +. n= palrs 0 at 0 serve 1n t e presence 0 
To assess the reversibility of decreased calcium concentration 
on the water flow response to vasopressin after the initial 30 min 
period with vasopressin in calcium-free serosal media, the vasopressin 
+ 
was washed out and after a 30 min recovery period, 1 mM Ca 2 was 
added to the calcium-depleted hemibladders. After 10 min, vasopressin 
was added again. In these hemibladders vasopressin still did not 
elicit a water flow response (Table XXV). In a similar experiment 1 
roM Ca 2 + was added during the 30 min recovery period, and the hemi-
bladders were incubated an additional 30 min, for a total of 60 min 
with 1 roM calcium. In these hemibladders a small amount of recovery 
occurred. Water flow in response to vasopressin after the recovery 
period was lI±3 mg/min/hemibladder compared to 6±1 mg/min/hemibladder 
in the absence of added calcium (p< 0.05, n=5) (Table XXV). However, 
control hemibladder response was 36±8 mg/min/hemibladder. Thus, 
simply the lack of extracellular calcium did not appear to be the 
cause of the lack of a response to vasopressin at low calcium concen-
trations. To assess the generality of the defect caused by a lack 
of serosal calcium other experiments were performed to assess the 
effects of exogenous cAMP and U466I9 on water flow. The response to 
cAMP was also abolished in the absence of serosal calcium (Table 
XXVI). In addition, the water flow response to U466l9 was inhibited 
(Table XXVI). 
Effect of altered extracellular calcium concentration on vaso-
pressin-stimulated water flow in the presence of magnesium or strontium. 
In many tissues removal of extracellular calcium is associated with 
TABLE XXV 
RE\~RSIBILITY OF THE EFFECTS OF DECREASED SEROSAL CALCIUM CONCENTRATION ON 
VASOPRESSIN-STIMULATED WATER FLOW 
WATER FLOW 
(mg/min/hemibladder 
READDITION OF CALCIUM FOR 10 MINUTES 
First Vasopressin Period 
Basal Vasopressin (1 mc/ml) 
COBtro] 




(1 Mrn Ca, Mg-free) 
Readdition of 
Ca (] m~1) 
Control 








Second Vasopressin Period 
READDITION OF CALCIUM FOR 60 MINUTES 
First Vasopessin Period 
1.8±O.4 
1.6±O.2 
Second Vasopressin Period 
1.4±O.4 
(One-half of above group) 1.B±O.4 
Readdition of 














a b p < 0.01, compared to control; p < 0.05, compared to no calcium, 60 min. 
Experimental hemibladders were incubated in Ringer's solution without added 
calcium for 60 min, the Ringer's solution being changed every 20 min. Control 
hemibladders were incubated in Ringer's solution containing 1 mM calcium. 
Vasopressin-stimulated water flow was measured for 30 min. 
In the upper 2 experiments n=5 pairs, each group. In the lower experiment 
n=10 pairs for control and no calcium. During the recovery period, the no 
calcium group was divided into 2 groups (n=5 in each) to yield the no calcium, 
60 min, and calcium, 60 min groups. 
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EFFECTS OF DECREASED SEROSAL CALCIUM ON 
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9. 4±1 .8 
a b P < 0.01, compared to control; p < 0.05, compared to control, n=5 pairs, 
each group. 
Experimental hemibladders were incubated in Ringer's solution without added 
calcium for 60 min, with Ringer's solution being changed every 20 min. Control 
hemibladders were incubated in Ringer's solution containing 1 mM calcium. 
cAMP-stimulated water flow was measured for 30 min. U46619-stimulated water 
flow was measured for 10 min in hemibladders which had been preincubated with 
indomethacin (50 ~M) for 1 hour. 
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structural damage. However, the role of calcium may still be studied 
in physiological processes by substituting another divalent ion such 
as magnesium. This ion will substitute for calcium in maintaining 
structural integrity, but will not substitute for calcium as a stimu-
Ius transducer (Putney and Askeri, 1980). In the toad bladder it 
has been reported that either Mg 2+ or Sr 2+ may substitute for Ca 2 + 
in maintaining vasopressin responsiveness (Bentley, 1959; Schwartz 
and Walter, 1972). Thus, several experiments were conducted to 
further investigate the necessity of extracellular calcium in the 
response to vasopressin without incurring the apparent structural 
alterations of the experiments described above. 
Control hemibladders were preincubated for 60 min in Ringer's 
solution containing 1 mM Ca 2+ and no Mg 2 +, while experimental hemi-
bladders were preincubated in Ringer's solution containing no Ca 2+, 
but containing 1 roM Mg 2 + or 1 mM Sr2+. Basal water flows were no 
different in control hemibladders compared to hemibladders incubated 
2+ 2+ with either Mg or Sr . Further, when vasopressin was added, water 
flow was not inhibited as it had been in the absence of any divalent 
cation. Sr2+ preserved vasopressin responsiveness completely (Table 
XXVII), whl'le Mg2+ d t thO d . (T bl XXVII) preserve wo- 1r s responSlveness a e . 
After vasopressin had been present for 30 min, it was washed 
out and the hemibladders were allowed to recover for 60 min. The 
control hemibladders were still incubated in Ringer's solution con-
taining 1 mM Ca 2 + while the hemibladders which had been incubated in 
or 
+ 
1 mM Sr2 were divided into 2 groups. In half, incuba-
• ° dOh f 1 roM Mg 2+ t10n contlnue 1n t e presence 0 or In the 
th h M 2+ S 2+ 1 d wl°th 1 roM Ca 2 +. o er group t e g or r was rep ace Thus, in 
Initial Period 
TABLE XXVII 
EFFECTS OF Mg 2+ OR Sr2+ SUBSTITUTION FOR CALCIUM 













Second incubation with vasopressin 
Second incubation with 
Con~rol 
Ca 2 replacing Mg 2 + 
Con~rol 
Ca 2 replacing Sr Z+ 





















Experi~ental hemibladders were in~ubated in Ringer's solution with 1 mM Mg 2+ 
or Sr2 substituting for 1 roM Ca z for 60 min, the Ringer's solutions being 
changed every 20 min. The c~ntrol hemibladders were incubated in Ringer's 
solution containing 1 roM Ca 2 . 
2+ 2+' In the initial period n=10 pairs for each group. The Mg and Sr heml-
bladders were then divlded int~ 2 groups (n=5, each). In one group incubation 
in ~he presence of Mg2 or Sf2 continued for 60 min; in the other group 1 mM 
Ca 2 was substituted for Mg2 or Sr2 and incubation continued for 60 min. In 
each case, Ringerts solutions were changed every 20 minutes. 
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these hemibladders the Ringer's solution during the recovery period 
was identical to the Ringer's solution bathing the control hemi-
bladders. 
After the 60 min recovery period vasopressin was again added 
and vasopressin-stimulated water flow was measured for 30 min. In 
those experimental hemibladders which were incubated in Ringer's 
+ 2+ solution containing Mg2 or Sr responsiveness was significantly 
reduced during the second incubation with vasopressin (Table XXVII), 
+ However, in those experimental hemibladders in which Ca 2 had been 
b · d f Mg 2 + or Sr 2+, f 11' . su stltute or u responslveness to vasopress1n was 
retained (Table XXVII). Thus, these experiments demonstrated that 
extracellular calcium is not an absolute requirement to maintain the 
fl . The presence of Mg2+ or Sr2 + water ow response to vasopressln. 
was required probably only to maintain intact connections among cells 
and basement membranes. 
+ 
However, hemibladders exposed to Mg2 or 
Sr2 +, in substitution for Ca 2 + were able to respond to vasopressin 
only one time. This suggests that subsequent responses to vasopressin 
may require a refilling of an intracellular calcium compartment to 
maintain responsiveness. 
Effect of stoichiometric chelation of serosal calcium on vaso-
pressin-stimulated water flow. Since in the previous experiments, 
hemibladders were incubated for extended periods of time in Ringer's 
solutions with altered divalent cation concentrations an additional 
experiment was performed in which the divalent cation concentrations 
were altered more acutely. In these experiments hemibladders were 
. b d R' , l' 'mM Ca 2 + and 1 mM Mg2+. lncu ate in lnger s so utlon containlng 1 
To one member of each pair of hemibladders was added 1 ruM EGTA to 
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stoichiometrically bind the serosal calcium and 5 min later vaso-
pressin was added and water flow determined for 30 min. The addition 
of EGTA did not affect basal water flow in control experiments during 
which EGTA was present for 30 min (Table XXVIII). 
Stoichiometric calcium chelation did not inhibit vasopressin-
stimulated water flow (Table XXVII). Further, when vasopressin was 
subsequently washed out but EGTA remained, water flow returned to 
basal rate (Table XXVIII). Thus, under conditions where no net 
calcium influx could occur, vasopressin was able to exert its full 
effect on water flow. 
Effects of organic calcium antagonists on vasopressin-stimulated 
water flow. Verapamil and its methoxy derivative D-600 are organic 
calcium antagonists which act by inhibiting the uptake of calcium 
through the plasma membrane of many cell-types. Bentley (1974) 
reported that verapamil in concentrations up to 100 ~M had no effect 
on vasopressin-stimulated water flow across the isolated toad bladder. 
Recently, however, Humes et ale (1980) reported that verapamil, after 
90 min preincubation at a concentration of 100 ~M, does inhibit vaso-
pressin-stimulated water flow. Since our data with the substitution 
of magnesium or strontium for serosal calcium suggested that extra-
cellular calcium is not required for vasopressin action we also 
assessed the effects of verapamil and D-600 on vasopressin-stimulated 
water flow. 
Hemibladders were incubated with verapamil (1-100 ~M) for 60 
min. Basal water flow was measured during this period. Vasopressin 
(1 mU/ml) was then added and vasopressin-stimulated water flow was 
measured for 30 min. Only at the highest concentration tested, 100 
TABLE XXVI I I 
EFFECT OF STOICHIOMETRIC CALCIUM CHEL~TION ON 
VASOPRESSIN-STIMULATED WATER FLOW 
Control (no EGTA) 
Experimental (EGTA, ] mM) 
Control (no EGTA) 
EGTA (1 roM) during the 
vasopressin period 













EGTA (1 mM) 
1.5±O.4 
1.4±O.4 
Vasopressin (1 mU/ml) 
36.8±5.4 
38.4±6.0 
Experimental hemibladders were incubated with EGTA (1 mM) for 5 min to chelate 
the serosal calcium (] roM). Then vasopressin was added and stimulated water 
flow was measured for 30 min., n=5 pairs, each group. 
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~M, was verapamil found to have any effect on vasopressin-stimulated 
water flow (Table XXIX). Similar experiments were performed using 
D-600_ D-600 was also observed to inhibit vasopressin-stimulated 
water flow to a small extent (Table XXIX). 
Since Humes et al. (1980) found that long periods of preincuba-
tion with verapamil were necessary to produce an inhibition in vaso-
pressin-stimulated water flow the possibility arose that the effect 
was due not to inhibition of calcium uptake ~ se, but to a reduc-
tion in the calcium concentration at some critical site, presumably 
intracellular, perhaps identical to that which appeared necessary to 
elicit a second response to vasopressin in the presence of magnesium 
or strontium. Further, verapamil does not act immediately to inhibit 
calcium uptake; calcium must first leave its binding site, after 
which it is replaced by verapamil (Langer et al., 1975). Thus, a 
series of experiments was performed in which the hemibladders were 
incubated for 30 min with D-600 (100 ~M), stimulated with vasopressin 
in the presence of D-600, washed in the presence of D-600 to remove 
vasopressin, allowed to recover for 30 min, and restimulated with 
vasopressin a second time, still in the presence of D-600. The 
rationale was that vasopressin should deplete intracellular calcium, 
and since D-600 would inhibit calcium uptake to "reload" the cells, 
the hemibladders would not recover within the 30 min period allowed. 
In the presence of 1 mM serosal calcium and 30 min preincubation, 
D-600 (100 ~M) did not significantly inhibit vasopressin-stimulated 
water flow, compared to paired control hemibladders (Fig. 34). How-
ever, upon restimulation with vasopressin, D-600 did elicit a signi-









































SEROSAL CALCIUM [~MJ 
* 
1.0 
Figure 34. Calcium dependence of the inhibition of 
vasopressin-stimulated water flow by D-6oo. Hemi-
bladders were incubated in Ringer's solutions with 
altered serosal calcium concentrations for 1 hour, 
the Ringer's solutions being cbanged every 20 min. 
D-6oo (100 uM) was added to 1 member of each pair 
and basal water flow was measured for 30 minutes. 
Then vasopressin (1 mU/ml) was added and stimulated 
water flow was measured ~or 30 minutes (open bars). 
Vasopressin was washed out by changing the serosal 
media every 10 minutes ~or 30 minutes, still in the 
presence of D-6oo where appropriate. Then vasopres-
sin was added again and stimulated water flow was 
measured for 30 minutes (hatched bars). 
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Figure 34. Calcium dependence or the inhibition of 
vasopressin-stimulated water ~low by D-6oo. Hemi-
bladders were incubated in Ringer's solutions with 
altered serosal calcium concentrations for 1 hour, 
the Ringer's solutions being changed every 20 min. 
D-6oo (100 uM) was added to 1 member of each pair 
and basal water ~low was measured ~or 30 minutes. 
Then vasopressin (1 mU/ml) was added and stimulated 
water flow was measured ~or 30 minutes (open bars). 
Vasopressin was washed out by changing the serosal 
media every 10 minutes ~or 30 minutes, still in the 
presence of D-6oo where appropriate. Then vasopres-
sin was added again and stimulated water flow was 
measured for 30 minutes (hatched bars). 




presence of 0.2 mM calcium, 30 min preincubation with D-600 (100 ~M) 
produced a significant inhibition of vasopressin-stimulated water 
flow (27±8%, p<0.05, n=6 pairs). Upon restimulation with vasopressin 
the inhibition rose (p<O.02) to 45±4% (p<O.Ol compared to control, 
n=6 pairs). When serosal calcium concentration was reduced to 0.025 
roM, 30 min incubation with D-600 (100 ~M) produced a 34±7% inhibition 
in vasopressin-stimulated water flow (p<O.05, n=6 pairs). However, 
when the hemibladders were restimulated with vasopressin, the inhibi-
tion rose (p<O.Ol) to 94±9% (p<O.Ol compared to control, n=6 pairs). 
Thus, D-600 was effective in inhibiting vasopressin-stimulated water 
flow, especially in the presence of low serosal calcium, or after 
the hemibladders had been depleted of calcium by previous exposure 
to vasopressin. 
Effects of lanthanum on vasopressin-stimulated water flow. 
Lanthanum, when added in low concentration (50 ~M) to Ringer's solu-
tion containing 1 roM calcium, does not inhibit basal 4 5 Ca uptake but 
does inhibit the stimulation in 4SCa uptake observed when the cells 
are incubated with A23187 or carbachol (Wiesmann et al., 1977, 1978). 
At high concentration (1-88 roM) lanthanum has been reported to inhibit 
4SCa efflux from several types of isolated cells as well (Langer and 
Frank, 1972; Weiss, 1978). Lanthanum (1 mM) was found to inhibit 
4 5 Ca efflux from prelabelled toad bladder epithelial cells (Chapter 
III). Thus, experiments were performed to determine whether a low 
concentration (50 ~M) of lanthanum affected vasopressin-stimulated 
water flow by inhibiting calcium influx, or whether a high concentra-
tion (1 mM) of lanthanum, by inhibiting calcium efflux, inhibited 
vasopressin-stimulated water flow. 
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These experiments were performed in tris-Ringer's solution. 
+ + 
The Ringerts solutions contained 1 roM Ca 2 but no added Mg2. During 
incubation with La 3 + (50 ~M) for 30 min basal water flow was unchanged 
(Table XXX). Vasopressin (1 mD/ml) was then added and water flow 
measured for 30 min. + La 3 (50 ~M) had no effect on vasospressin-
stimulated water flow (Table XXX). Incubation with La 3 + (1 roM) 
caused a small, but significant enhancement in basal water flow 
(Table XXX). When vasopressin (1 mD/ml) was added water flow was 
enhanced in the control hemibladders, but La 3 + (1 roM) completely 
blocked the effect of vasopressin to enhance water flow (Table XXX). 
4SCa uptake by isolated toad bladder epithelial cells. Using 
the EGTA technique for removing extracellular calcium described in 
the Methods, 45Ca uptake into the cells was assessed. Even though 
this uptake method has been described in the literature (Wiesmann et 
al., 1977, 1978; Arruda et al., 1980 a,b; Humes et al., 1980) experi-
ments were performed to test the validity of the method. The divalent 
cation ionophore A23187 has been reported to enhance 4 SCa uptake 
into isolated toad bladder epithelial cells (Wiesmann et al., 1977). 
In the isolated epithelial cells used in the present experiments, 
preincubation with A23187 (10 ~M) for 30 min increased 4SCa uptake 
from 1.48±0.12 nmol/10 min/mg protein in control suspensions to 5.04± 
0.70 nmol/l0 min/mg protein (p<O.Ol, n=4 pairs). Similarly, replace-
ment of bathing medium sodium with choline has been reported to 
enhance uptake of 4 S Ca into intact frog skin, a related epithelium 
(Grinstein and Erlij, 1978). In the isolated epithelial cells used 
in the present experiments, replacement of bathing medium sodium 
with choline for 30 min enhanced 4 SCa uptake from 1.16±O.06 nmol/10 
TABLE XXX 




Lanthanum (50 ~M) 
Control 






Vasopressin (1 mU/ml) 
34.8±3.6 
35.6±2.8 
28. 2±1 .7 b 
1.6±O.4 ,c 
abc p < 0.05, p < 0.001, compared to control; not significantly 
different from basal, n=5 pairs, each group. 
Lanthanum was added to the serosal medium (tris-Ringer's, 1 roM Ca, 
Mg-free) and basal water flow measured for 30 min. Vasopressin 
(1 mUjml) was then added and stimulated water flow was measured 
for 30 min. 
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min/mg protein to 2.84±0.60 nmol/IO min/mg protein (p<O.OS, n=4 
pairs). 45Ca uptake was 0.34±O.04 nmol/IO min/mg protein in the 
presence of 0.1 mM extracellular calcium, 1.0B±0.II nmol/IO min/mg 
protein in the presence of 1 roM extracellular calcium, and 2.12±0.31 
nmol/ 10 min/mg protein in the presence of 10 mM extracellular calcium 
(n=4, each group). 
45Ca uptake increased with time to a pseudo-steady state level: 
O.98±O.12 nrnol/rug protein after 5 min to 1.72±0.12 nmol/mg protein 
after 10 min to 2.80±0.S2 nmol/mg protein after 30 min to 2.90±0.22 
nmol/mg protein after 60 min to 2.97±0.20 nmol/mg protein after 90 
min (n=5). Thus, it appeared that the EGTA method of assessment of 
45Ca uptake into the cells was valid. 
Effects of vasopressin on 45Ca uptake into toad bladder epithe-
lial cells. Several protocols were devised to determine whether 
vasopressin causes enhanced labelling of cellular calcium wth 45Ca. 
In the first experiments vasopressin (10 mD/ml) was added to the 
experimental suspension together with the 45Ca. As shown in Fig. 
35a, vasopressin had no significant effect on 45Ca uptake at any 
individual point. Upon transforming the data to In(45Caoot-45Cat) 
versus time, two linear components were observed,S to 30 min and 30 
to 90 min. An analysis of variance performed from 5 to 30 min or 30 
to 90 min demonstrated that in the presence of vasopressin less 45Ca 
was accumulated by the cells (p<0.02 for 5 to 30 min and p<O.Ol for 
30 to 90 min) compared to the controls. In similar experiments vaso-
pressin (10 mD/ml) was added to the experimental suspensions 15 min 
prior to the addition of 4 5Ca. In these experiments (Fig. 35b) the 
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Figure 35. Effects of vasopressin (10 mU/ml) on 45Ca 
uptake. ra) Vasopressin was added at time = 0, n = 
5 pairs of suspensions, b) Vasopressin was added 
15 minutes prior to 45Ca, n = 6 pairs of suspensions. 
Filled circles represent uptake into control suspen-
sions and open circles represent uptake into vaso-




to 90 min points by paired-t analysis at each time (p<O.OS, each 
time) or by analysis of variance (p<O.Ol for 5 to 30 min and p<O.OOl 
for 30 to 90 min). 
Effects of U46619 on 4SCa uptake into toad bladder epithelial 
cells. When U46619 (1 ~M) was added to the epithelial cells at the 
same time as 45Ca, no significant effect on 4SCa uptake was observed 
at any individual time point (Fig. 36). However, when the 5 to 30 
min points were analyzed together by an analysis of variance, the 
cells which were incubated with U46619 took up significantly less 
45Ca over this period (p<O.OI). By the 60 and 90 min time points, 
it is clear that the cells incubated with U46619 took up a similar 
amount of 45Ca to the control cells. 
EFFECTS OF COMPOUNDS WHICH INHIBIT VASOPRESSIN-STIMULATED WATER 
FLOW ON 4 SCa METABOLISM 
Effects of PGE
1 
on 4SCa efflux from isolated toad bladder epithe-
lial cells in suspension. PGE
1 
inhibits vasopressin-stimulated water 
flow (Orloff et al., 1965). Since prostaglandins have been implicated 
in the regulation of cellular calcium metabolism in a variety of 
tissues (see Chapter I), the effects of PGE
1 
on 4 SCa metabolism in 
toad bladder epithelial cells were assessed. PGE
1 
(1 ~M) was added 
to epithelial cells undergoing desaturation. PGE
1 
(1 ~M) caused an 
enhancement in 4 SCa efflux of 34±8% after 10 min (Fig. 37). Efflux 
remained enhanced the entire 30 min during which PGE
1 
was present, 
but had decreased to only 20±5% above control by 30 min (p<O.OS, n=5 
pairs) (Fig. 37). 
Effects of PGE
1 
on steady state 45Ca content and efflux. The 
enhancement in 4SCa efflux observed upon addition of PGE
1 
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Figure 36. Effects of U46619 (1 ~) on 45Ca uptake. 
a) u46619 was added at time = 0, n = 6 pairs of 
suspensions, b) U46619 was added 15 minutes prior 
to q5Ca, n = 6 pairs of suspensions. Filled circles 
represent uptake into control suspensions and open 
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TIME (min.) 
Figure 37. Effect of PGEl on 45Ca efflux from isolated toad bladder epithe~ial cells In suspension. Cell suspensions were 
labelled with 5Ca for 90 minutes. The suspensions were each 
divided into 2 aliquots and desaturated simultaneously. After 
40 minutes of desaturation PGEI (1 ~) was added to 1 member 
of each pair of aliquots. (*p < 0.05, **p < 0.02, n = 6 pairs) 
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epithelial cells undergoing 45Ca desaturation suggested that PGE
1 
may affect cellular calcium metabolism in a manner similar to that 
observed in the presence of vasopressin. Thus, the effect of PGE
1 
was determined on 45Ca efflux under steady state conditions. Suspen-
sions were incubated with PGE
1 
(1 ~M) prior to labelling with 45Ca. 
Preincubation with PGE
1 
resulted in significantly greater total 
uptake of 45Ca (11.36±1.23 nmoll mg protein versus 7.B2±O.85 nmol/mg 
protein in control suspensions) (p<O.Ol, n=4 pairs) (Fig. 38). Com-
partmental analysis revealed that the size of pool 53 was greatly 
increased by PGE
1 
(p<O.Ol, n=4 pairs) (Table XXXI). Further, the 
rate constants of exchange from the second and third compartments 
were increased in the presence of PGE
1
. The sizes of pools S1 and 
52 were not significantly affected (Table XXXI). 
Effects of cylcooxygenase inhibitors on steady state 45Ca content 
and efflux. Indomethacin and other non-steroidal antiinflammatory 
agents have been reported to inhibit calcium binding to several cell-
ular membranes (Northover, 1973) and to inhibit several calcium-
dependent cellular processes (Northover, 1977a). Thus, the effects 
fo the non-steroidal antiinflammatory agents/cyclooxygenase inhibi-
tors, indomethacin and meclofenamate were assessed on 45Ca kinetics 
in the isolated epithelial cells. Cells were pretreated with either 
indomethacin (50 ~M) or meclofenamate (10 ~M) for 30 minutes, then 
labelled with 45Ca. The results were pooled since the effects of 
the two agents were similar. Neither indomethacin nor meclofenamate 
had a significant effect on the calcium pool 51 (Table XXXII). How-
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Figure 38. 45 Ca efflux from isolated toad bladder epithelial 
cells preincubated with PGEI (1 ~M). Cell suspensions were 
divided into 2 aliquots, 1 of which was incubated for 15 minutes 
with PGE+ (1 ~). Then both aliquots were labelled with 45Ca 
for 90 rnanutes . and desaturated. The experimental aliquots 
contained PGE1 during the labelling and desaturation periods. 
Each PGEI point is different from the respective control point 
(p < 0.02 - 0.05, n = 4 pairs). 45Ca content at time = 0 were 




EFFECT5 OF PGEI ON 45Ca KINETICS 











Fast Pool (SI) 
----..-. __ c-.,. ___ .~ ___ •. _. ____ ~~~ 
s] P10 kID 
1. 58 0.437 0.276 
±0.26 ±0.028 ±O.O34 
1. 74 0.526 0.296 
±0.26 ±0.047 ±0.03B 
Intermediate Pool (52) 
52 P20 k20 
1.02 0.072 O.074a 
±O.34 ±O.006 ±O.OO7 
0.B2 0.076 0.092 
±0.32 ±O.OOB ±O.OIO 
Slow Pool (S3) 
-.-----~~-
S3 P30 k30 
6.81 b O.044a 0.0068a 
±O.84 to.OO2 ±O.OOO6 
9.92 0.09] 0.0094 
±0.98 ±O.OII ±O.OO]1 
• __ --,,--.,_n..-.-._ •• ____ , .• _. __ ~~ __ ~ __ . __ ..........--. ___ ~ __ c __ ••• _____________ • ___ ~ 
- ~ __ ~ . __ 0_- __________ . ___ ~ _____ _ 
Fa s t Poo I ( S 1 ) 
SI PIO kiD 
1.5B 0.437 0.276 
±O .16 ±0.02B ±O.034 
1. 74 0.526 0.296 
±0.26 ±0.047 ±O.O38 
Intermediate Pool (52) 
----_ ... ,---------
S2 P20 P23 k20 k23 
2.20 0.114 0.057 b 0.050 O.024c 
±O.29 ±O.Oll ±0.007 ±O.OO6 ±O.OO3 
2.03 0.128 O. 1] B 0.065 0.059 
to.38 ±O.OI4 ±O.OI4 ±O.OOB ±O.OO9 
Slow Pool (S3) 
5 3 P32 k32 
5.57 c O.OS7c O.OO99 b 
to.58 ±0.OO7 ±0.OOI4 
8.62 O. lIB 0.0]43 
±0.74 ±O.OI4 ±O.DOIS 
-- ------ -~- --- ------ --- ----~ - -~ - --
n=4. All results are expressed as mean ± S.E.H. S = pool size, nmoJ/mg protein; p . = exchange rate 
(fl~x) from pool j to pool j, IUTlol/min/mg protein; k .. = ratt' (oIlsLJnt of cfflux frol~IJpool i to pool j, 
min 1. Ba t hi n g med i a r a Ie i um = I mM t PGE I = 1 IJM. 1 J 




TABLE XXXI r 
EFFECTS OF CYCLOOXYGENASE INHIBITORS ON 4SCa KINETICS 
~-----~-~~ ------~-~------- ~--.---~-~~---- --~--~~---- - ,- .. -._------- -------------.-.~ 
Parallel Case Series Case 
--.~--~~~---. ------ .. -----.-.--~-
Fast Pool (SI) Fast Pool (51) 
51 PIO k l0 SI PIO k10 
Control 1. 42 0.362 0.254 1 .42 0.362 0.254 ±O.34 ±0.048 ±O.042 ±0.34 ±0.048 ±O.O42 
Cyclooxygenase 1. 16 0.324 0.276 1. 16 0.324 0.276 
Inhihitors ±O.2S ±O.054 ±0.054 fO.2B ±O.054 ±O.054 
Intermediate Pool (8
2




S2 P20 k20 82 P20 P23 k20 k23 
Control 1.23
a 0.101 a O.086b 2.70b 0.161 0.064a 0.058b 0.022 
±0.18 ±O.013 to.OIO ±O.16 ±0.OI2 ±O.OOB ±O.007 ±0.a02 
Cyclooxygenase 1 .07 0.132 0.126 1 .83 D.178 0.048 0.094 0.025 
Inhibitors ±0.12 ±O.01S to.OlB ±O.14 ±0.013 ±0.006 to.012 ±O.OO3 
Slow Pool (S3) Slow Pool (S3) 
-.----------~ 
S3 P30 k30 S3 P32 k32 
Control 7.12
a 0.054a 0.0080 5.68a 0.064a 0.0112 
±0.64 ±0.D06 ±0.OO07 ±O.63 ±O.OOB ±O.0014 
Cyclooxygenase 5.03 0.042 0.00B8 4.28 0.04B 0.0111 
Inhibitors iO.70 ±0.O05 ±O.0009 ±O.58 ±0.OO6 ±0.OOI7 
0=5. All results are expressed as mean ± S.E.H. S. = pool size, nmol/rng protein; p .. = exchange rate 
(fl~x) from pool i to pool j, nmol/min/mg protein; R .. = rate constant of efflux froffiJpool i to pool j, 
min 1. Bathing media calcium = 1 mM, Meclofenamate !J IO J.JH; indomethacin = 50 tJH. 





presence of these agents. Further, the rate constant of efflux from 
pool 8
2 
was increased (Table XXXII). 
Effects of agents which inhibit vasopressin-stimulated water 
flow on 4SCa uptake. A number of compounds which inhibit vaso-
pressin-stimulated water flow are thought to act by increasing the 
concentration of free ionized calcium in the cytoplasm. Among these 
are the divalent cation ionophore A23187 (Wiesmann et al., 1977; 
Hardy, 1978; Taylor et al., 1979), acetylcholine and its analog carba-
mylcholine (Wiesmann et al., 1978; Arruda and Sabatini, 1980a), and 
quinidine (Arruda et al., 1980b). In addition, substitution of cho-
line for serosal sodium (Davis et al., 1978; Grinstein and Erlij, 
1978), removal of serosal potassium (Bentley, 1959; Davis et al., 
1978; Taylor et al., 1979), and high serosal calcium concentration 
(Petersen and Edelman, 1969; Argy et al., 1967) all inhibit vaso-
pressin-stimulated water flow and may enhance calcium uptake. Since 
many of these experiments measured the effects of these agents or 
maneuvers on only vasopressin-stimulated water flow and not calcium 
uptake, and others were performed using allied epithelia such as 
frog skin, turtle bladder, and frog bladder, the following experi-
ments were performed in order to test all of these compounds on both 
vasopressin-stimulated water flow and 4SCa uptake. 
The 4SCa uptake studies were all of a single kind. Since all 
of the drugs or maneuvers are thought to enhance cytoplasmic free 
calcium concentration, 4SCa uptake was performed for 5 and 10 minutes 
to gain an assessment not of intracellular pool size but of inward 
directed permeability to calcium. That the measurement of uptake 
represented a measure of relative permeability was assumed because 
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uptake was linear between 5 and 10 minutes for each agent. No attempt 
was made to measure intracellular calcium pools since some of these 
agents may actually decrease total exchangeable calcium but increase 
cytoplasmic free calcium (Shelby et a1., 1976). 
The data are contained in Table XXXIII. A23187 (10 ~M) signifi-
cantly stimulated basal water flow. However t vasopressin-stimulated 
water flow was inhibited 46.8±5.7% (p<0.02, n=6 pairs). A23187 
enhanced 45Ca uptake 3.4-fold, the uptake being linear over the 10 
min range. Carbachol (100 ~M) inhibited vasopressin-stimulated water 
flow 52.6±5.2% (p<O.Ol, n=6 pairs) while enhancing 4 5Ca uptake 1.90-
fold (p<O.02, n=4 pairs). Quinidine (1 mM) inhibited vasopressin-
stimulated water flow 60.3±8.2% (p<O.OI, n=6 pairs) while 45Ca uptake 
was not altered by this agent. Epinephrine (1 ~M) inhibited vaso-
pressin-stimulated water flow 38.2±4.6% (p<O.02, n=6 pairs), while 
enhancing 4 5 Ca uptake 1.82-fold (p<O.02, n=6 pairs). PGE
1 
(1 ~M) 
inhibited vasopressin-stimulated water flow 98.6± 2.0% (p<O.OOI, n=6 
pairs), while enhancing 4 5 Ca uptake 1.S-fold (p<O.02, n=6 pairs). 
Substitution of choline for serosal sodium inhibited vasopressin-
stimulated water flow 66±11% (p<O.02, n=5 pairs), while enhancing 
45Ca uptake 2.45-fold (p<O.02, n=6 pairs). To assure that this effect 
was not due to stimulation of a cholinergic receptor, another experi-
ment was performed using sucrose to substitute for NaCl. In the 
hemibladers incubated in sucrose-Ringer's solution (180 mM sucrose) 
vasopressin-stimulated water flow was inhibited 53±11% (p<O.02t n=5 
pairs) while 4 5 Ca uptake was enhanced 2.21-fold (Table XXXIII). 
Removal of serosal potassium inhibited vasopressin-stimulated water 
flow 48±7% (p<O.Ol, n=6 pairs), while enhancing 4 5Ca uptake 1.48-
TABLE XXXIII 
EFFECTS OF SEVERAL AGENTS ON VASOPRESSIN-STIMULATED 
WATER FLO~ AND 4SCa UPTAKE 
Agent 
Control 
A23187 (10 ~M) 
Control 
Carbachol (100 ~M) 
Control 
Quinidine (1 mM) 
Control 
Epinephrine (1 ~M) 
Control 




Calcium (10 mM) 
Co~trol 
Na replacing K+ 
Control . + Choline replac~ng Na 
Control 



































































abc d P < 0.05, p < 0.02, p < 0.01, p < 0.001, compared to experimental. 
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fold (p<O.05, n=6 pairs). Incubation with ouabain (10~nM) fo~ 1 
hour had no effect on vasopressin-stimulated water flfltw an'd'" did not 




These studies have shown that uptake of calcium from the extra-
cellular bathing media is not required for vasopressin to exert its 
antidiuretic effect in the toad bladder. However, intracellular 
calcium does seem to be required, either to exert some direct effect 
or to allow the tissue to recover the ability to respond to vaso-
pressin a second time. Further, vasopressin does not cause enhanced 
uptake of 4SCa into toad bladder epithelial cells. Finally, several 
inhibitors of vasopressin-stimulated water flow cause enhanced 4SCa 
uptake into epithelial cells isolated from the toad urinary bladder. 
Removal of all calcium from the Ringer's solution bathing the 
mucosal surface of the toad bladder did not affect the hydroosmotic 
response to vasopressin. This observation was not unexpected since 
the calcium concentration in urine would be expected to vary tremen-
dously and in random fashion. Further, it is common practice to 
bath the mucosal surface with distilled water during water flow 
experiments. However, when calcium was progressively removed from 
the serosal Ringerts solution without adding any other divalent 
cation, vasopressin-stimulated water flow was progressively inhibited. 
This observation suggested that calcium uptake might be necessary 
for vasopressin to exert its effect. The inhibition was not rever-
sible, even when the usual amount of calcium was added back to the 
serosal Ringer's solution for 1 hour. Further, since the phenomenon 
of inhibition of water flow was also exhibited in response to cAMP 
and U46619, two other agents which stimulated water permeability in 
the control hemibladders, a nonspecific effect of decreased calcium 
concentration was suspected. In fact, Hardy and DiBona in a recent 
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abstract (1981) found that bathing toad bladders in a serosal medium 
devoid of calcium or other divalent cation caused marked detachment 
of the mitochondria-rich and granular cells from the basal cells and 
supporting connective tissues while the cells remained interconnected 
among themselves by tight junctions. Further, they found that while 
osmotic water flow in response to vasopressin was inhibited, the 
diffusional permeability response was not lost. 
Since calcium appears to be required for maintenance of bladder 
structure (Hays et a1., 1965), it was thought that inclusion of 
another divalent ion might preserve structural integrity and allow 
the determination of whether extracellular calcium is, in fact, 
required for vasopressin action. Magnesium often substitutes well 
for calcium in maintaining structural integrity, while it is not 
able to substitute for calcium in transducing biochemical messages 
(Putney and Askari, 1980). Thus, in additional experiments when the 
Ringer's solution was devoid of calcium, magnesium (1 roM) was included. 
When magnesium was present to substitute for calcium, vasopressin-
stimulated water flow was only slightly inhibited by the reduced 
extracellular calcium. Further, if calcium was then substituted for 
magnesium, the hemibladders responded to vasopressin normally. How-
ever, if vasopressin was washed out of the hemibladders which were 
bathed in magnesium-Ringer's solution (no calcium), the hemibladders 
did not respond to vasopressin a second time. Similar results were 
obtained when strontium was substituted for calcium. When strontium 
was used the initial response to vasopressin was not inhibited at 
all. However, when vasopressin was added a second time to hemi-
bladders incubated with strontium, no water permeability response 
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was observed. When calcium was added back and the hemibladders were 
stimulated with vasopressin, the full permeability response was 
restored. Thus, strontium appeared to not be substituting for calcium 
as a biochemical messenger, but only in the maintenance of structural 
integrity. 
Verapamil and its methoxy derivative, D-600, are organic calcium 
antagonists which act by inhibiting the uptake of calcium through 
the plasma membrane of many types of cells (Triggle and Swamy, 1980). 
Bentley (1974) reported that verapamil, in concentrations up to 100 
~M, had no effect on vasopressin-stimulated water flow across the 
isolated toad bladder. Recently, however, Humes et ale (1980) repor-
ted that verapamil, after 90 min preincubation, does inhibit vaso-
pressin-stimulated water flow in a dose-dependent fashion. Since 
the data with cation substitution suggested that extracellular calcium 
is not required for vasopressin to enhance water permeability, the 
effects of verapamil and D-600 were assessed on vasopressin-stimulated 
water flow. Only at very high concentrations after long preincubation 
were these agents observed to slightly inhibit vasopressin-stimulated 
water flow. 
Since these organic calcium antagonists bind to the same sites 
as does calcium, it was thought that stimulation of water flow and 
calcium efflux with vasopressin might allow the agents to more 
readily gain access to their binding sites and thus inhibit the water 
flow response to a second challenge with vasopessin. Thus, hemi-
bladders were incubated with vasopressin for 30 min in the presence 
of D-600. No inhibition of water flow was observed during the first 
vasopressin period. The hemibladders were then allowed to recover 
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for 30 min and then incubated with vasopressin a second time. Water 
flow was inhibited 28% (p<0.05) during the second vasopressin period. 
When the same protocol was used with hemibladders incubated with 
lower serosal concentrations of calcium, a greater effect of D-600 
was observed. Thus, in the presence of 200 ~M serosal calcium inhibi-
tion of the water flow response during the first vasopressin period 
was 27% and during the second vasopressin period water flow was inhib-
ited 45%. In the presence of 25 ~M serosal calcium inhibition of 
water flow during the initial vasopressin period was 34% and increased 
to 94% during the second inhibition. These results are consistent 
with more ready access of D-600 to its binding site after vasopressin 
has displaced calcium. However, since D-600 inhibited basal 4SCa 
uptake 35%, these data are also consistent with the hypothesis invoked 
to explain the results with magnesium and strontium substitution. 
That is, vasopressin induces the release of intracellular calcium. 
D-600, during the 30 min recovery period, inhibited complete reuptake 
of the calcium. Thus, when the hemibladders were restimulated with 
vasopressin, the full response could not be developed since some 
critical intracellular calcium pool was not reloaded. Thus, when 
the serosal calcium concentration was 1 mM a large uptake still 
occurred and little inhibition was noted when the hemibladders were 
restimulated with vasopressin. However, when the serosal calcium 
concentration was reduced, reuptake of calcium was more readily comp-
romised by D-600 and the response to the second stimulation with 
vasopressin was markedly reduced. 
Lanthanum at low concentration (50 ~M) has been shown to not 
affect basal 4 SCa uptake into toad bladder epithelial cells (Wiessmann 
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et a1., 1977, 1978; Arruda and Sabatini, 1980b). However, it inhibits 
enhanced 45Ca uptake in response to carbachol or A23187 (Wiesmann et 
a1., 1977, 1978; Arruda and Sabatini, 1980b). In the present experi-
ments serosal lanthanum, 50 ~M, did not affect vasopressin-stimulated 
water flow. At a high concentration (> 1 mM) lanthanum inhibits 
4SCa efflux as well as influx from several types of cells (Langer 
and Frank, 1972; Lee and Auersperg, 1980). In the experiments 
described in Chapter III, lanthanum (1 roM) was observed to signi-
ficantly inhibit basal 45Ca efflux from isolated toad bladder epithe-
lial cells. Lanthanum, 1 roM, was found to inhibit vasopressin-
stimulated water flow completely, suggesting that blockade of calcium 
efflux may contribute to this inhibitory effect. However, the signif-
icance of this observation must be held suspect. Cuthbert and Wong 
(1974) reported that calcium release in response to vasopressin occurs 
only from the mucosal surface. Since lanthanum does not cross the 
toad bladder plasma membrane (Davis, 1981), its effect in this 
experiment may not have been due to inhibition of calcium efflux, 
unless inhibition of basal calcium efflux via the serosal sodiurn-
calcium exchange (Chase and Al-Awqati, 1981) had increased cyto-
plasmic calcium to a concentration which vasopressin could not dis-
place. The effect of lanthanum in these experiments may have been 
at the level of vasopressin receptor-adenylate cyclase coupling. 
Coupling of these proteins has been reported to be calcium-dependent 
(Bockaert et al., 1972). Of course, some other site may have been 
affected. 
Neither vasopressin nor U46619 enhanced calcium uptake into 
isolated toad bladder epithelial cells. Vasopressin significantly 
reduced the equilibrium amount of 4 S Ca taken up into the cells and 
the rate of influx during the linear portion of uptake (to 10 min). 
The equilibrium calcium uptake was about 0.7 nmol/mg protein less 
than control, similar to the findings of the experiments described 
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in Chapter III. U46619 reduced slightly the rate of 4 S Ca influx 
during the linear portion of influx (to 30 min). However equilibrium 
4SCa uptake was identical in control cells and in cells incubated in 
U46619. Thus, when the present observations are combined with those 
in Chapter III, it appears that vasopressin has no effect on calcium 
influx into the cells; however, an enhancement in the rate of efflux 
results in a net reduction in the amount of calcium in one cellular 
compartment (S3). U46619, on the other hand, reduces influx of 
calcium while not affecting efflux. Thus, total cell calcium is 
little changed. However, the amount of calcium in one cellular com-
partment (S3) is reduced, similar to the effect observed with vaso-
pressin. 
Several agents which are thought to increase cytoplasmic calcium 
concentration inhibit vasopressin-stimulated water flow. PGE
1 
was 
found to enhance 4SCa influx and efflux, resulting in net calcium 
accumulation. The accumulation was into that compartment from which 
vasopressin released calcium. Indomethacin and meclofenamate, at 
concentrations which nearly completely inhibit PGE synthesis, reduced 
the sizes of pools S2 and 53. Thus, PGE may be implicated in main-
taining cellular calcium homeostasis. However, these agents have 
been implicated as cellular calcium antagonists, an action which may 
be independent of prostaglandin synthesis inhibition (Northover, 
1977b). 
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Epinephrine and carbachol both enhanced 4SCa uptake to an extent 
similar to PGE 1 . However, while PGE 1 inhibited vasopressin-stimulated 
water flow completely, epinephrine and carbachol inhibited water 
flow only about 50%. Thus, PGE 1 may have some additional effect. 
However, since dose-response experiments were not performed in these 
studies, differences among the apparent effectiveness of the agents 
must remain in question. The enhanced net cellular accumulation of 
calcium in response to PGE 1 may explain the greater effect of this 
compound, since in other systems carbachol has been shown to enhance 
cytoplasmic free calcium concentration, and thus 4 5 Ca uptake while 
actually reducing the amount of membrane-bound calcium (Shelby et 
a1., 1976). 
Quinidine inhibited vasopressin-stimulated water flow confirming 
the observations of Taylor et al. (1979). However, no enhancement 
in 45Ca uptake was noted in response to this compound. Recently, 
Arruda and Sabatini (1980b) found that quinidine did not enhance 
4 SCa uptake into turtle bladders. However, they found that quinidine 
did enhance 4SCa efflux from prelabelled hemibladders. Thus, quini-
dine may act to inhibit vasopressin-stimulated water flow by enhancing 
the release of calcium from an internal membrane to enhance cytoplasmic 
free calcium. 
Substitution of serosal sodium with choline or sucrose inhibited 
vasopressin-stimulated water flow and enhanced 4SCa uptake. These 
results may be due to the existence of a sodium-calcium exchange on 
the serosal plasma membrane (Chase and Al-Awqati, 1981). Removal of 
serosal potassium also inhibited vasopressin-stimulated water flow 
and enhanced 45Ca uptake. This result may have been due to inhibition 
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of the sodium pump by lack of potassium associated with enhanced 
intracellular sodium which is exchanged for extracellular calcium by 
means of the sodium-calcium exchange. Alternatively, lack of potas-
sium may also have reduced the membrane potential to a more negative 
value, which also would be expected to enhance the activity of the 
sodium-calcium exchanges. However, incubation with ouabain did not 
inhibit vasopressin-stimulated water flow or enhance 4SCa uptake. 
Thus, removal of potassium may have inhibited vasopressin-stimulated 
water flow and enhanced 4SCa uptake by some mechanism other than 
inhibition of the sodium pump. 
Thus, the present studies suggest that vasopressin-stimulated 
water flow is not dependent on extracellular calcium or stimulation 
of calcium influx. However, intracellular calcium does appear to be 
required for vasopressin to elicit its antidiuretic effect. 
CHAPTER V 
GENERAL CONCLUSIONS: A HYPOTHETICAL MODEL FOR THE 
INTERACTIONS AMONG PROSTAGLANDINS, THROMBOXANES, CALCIUM, 
AND CYCLIC NUCLEOTIDES IN THE ANTIDIURETIC RESPONSE TO 
VASOPRESSIN, AND PROPOSED DIRECTIONS FOR FUTURE RESEARCH 
A MODEL TO DESCRIBE THE INTERACTIONS AMONG PROSTAGLANDINS, THROMBOXANES, 
CALCIUM, AND CYCLIC NUCLEOTIDES IN RESPONSE TO VASOPRESSIN 
As a result of the work described 1n this dissertation and a 
review of the literature, a working model has been developed in an 
attempt to describe the possible relationships between vasopressin's 
stimulation of water permeability and alterations in prostaglandin, 
thromboxane, calcium, and cyclic nucleotide metabolism. The model 
is presented in Fig. 39 and the following text is keyed to the figure. 
(1) Vasopressin binds to receptors on the serosal surface of 
the epithelial cells of the toad urinary bladder. Two classes of 
receptors have been identified based on [3H]-oxytocin binding (Bockaert 
et al., 1970). One receptor class is coupled to adenylate cyclase 
as demonstrated by activation of adenylate cyclase activity by vaso-
pressin in broken cell preparations from the toad bladder (Bar et 
al., 1970; Bockaert et al., 1972). That the other class of receptors 
may be physiologically relevant is supported by several observations: 
a) several vasopressin analogs differentially activate water perme-
ability and sodium transport (Bourguet and Morel, 1967); b) a number 
of vasopressin analogs are able to completely activate water perme-
ability at concentrations below which any enhancement may be observed 
in adenylate cyclase activity (Kirchberger et al., 1977); and c) 
vasopressin activates PGE and TXA2 synthesis (Zusman et a1., 1977; 
Burch et al., 1980) while theophylline and cAMP both stimulate water 
1 
SEROSAL I MUCOSAL 
Ca+t 
phosphatidate 
Figure 39. Scheme of postulated events may modify 
vasopressin's hydroosmotic effect in the toad urinary 
bladder. Pictured is an epithelial cell. The serosal 
surface is backed by connective tissue/smooth muscle 
layer. The epithelial cells are 20 urn across maximally, 
while the entire tissue including the supporting layer 
is 100 pm across. The numbers are keyed to the text. 
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flow via an enhancement in cellular cAMP concentration without affec-
ting PGE or TXA2 synthesis (Zusman et al., 1977; Burch et aI, 1980). 
(2) The vasopressin receptor coupled to adenylate cyclase 
induces an enhancement in the metabolism of ATP to cAMP (Handler et 
al., 1965). cAMP is generally thought to act by altering the level 
of phosphorylation of proteins. Greengard and associates have found 
that addition of vasopressin or exogenous cAMP to intact toad bladder 
epithelial cells or broken epithelial cell preparations from the 
toad bladder is associated with a reduction in the level of phosphory-
lation of at least one protein (DeLorenzo et al., 1973; Greengard, 
1976). The identity of this protein remains unknown. However, its 
dephosphorylation appears to correlate more closely with enhanced 
sodium transport than with altered water permeability (Walton et 
al., 1975). The results of the present experiments suggest that 
cAMP may alter calcium kinetics in the epithelial cells of the toad 
bladder. Thus, exogenous cAMP reduced the size of exchangeable 
calcium pool S3' while increasing the size of pool 8
2
. Hormones 
acting through cAMP such as ACTH have been reported to cause an 
intracellular shifting of calcium from one cellular pool to another 
while inhibiting 45Ca efflux (Jaanus and Rubin, 1971). Pool S3 may 
represent mitochondrial calcium. cAMP has been reported to release 
calcium from mitochondria isolated from several sources (Borle, 1974; 
Matlib and O'Brien, 1974). Pool S2 may represent primarily calcium 
bound to endoplasmic reticulum and other cytoplasmic structures. 
cAMP has been reported to enhance calcium uptake into the sarcoplasmic 
reticulum in heart (Tada et al., 1974). Further, fibroblasts, hepato-
cytes, and adipocytes, among other cell types, contain active calcium 
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uptake systems in their endoplasmic reticuli (Moore and Pastan, 1978; 
Becker et al., 1980; Black et al., 1981), and these uptake systems 
have been shown to increase calcium-binding activity in response to 
peptide ho~mones (Andia-Waltenbaugh et a1., 1980; Reinhart and Bygrave, 
198]). Calcium ion potently inhibits vasopressin-sensitive adenylate 
cyclase in the toad bladder (Hynie and Sharp, 1971). Thus, vasopressin 
may induce some conformational change in its receptor such that coup-
ling to adenylate cyclase occurs (Rodbell, 1980) resulting in enhanced 
cAMP synthesis. The initially-formed cAMP may act to lower the con-
centration of cytoplasmic calcium near the adenylate cyclase, perhaps 
by dephosphorylating a membrane protein in the endoplasmic reticulum 
to induce calcium uptake by this organelle. The lowered cytoplasmic 
calcium concentration may further activate the vasopressin-receptor-
adenylate cyclase complex. 
(3) There are two classes of vasopressin receptors present on 
the epithelial cells. Since vasopressin appears to enhance PGE
2 
and 
TXA2 synthesis independent of cAMP (Zusman et al., 1977; Burch et 
al., 1980), the second class of vasopressin receptors may be coupled 
to a phospholipase. The phospholipase may include at least 2 pools 
of enzymes based on the studies which demonstrate that calcium alters 






(4) TXA2 acts in a manner similar to exogenous cAMP. That is, 
it decreases the size of calcium pool S3 and increases the size of 
pool S2" A similar effect of PGI
2 
to cause an intracellular shift 
of calcium from one pool to another has been postulated (Rubin et 
al., 1980). The ultimate effect of TXA2 may well be enhancement of 
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cAMP production (Vesin, 1979), perhaps by lowering the concentration 
of calcium near the vasopressin-sensitive adenylate cyclase. 
(5) Acetylcholine and its active analogs inhibit vasopressin-
stimulated water flow (Wiesmann et al., 1978). Acetylcholine gener-
ally is considered to increase cellular influx of calcium through a 
specific channel (Berridge, 1980). Recent observations of Cuthbert 
and associates (Cuthbert and Wilson, 1981) suggest that acetylcholine's 
actions may involve prostaglandins. Since current hypotheses suggest 
that the calcium channel is opened by activation of a phospholipase 
C to enhance phosphatidylinositol turnover (Berridge, 1980), acetyl-




(6) The toad bladder has an a-adrenergic receptor on the serosal 
surface of the epithelial cells (Handler et al., 1968). Occupation 
of this receptor by a-agonists markedly inhibits vasopressin-stimu-
lated osmotic water flow (Handler et al., 1968; Cuthbert and Wong, 
1972). The water flow response to theophylline was also inhibited 
by a-agonists, while these agents had no effect on cAMP-stimulated 
water flow (Handler et al., 1968). a-Agonists often enhance calcium 
uptake (Berridge, 1980) and, since, theophylline-stimulated water 
flow is inhibited by these agents, basal adenylate cyclase activity 
must be inhibited. Calcium and PGE are the 2 endogenous agents most 
often associated with this effect in the toad bladder. a-Agonists 
have been shown to enhance prostaglandin synthesis in the MOCK line 
of cultured kidney epithelial cells (Levine and Moskowitz, 1979). 
Further, clonidine, an a
2 
agonist, has been shown to antagonize the 




synthesis (Ercan et al. 1979). Recently 
(Cuthbert and Wilson, 1981) cyclooxygenase inhibitors have been shown 
to abolish the effects of a-adrenergic agonists on sodium transport 
across isolated frog skin. 
(7) Exogenous PGE
2 
inhibits vasopressin-stimulated water flow 
(Orloff et al., 1965). Its action has been suggested to include 
inhibition of the vasopressin-sensitive adenylate cyclase (Lipson 
and Sharp, 1971). Indeed, exogenous PGE
1 
has been reported to inhibit 
the cellular accumulation of cAMP in response to vasopessin (Omachi 
et al., 1974). However, PGE
1 
did not inhibit vasopressin-stimulated 
adenylate cyclase activity in broken cell preparations from toad 
bladder (Bar et al., 1970). Thus, its action appears to be indirect. 
The present studies demonstrate that exogenous PGE increases the 
calcium permeability of the epithelial cell plasma membranes, resul-
ting in net calcium accumulation. Since calcium inhibits vasopressin-
sensitive adenylate cyclase activity (Hynie and Sharp, 1971) PGE may 
inhibit adenylate cyclase activity by increasing the calcium concen-
tration near the vasopressin-sensitive adenylate cyclase. This hypoth-
esis has been presented as a general mechanism for PGE inhibition of 
cAMP accumulation by Silver and Smith (1975). 
(8) Vasopressin induces a net release of calcium from the epithe-
lial cells, apparently from the mucosal side (Cuthbert and Wong, 
1974). However, neither exogenous cAMP nor U46619 do so, suggesting 
that the calcium release occurs by some mechanism other than accumu-
lation of cAMP. Some messenger molecule must mediate the calcium 
release since release occurs from the mucosal side while vasopressin 
binds to the serosal side. Phosphatidate is here invoked as the 
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messenger. There is no experimental evidence for phosphatidate medi-
ation of the calcium release, however, phosphatidate is a potent and 
effective calcium ionophore (Tyson et al., 1976; Serhan et al., 1981), 
and a vasopressin receptor appears to be coupled to a phospholipase 
in the toad bladder. Further, vasopressin causes a shift of [3H]-
arachidonate from one phospholipid pool to another in the toad bladder 
(Halushka, et al., unpublished observations). In platelets, a similar 
shift is observed in response to some agonists, and an intermediate 
of the shift appears to be phosphatidate (Lapetina et al., 1980). 
The calcium release may occur from mitochondria or from the mucosal 
plasma membrane. 
Plasma membrane release is favored by the observation that EDTA 
displaces 4SCa from the same slowly exchanging pool as does vaso-
pressin (Cuthbert and Wong, 1974). Further, the presence of lanth-
anum in the mucosal bathing solution did not inhibit vasopressin-
stimulated water flow (Weitzerbin et al., 1974). However, if lanth-
anum was present in the mucosal bathing solution while vasopressin 
was present, and remained while vasopressin was washed out, inhibi-
tion of water flow to a second challenge with vasopressin occurred. 
Thus, lanthanum may have been able to bind to calcium sites from 
which vasopressin had displaced calcium which usually was only slowly 
exchanged. 
Calcium release from mitochondria is favored by the following 
data. Incubation of toad baldders with mitochondrial inhibitors did 
not inhibit the induction of vasopressin-stimulated water flow (Masters 
and Fanestil, 1979). However, the Hoff-time," that is, the time 
taken for water flow to return to basal level after washing out 
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vasopressin, was significantly lengthened in the presence of mitochon-
drial inhibitors (Masters and Fanestil, 1979). Mitochondrial inhibi-
tors decreased the size of calcium pool S3 (the pool from which 
vasopressin released calcium), suggesting that the lengthened "off-
time" in the presence of the mitochondrial inhibitors may have been 
due to impaired ability of the mitochondria to take up calcium. 
Amiloride inhibited the release of calcium from intact hemi-
bladders in response to vasopressin (Cuthbert and Wong, 1974). 
Further, in toad bladder epithelial cells, amiloride appeared to 
have marked effects on mitochondrial structure (D. Baron, unpublished 
observations). No data exist which demonstrate whether amiloride 
blocks the vasopressin-induced calcium release directly, or depletes 
this pool of calcium prior to the addition of vasopressin. It would 
be interesting to determine the effect of amiloride on the off-time 
of the vasopressin response. Since EDTA depleted only about half of 
pool S3 and mitochondrial inhibitors depleted only about half, pool 
8
3 
may represent 2 calcium pools with similar rate constants of efflux, 
one mitochondrial and the other slowly-exchanging plasma membrane-
bound calcium. Thus, both sites may have been affected by vasopessin. 
(9) Incubation of intact hemibladders on the serosal surface 
with a nonspecific phospholipase C inhibited vasopressin-stimulated 
water flow and calcium release (Cuthbert et al., 1971; Cuthbert and 
Wong, 1973). However, phospholipase C did not block intracellular 
accumulation of cAMP in response to vasopressin (Cuthbert et al., 
1971). Thus, phospholipase C affected the vasopressin-induced alter-
ation in water permeability of the mucosal membrane by an action on 
the serosal membrane. The step affected was not the vasopressin 
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receptor-adenylate cyclase coupling. It is suggested that phospholi-
pase C acted to destroy coupling of the second vasopressin receptor 
to its specific phospholipase. It may be argued that the incubation 
with phospholipase C would have caused formation of phosphatidate, 
which, according to the model, should have enhanced calcium release 
and perhaps water flow. However, hormone-sensitive phospholipases C 
which have been described are found free in the cytosol and probably 
catalyze formation of phosphatidate from intracellular membranes 
(Billah et al., 1980; DiRenzo et a1., 1981). The exogenously applied 
phospholipase C would only have cleared phosphatidate from the external 
face of the serosal plasma membrane. 
The model which has been presented provides a hypothesis which 
may be subjected to experimental testing. Several components are 
supported by only little data or indirect data, however, the model 
does account for many phenomena which have been described. It is 
the first attempt since that of Berridge (1975) to bring together 
all of the disparate data which have been collected concerning possi-
ble interactions among cyclic nucleotides, calcium, and now, arachi-
donate metabolites in controlling vasopressin-stimulated water flow. 
A great shortcoming of the model is that it does not explain how the 
interactions of these myriad ftsecond messengers" bring about enhanced 
water permeability. No arrows may be drawn to the water entry step 
at the mucosal membrane. In this regard, after 23 years of intense 
study of the "mechanism" of vasopressints effect on the water perme-
ability of the toad bladder, only a "black box" can be depicted .. 
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DIRECTIONS FOR FUTURE RESEARCH 
The basic molecular mechanism by which vasopressin elicits an 
enhancement of water permeability across several epithelia remains a 
mystery. The data presented in this dissertation suggest that TXA2 
and intracellular calcium may play roles. A role for calcium has 
been suggested often in the past but definitive experiments have yet 
to be performed. TXA2 is a new putative mediator. 
The studies presented here demonstrate that the toad bladder 
synthesizes TXA2 in response to vasopressin. This observation has 
recently been extended to isolated mammalian collecting tubules 
(Kirschenbaum et al., 1981). This dissertation suggests that TXA2 
may be a positive modulator of vasopressin-stimulated water flow 
based on experiments using TXA2 synthesis inhibitors, TXA2 antago-
nists, and TXA2 mimetics. Unfortunately, none of the experiments 
were conclusive. The TXA2 synthesis inhibitors, imidazole and an 
imidazole analog, 7IHA, may well have inhibited vasopressin-stimulated 
water flow by an interaction with calcium (Yu et al., 1967). 
The TXA2 antagonist, t13APA appeared to destroy isolated toad 
bladder cells by means of some detergent effect at concentrations 
found to inhibit vasopressin-stimulated water flow. Thus, inhibition 
of vasopressin-stimulated water flow may have occurred in response 
to nonspecific interactions of t13APA with the hemibladders. This 
possibility is weakened by the observation that c13APA, which also 
destroyed the isolated cells, did not affect vasopressin-stimulated 
water flow across the intact hemibladders. 
The TXA2 mimetics U46619, U44069, and TXB
2 
mimicked vasopressints 
hydroosmotic effect. However, U46619 and U44069 are actually endo-
peroxide analogs. Thus, a locus for their effects is uncertain. 
Further, the duration of action of these compounds was quite short 
compared to vasopressin. That the compounds were acting as TXA2 
mimetics is suggested by the observation that t13APA but not c13APA 
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antagonized the water permeability response to these compounds. 
U46619 mimicked the effect of cAMP on 45 Ca kinetics in the isolated 
cells. In another system U46619 appears to act by enhancing cellular 
accumulation of cAMP. Thus, these compounds may have acted to enhance 
water permeability by enhancing cAMP accumulation. 
The shortcomings of the studies described above suggest several 
areas in need of further investigation. 1) More specific TXA2 synthe-
sis inhibitors are needed to determine whether TXA2 synthesis inhibi-
tion is associated with inhibition of vasopressin-stimulated water 
flow, 2) more specific TXA2 antagonists are needed to determine the 
role of TXA2 , 3) studies should be performed to determine whether 
U46619, U44069, and TXB2 enhance water flow by enhancing cAMP accumu-
lation. If this is found to be the case then further experiments 
with these compounds need to be performed to determine how they are 
able to enhance cAMP accumulation. 
Perhaps the most important area for research concerning the 
role of TXA2 is the determination of whether the mammalian kidney 
synthesizes TXA2 in response to vasopressin and whether TXA2 may 
playa role in modulating vasopressin-stimulated water flow. If the 
toad bladder is studied as an alternative model for the mammalian 
kidney, then, until evidence that TXA2 plays a role in free water 
clearance in the kidney has been obtained, it seems unwarranted to 
pursue the mechanism of action of TXA2 in the toad bladder. 
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